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Aim of the thesis 
 
Integrin and growth factor receptor (GFR) signalling crosstalk controls critical biological 
processes such as cell proliferation, differentiation, migration, spreading and immune 
response. The crosstalk occurs through a pool of signalling molecules that link integrin and 
growth factor signalling pathways. The molecular players of the integrin-GFR signalling 
crosstalk and the way they function at the mechanistic level have been remained largely 
uncharacterized. The overall goals of this thesis were: 
 
I. Identification of novel molecule(s) that intersect integrin and GFR signalling pathways. 
II. Analysis of the molecular mechanisms by which the identified intersector(s) mediate 
integrin and GFR signalling crosstalk. 
 
To identify molecular players that link integrin-GFR signalling pathways, we established a 
screening strategy that combined SILAC-based quantitative proteomics followed by 
siRNA-mediated depletion of candidate proteins. The readout of our screening assay was 
circular dorsal ruffles, which are transient actin-based structures induced through integrin-
GFR co-signalling. Subsequently, we used different biochemical approaches to investigate 
the mechanistic role of the novel proteins. 
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IV 
Summary 
 
Integrin and growth factor receptor (GFR) signalling can converge to conduct a vast range 
of biological processes. The integrin-GFR crosstalk is achieved through activation of 
numerous signalling molecules that can operate ubiquitously or in a cell type- and/or 
developmental stage-specific manner. The molecular details underlying the integration of 
both signalling networks remain largely uncharacterized. We identified a signalling axis 
consisting of a fibronectin/α5β1 integrin/ILK complex that, in concert with epidermal 
growth factor receptor (EGFR) cues, controls the formation of transient actin-rich circular 
dorsal ruffles (DRs) in fibroblasts. Using DRs as readout and a SILAC-based 
phosphoproteomics screen, we identified two novel intersectors of integrin/EGFR 
signalling crosstalk; one is Cyld and the other we termed Babak-2 (Plekhh2). 
We showed that EGFR triggers Cyld tyrosine phosphorylation which requires integrin/ILK 
and c-Src, and that the Cyld phoshorylation is a prerequisite for DR formation (publication 
I). We also identfied Babak-1 and -2 (Plekhhs) a novel family of focal adhesion (FA) 
molecules that localize to integrin adhesion sites and punctate structures in the cytoplasm of 
fibroblasts and Hela cells. We show that the recruitment of Babaks to FAs is dependent on 
their interaction with paxillin. The paxillin binding sequence (PBS) in Babak-1 and -2 is 
present in the N-terminal half of the protein. Analysis of expression pattern of Babak-2 and 
Babak-1 in vivo revealed that both genes are widely expressed in different tissues. Babak-2-
deficeint mice are fertile and did not show any phenotype, suggesting redundancy of 
Babak-2 function by Babak-1 (publication II). This study provides evidence that Cyld and 
Babak-2 link integrin/ILK and EGFR signalling pathways to induce rapid F-actin 
reorganisations. 
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Publications 
 
This thesis is based on the following publications, which are referred to in the text by their 
Roman numerals (I-III): 
 
I. Azimifar S. Babak, Böttcher RT, Zanivan S, Grashoff C, Krugel M, Legate K, Mann M 
and Fässler R. The induction of membrane circular dorsal ruffles requires 
integrin/ILK and EGF receptor co-signalling. Journal of Cell Science. (in press) 2011. 
II. Moritz Widmaier, Emanuel Rognoni, Korana Radovana, S. Babak Azimifar, and 
Reinhard Fässler. Integrin-linked kinase at a glance. Journal of Cell Science (in press) 
2011. 
III. Azimifar S. Babak, Manndoph Wang and Fässler R. Babak-1 and Babak-2 are novel 
focal adhesion proteins that bind paxillin and regulate the assembly of membrane 
circular dorsal ruffles. (Manuscript in progress). 
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Abbreviations 
 
Abl  Abelson leukemia protein tyrosine kinase 
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ADP  adenosine diphosphate 
Akt   RAC-alpha serine/threonine protein kinase 
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HGF   hepatocyte growth factor 
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Introduction 
 
 
1. Integrins 
 
1.1. Integrin family of cell surface receptors 
 
The evolution of multicellularity from their unicellular ancestors crucially relied on the 
appearance of novel proteins that can orchestrate and maintain integrity of tissues and 
organs. Special classes of these proteins mediate cell-cell and cell-extracellular matrix 
(ECM) adhesions. Integrins are the major family for cell-ECM adhesion. They are 
heterodimeric transmembrane cell surface receptors that represent ’’integrators’’ as they 
integrate extracellular (ECM) with intracellular (F-actin cytoskeleton) polymers at focal 
adhesions (FAs), hemidesmosomes and cell-cell adhesion sites. They consist of α and β 
subunits both of which are transmembrane type I proteins (see section 1.2). They are  
ubiquitously expressed by almost all cell types of higher organisms (Barczyk et al., 2010; 
Hynes, 2002; van der Flier and Sonnenberg, 2001). 
Before integrins became functional and diversified in higher biological systems, their 
structures evolved from earlier organisms. Sequence-based searches revealed that a 
cyanobacterium (Trichodesmium erythraeum) is expressing a protein with partial homology 
with the β integrin ectodomain (Johnson et al., 2009). A clear α/β integrin heterodimer is 
present in a Metazoan, the sponge Geodia cydonium, which is more than 600 million years 
distant from mammals (Brower et al., 1997). A recent study showed that ‘primitive’ 
integrins able of mediating cell-ECM adhesions emerged much earlier than Metazoans, in a 
filose amoeboid (C. owczarzaki) which expresses 4 α and 4 β integrin subunits (Sebe-
Pedros et al., 2010).  In the nematode Caenorhabditis elegans, two integrin heterodimers 
are assembled through combination of  two α integrins (Ina-1 and Pat-2) and one β integrin 
(Pat-3) (Gettner et al., 1995; Johnson et al., 2009). Fruit flies (Drosophila melanogaster) 
have five integrins made of five α subunits (αPS1 to 5) and one β subunit (βPS) (Brabant 
and Brower, 1993; Roote and Zusman, 1995; Zaidel-Bar, 2009). 
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Vertebrate integrin subunits diversified significantly. The expansion of the integrin family 
was essential to coordinate cell behaviours in response to heterogeneity and complexity of 
the tissue environment at different stages of the life cycle. In Zebra fish (Danio rerio) 
possess all mammalian α and β subunits except αL integrin, which is a leukocytes specific 
receptor (NCBI-Gene-search, 2011; Takada et al., 2007). Mammalians have 18 α and 8 β 
subunits (Fig. 1) which assemble 24 different heterodimeric receptors (Hughes, 2001; 
Johnson and Tuckwell, 2003; Zaidel-Bar, 2009). 
 
 
 
Figure 1. Mammalian family of integrin heterodimers. Integrin subunits can be divided based on their 
structure, ligand specificity and expression pattern. α subunits with αI/A domain insertion (red), α4, α9 
(green) and β2-β8 subunits are restricted to chordates. Homologues of β1 and α subunits of Laminin- (purple) 
or RGD- (blue) receptors are found throughout Metazoans. Modified from (Barczyk et al., 2010). 
 
Integrins provide many advantages which pushed their molecular evolution forward. 
Consequently, integrins bind a wide variety of ligands (Fig. 2). They establish cell-ECM 
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adhesions (see section 3) through binding to ECM extracellularly and to actin in the 
cytoplasm (Hynes, 2002). Integrins mediate cell-cell adhesions by binding to counter 
receptors that are present on the cell surface of other cells such as ICAM (Bella et al., 1998; 
Diamond et al., 1991; Staunton et al., 1990), VCAM (Klemke et al., 2007), MadCAM-1 
(Gorfu et al., 2009; Wagner et al., 1996), PECAM-1 (Piali et al., 1995), ADAM (Bridges et 
al., 2005; McGinn et al., 2011), E-cadherin (Taraszka et al., 2000) and bacterial or viral 
surface antigens (Flaherty et al., 1997; Ruiz-Saenz et al., 2009). 
Integrins transduce signals bidirectionally across the plasma membrane (Hynes, 2002; 
Legate et al., 2009). Moreover, their signals are integrated with other cell surface receptors 
cues such as growth factor receptors (GFRs; see section 4), calcium-dependent adhesions 
(Cadherins) and Syndecans. This signalling integration regulates a broad range of 
biological events including actin cytoskeletal rearrangement, cell adhesion, spreading, 
polarity, migration, survival, proliferation, differentiation, immune response and 
morphogenesis (Barczyk et al., 2010; Huveneers and Danen, 2009; Hynes, 2002). 
 
1.2. Integrin structure 
 
Integrins are type I transmembrane (TM) heterodimers that consist of non-covalently 
associated α and β glycoprotein subunits. Each subunit consists of three regions: a large 
extracellular domain (also called ectodomain composed of ~ 800 amino acids (aa)), a TM 
helix (~20 aa) and a short cytoplasmic tail (13 to 70 aa; except the β4 tail with 1018 aa). 
Some integrin genes come in different splice variants that further increase the diversity of 
integrins. The largest part of integrins is their ectodomain with approximately 700 (β 
subunits) to 1000 (α subunits) aa. Integrin ectodomains form a globular head containing the 
ligand-binding pocket and an elongated flexible stalk that undergoes huge conformational 
changes during integrin activation. 
The globular head of α subunits is composed of seven β-propeller motifs followed by three 
β sandwich domains (tight, Calf -1 and Calf-2) of stalk region (fig. 3). An additional αA/αI 
domain insertion present in the head regions of 9 out of 18 different α subunits is composed 
of a Rossman fold with 7 α helices around 5 β-sheets. 
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Figure 2. Integrin ligands. Adopted from (Humphries et al., 2006). 
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The β subunit head consists of a Plexin-Sempahorin-Integrin (PSI) domain, a βI domain 
which is embedded in a Hybrid domain and four integrin-cysteine-rich epidermal growth 
factor (I-EGF) repeats in the integrin stalk. Several metal-ion-dependent adhesion sites 
(MIDAS) are found in the integrins ectodomain that affect ligand-binging affinity (Fig. 3). 
αI domains contain Mg++ binding MIDAS, while βI domain have Mg++ coordinating 
MIDAS and an adjacent to MIDAS (AMIDAS) motif, which promotes activation or 
inhibition of integrins by binding to Mn++ or Ca++, respectively. 
 
 
Figure 3. The structure of integrin heterodimers. (A) Structural motifs of α and β subunits. The position of 
Mg++ MIDAS (red stars), Ca++ MIDAS (black stars) and Mn++/Ca++ AMIDAS (blue star) are indicated. 
(B) Schematic view of integrin heterodimer. αI/αA motif are only present in α subunits of collagen-binding 
and leukocyte-specific integrins.  
 
One of the recent evolutional diversification of α integrins was the appearance of the αI 
ectodomain in α subunits. Out of 9 mammalian αI domain-containing α subunits, four α 
subunits bind fibrillar collagen while the remaining α subunits dimerize with β2 or β7 
subunits to form the leukocyte integrins of immune system (Fig. 4A) (Hughes, 2001; 
Johnson et al., 2009; Sebe-Pedros et al., 2010). The late emergence of αI ectodomain in α 
integrins might represent an adaptation to novel cell-ECM interactions which was 
necessary during the evolution of cartilage, bone and immune system. β integrin subunits 
can be divided into three major phylogenetic groups: two vertebrate β1 and β3 integrin 
families and one invertebrate β integrin family (Fig. 4B). An exception is β4 integrin that 
stays as an outlier in the vertebrate cluster and shows no homology with any other β 
integrin subunits present in the phylogeny with its long cytoplasmic tail (about 1018 aa). 
Introduction 
 
 
 
6 
 
 
Figure 4. Generalized evolutionary tree for the family of human integrins. (A) human 
α subunits divided into two big groups based on existence of αI motif that emerged very 
early in vertebrates. (B) β subunits showed no obvious homology to invertebrates β 
integrins and can be classified into A and B groups. An expectation is β4 subunit that 
contains a long cytoplasmic tail and clusters as an outlier of group B. Adopted from 
(Johnson et al., 2009). 
 
The TM region of integrin subunits consists of right handed coil-coil α helices that prolong 
to a membrane proximal motif to the cytoplasmic tail (Wegener and Campbell, 2008). The 
structure of the TM region is not well defined due to the lack of a high resolution structure. 
Among all integrins, the TM region of αIIbβ3 integrin has been studied most extensively 
(Fig. 5A). The TM of β3 integrin has 30 residues and is supposed to be tilted within the 
plasma membrane. The sequences of the TM regions are well conserved among integrins, 
suggesting that the packing interactions between consensus reciprocal groups on 
neighboring α and β helices are essential for integrin heterodimer formation. NMR analysis 
of TM domains of αIIbβ3 integrins proposed that the association of αIIb and β3 subunits in 
the TM regions is mediated by the interaction of conserved Glycine residues (αIIb G972, 
αIIb G976 and β3 G708) forming the so called outer membrane clasp (Fig. 5B and D) as 
well as a hydrophobic interaction of αIIb F992-F993 residues and the electrostatic bridge 
between αIIb R995-β3 D723 residues (Fig. 5C-D) forming the inner membrane clasp 
(Berger et al., 2009; Lau et al., 2009; Ulmer, 2010; Yang et al., 2009). 
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Figure 5. Intersubunit interactions of cytoplasmic tails and TM regions of integrin heterodimers. (A) 
Sequence alignment of TM and cytoplasmic tails of αIIbβ3. The αIIbβ3 integrin is the main integrin of 
platelets. A salt bridge forms between R and D residues in membrane proximal regions of αIIb and β3 
subunits. Modified from (Wegener and Campbell, 2008). Inter-subunit interactions of the TM segment of 
αIIbβ3 integrin in the (B) outer- or (C) inner- plasma membrane leaflet. The structures were predicted by 
NMR for the resting conformation of αIIbβ3 integrins embedded in a bicellar lipid environment. (D) 
Sequence alignment of human α and β integrin subunits reveals a high homology between the TM regions of 
different integrins. Adopted from (Lau et al., 2009). 
 
It has been suggested that the membrane proximal regions of inactive integrins mediate an 
inter-subunit salt bridge between D and E residues of the HDRKE motif of the β subunit 
and the R residue of the GFFKR sequence in the α subunit. During integrin activation, this 
salt bridge and the Van der Waal-like inter-subunit interactions between TM regions are 
disrupted (Luo et al., 2004; Vinogradova et al., 2002). The salt bridge is considered to be 
important for restraining the inactive integrin conformation which is essential for 
leukocytes and platelets. Although, there are reports indicating that the salt bridge plays a 
role during integrin clustering (Cluzel et al., 2005), integrin activation (Hughes et al., 
Introduction 
 
 
 
8 
1996), cell adhesion and migration (Imai et al., 2008; Sakai et al., 2001), the disruption of 
salt bridge in β1 (D759A) integrin resulted in no obvious phenotype in mice (Czuchra et al., 
2006). Perhaps, other inter-subunit interactions in TM regions (Berger et al., 2009; Luo et 
al., 2004) or binding of uncharacterized proteins to integrins cytoplasmic tail have a much 
more prominent effect on restraining integrins in their inactive conformation.  
 
 
 
Figure 6. Sequence alignment of leuko-integrin cytoplasmic tails. Cytoplasmic tails of β subunits contain a 
MP and a MD consensus NXXY motif (highlighted blue) that mediates integrin signalling. The formation of a 
salt bridge occurs through the interaction of D and E residues in the β subunit HDRKE sequence with an R 
residue in the α subunit GFFKR sequence (highlighted yellow). 
 
The intracellular domain of integrins is very short (>70 aa; except β4 subunit) and lacks 
enzymatic activity. The cytoplasmic tail of integrins has been the focus of many studies as 
it transduces bidirectional signaling, i.e. first, inside-out signaling leading to 
conformational changes and second, ligand binding and outside-in signalling (Hynes, 2002; 
Moser et al., 2009; Shattil et al., 2010). Despite the high divergence of cytoplasmic tails of 
α subunits they only show homology in the membrane proximal GFFKR sequence. The 
intracellular tails of β subunits have 3 motifs in common; HDR (R/K)E, membrane 
proximal NPXY and membrane distal NXXY (Fig. 6). The NPXY and NXXY motifs 
mediate interactions that are essential for Clathrin-mediated internalization of integrins (see 
section 1.3; (Pellinen et al., 2008)) as well as integrin signalling (see section 2.1 and 2.2). 
The conformational changes in the TM and the cytosolic tails of integrins are key points in 
understanding the molecular mechanism of integrin activation. Our knowledge about 
integrin structure is limited to αIIbβ3 integrin and it is not clear to what extend other 
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integrin heterodimers follow the same structure-function mechanism. In addition, the 
models that have been proposed so far are controversial due to lack of high resolution 
structure for different affinity states of native integrins in complex with the plasma 
membrane. The development of new crystallization methods for integrin-macromolecule 
complexes and novel high resolution microscopy techniques will provide answers to some 
of these questions in future. 
 
1.3. Integrin expression, maturation and trafficking 
 
Mammalians integrins have 26 different integrin genes. In human, the loci of some 
integrins cluster near each other in the same chromosomal arm (e.g. α1 and α2 at 5q11.2; 
αL, αM, αD and αX at 16p11.2), suggesting that integrins evolved from an ancestral gene 
by gene duplication followed by molecular evolution (Table 1). Almost all cells in man 
express integrins with a specific integrin expression profile which varies depending on cell 
type and the stage of development. The most common integrin subunit is β1 that forms 12 
different integrin heterodimers and is highly expressesed in most cells including embryonic 
stem cells. 
Integrin mRNAs are transferred to rough endoplasmic reticulum (ER), where they are 
expressed and released into the lumen of the ER. The splice variants of integrins expand the 
diversity of integrin functions in different tissues during development (van der Flier and 
Sonnenberg, 2001). Most of the integrins form one isoform (Table 1). The ubiquitously 
expressed β1 subunit has 5 different isoforms (NCBI database), most likely due to its 
divergent role with α subunits in different cell types. For example, the β1A isoform is 
present in all tissues, while it is replaced by β1D isoform during the differentiation of 
cardiac and skeletal muscles (van der Flier et al., 1997; van der Flier and Sonnenberg, 
2001). Notably, subunits of the α6β4 integrin are forming the highest number of isoforms, 
suggesting that simplicity at gene level is compensated by diversity at transcriptional and 
translational levels. 
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Table 1. Characteristics of human integrin α and β subunits. Clusters of integrin loci are indicated by 
same colors. Data retrieved from NCBI database (http://www.ncbi.nlm.nih.gov). 
 
Chaperon proteins, such as Calnexin, mediate the correct folding and dimerization of 
nascent integrin subunits in the ER (Isaji et al., 2006; Mitchell et al., 2006). The exact 
mechanism of dimerization in the ER is not well understood. However, it is clear that only 
properly folded integrins are heterodimerized, transferred to the Golgi and routed to the cell 
surface. Integrin subunits undergo N-glycosylation that initiates before heterodimerization 
in the ER and is followed by further glycosylation and Sialylation in the Golgi (Janik et al., 
2010). The N-glycosylation and Sialylation of integrins is essential for integrin 
dimerization, maturation and their ligand binding affinity (Isaji et al., 2006; Janik et al., 
2010). The mature integrin heterodimers are transported from the Golgi apparatus to the 
plasma membrane where they engage in different adhesion and signalling complexes (Fig. 
7). The mature integrins, which reach the cell surface, can be internalized and recycled to 
the plasma membrane by complex highly dynamic endosomal pathways (Caswell et al., 
2009; Wickstrom and Fassler, 2011). 
Interestingly, integrins themselves can affect endosomal trafficking of other receptors both 
positively and negatively (Caswell et al., 2009; Collinet et al., 2010; Pelkmans et al., 2005). 
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Figure 7. Integrin trafficking. Integrins are internalized (blue arrows) via at least four different endocytotic 
routes. Internalized integrins join a complex endosomal trafficking network, before recycle to the cell surface 
or guided to a proteasomal/lysosomal degradation route. Nascent integrins are expressed and heterodimerize 
in the endoplasmic reticulum (ER), undergo further maturation in Goli apparatus and traffic to the cell surface 
via endosomal trafficking network. Internalized integrin recycle back to the cell surface (green arrows) via 
short Rab4-mediated- (t1/2~3min) or long Rab11-mediated- (t1/2>10min) trafficking routes. (*) indicates that 
internalized integrin was reported in an active conformation. (♣) Integrin signals control trafficking of GFRs, 
for example both αvβ3 and VEGFR2 traffic to the cell surface by Rab4. Blocking of αvβ3 integrin suppresses 
VEGFR2 degradation and promotes VEGFR2 recycling to the cell surface and tumor angiogenesis. Moreover, 
(♠) integrins share trafficking routes with GFRs, for example α5β1 and EGFR colocalize in Rab11-positive 
endosomes before trafficking to the cell surface. The colocalization of integrin and GFRs in trafficking 
endosomes might facilitate integrin-GFR complex formation and cosignalling in endosomes. Abbreviations 
are GFRs: growth factor receptors; VEGFR2: vascular endothelial growth factor receptor; GPCR: G protein 
coupled receptor and ARF6: ADP-ribosylation factor 6. Data retrieved from (Caswell and Norman, 2006; 
Caswell et al., 2009). 
 
The internalization of integrin heterodimers can be classified into 4 endocytotic routes (Fig. 
7). 1) Clathrin-dependent integrin internalization mediated by adaptor proteins such as AP2 
that interact with NXXY motif in the cytoplasmic tail of β integrin subunits or through 
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integrin-associated proteins such as DAB2 and Numb (Caswell et al., 2009). 2) Caveolin-
dependent pathway shown to be responsible for endocytosis of αvβ3, αLβ2 and α5β1 
integrins that, in the case of α5β1, is mediated by direct interaction of protein kinase Cα 
(PKCα) with cytoplasmic tail of β1 subunit (Caswell et al., 2009; Ng et al., 1999; Shi and 
Sottile, 2008). 3) The Rab21 route, a Clathrin-independent pathway, starts by direct binding 
of Rab21 to cytoplasmic tails of α subunits (Pellinen et al., 2006; Pellinen et al., 2008). 4) 
there are a few uncharacterized integrin internalization mechanisms that are mediated 
through proteins such as JAM-A or BRAG2 (Cera et al., 2009; Dunphy et al., 2006). 
Like integrin internalization, integrin recycling to the plasma membrane is mediated 
through distinctive routes that require Rab family guanine triphosphate hydrolases 
(GTPases) such as Rab4 (Roberts et al., 2001; Vukmirica et al., 2006; Woods et al., 2004), 
Rab5 (Torres and Stupack, 2011), Rab11 (Eva et al., 2010; Skalski and Coppolino, 2005), 
Rab21 (Pellinen et al., 2006; Pellinen et al., 2008) and Rab25 (Caswell et al., 2007). For 
example, αvβ3 integrin is transported from early endosomes to the plasma membrane 
through Rab4-dependent pathway in platelet-derived growth factor (PDGF)-triggered cells 
(Fig. 7), while the exocytosis of αvβ3 integrin in non-stimulated cells and of α5β1 integrin 
are carried out by Rab11 and Arf6 from a prinuclear recycling compartment to the leading 
edge of the cell (Roberts et al., 2001). 
Integrin trafficking exerts crucial effects on different biological functions that are regulated 
by integrins including cell division, adhesion, migration and tumorigenesis. However, the 
precise molecular mechanism of integrin recycling remains unknown. Like GFRs, some 
internalized integrins adopt an active conformation in endosomes and potentially could 
mediate signalling. Moreover, as the formation of integrin-GFR complexes at the plasma 
membrane is one of the mechanisms of underlying integrin-GFR cosignalling (see section 
4.1), the colocalization of integrins with growth factors in trafficking vesicles might further 
facilitate signalling events (Caswell et al., 2008). The power of the proteomics technology 
in combination with advanced microscopy techniques and photoactivatable molecules will 
further improve our understanding of novel molecular players, dynamic and signalling 
outputs of trafficking integrins. 
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2. Integrin signalling 
 
In all organisms the cell fate is determined by a labyrinthic signalling network which is 
programmed by inherited machines that are activated in response to environmental 
challenges. Consequently, sensing various extracellular stimuli is crucial for cells to 
properly coordinate their signalling homeostasis. Cells achieve such coordination through 
ultrasensitive cell surface receptors that transduce signals across the plasma membrane 
barrier. In higher organisms, a large variety of cell surface receptors emanate signals upon 
interaction with extracellular molecules in order to induce and orchestrate cellular actions 
in tissues at different developmental stages. Among them, integrins play a decisive role in 
tuning cell signalling network in several ways:  
Firstly, integrins can trigger signals bidirectionaly across the plasma membrane (Hynes, 
2002). Secondly, integrins are the core components of cell adhesions, the highly dynamic 
signalling platforms where other signalling molecules are recruited, interact with each other 
and trigger additional cues (Zaidel-Bar and Geiger, 2010; Zaidel-Bar et al., 2007). Thirdly, 
integrins interaction with ECM molecules facilitates receptor-ligand binding (e.g. 
transforming growth factor β (TGFβ) receptor) and signalling of other cell surface receptors 
(Margadant and Sonnenberg, 2010; Wipff and Hinz, 2008). Fourthly, integrins regulate 
endosomal trafficking which could potentially affect signalling of all endosomal trafficking 
components including GFRs (Caswell et al., 2009; Wickstrom and Fassler, 2011). Finally, 
integrins signals crosstalk with signals of other cell surface receptors (e.g. GFRs and 
Syndecans) to control various biological events in different cell types (Cabodi et al., 2004; 
Huveneers and Danen, 2009). 
Classically, integrin signal transduction has been classified into two classes based on the 
direction and position of cues that they transduce across the plasma membrane. 1) Integrin 
inside-out signalling refers to the intracellular signalling events that modulate the integrin 
binding affinity to extracellular ligands. 2) Integrin outside-in signalling assigns the 
signalling process that starts extracellularly by binding of integrins to ligands which, in 
turn, trigger various integrin signalling pathways inside the cell (Fig. 8). Based on recent 
studies, a third class of integrin signals might be considered as 3) intracellular integrin 
signalling events that occurs by trafficking integrins, far away from the plasma membrane. 
It has been shown that NPXY motif of integrin cytoplasmic tails signals intracellularly 
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during trafficking of endosomal integrin to the cell surface (Caswell et al., 2009; Collinet et 
al., 2010). In addition, internalized endosomal integrins, could still maintain in their active 
conformation and therefore, like active internalized GFRs, could potentially elicit signals 
(Caswell et al., 2009; Wickstrom and Fassler, 2011). 
 
 
Figure 8. Integrin signalling. Integrin cues can be divided into (A) inside-out and (B) outside-in signalling 
pathways. Based on recent studies, an emerging class of integrin signals can be considered eliciting from (C) 
intracellularly active integrins that localized to endosomes. 
 
In this section, classical integrin inside-out- and outside-in- signalling pathways and 
emerging concepts of integrin mechanotransduction will be discussed. 
 
2.1. Integrin inside-out signalling 
 
It is essential for physiological function of different cell types to tightly regulate integrin 
activation process, particularly for leukocytes and platelets that circulate in different tissues 
and therefore, should keep their integrins in a low affinity and inactive conformation. The 
main integrin of platelets is αIIbβ3 (Fig. 5), which has long been known for its role in 
platelet spreading on ECM and blood coagulation. A broad range of different agonists, 
including thrombin, collagen, adenosine diphosphate (ADP), trigger different cell surface 
receptors in platelets and mediate complex intracellular signals that finally activate αIIbβ3 
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integrin (Kasirer-Friede et al., 2007). Activated αIIbβ3 integrin can bind to Arginine, 
Glycine and Aspartate (RGD)-containing ligands including fibrinogen, thrombospondin, 
Von Willebrand factor, fibronectin (FN) and vitronectin. Subsequently, the bound platelets 
release coagulants (e.g. fibrinogen, thrombospondin, von Willebrand factor, FN) from their 
α-granules that leads to further platelet aggregation (Kasirer-Friede et al., 2007). 
Leukocytes integrins are α4β1 (VLA-4), α4β7, αLβ2 (LFA-1) and αMβ2 (MAC-1) that 
maintain in low affinity state before their rapid activation via integrin inside-out signalling 
pathway (Fig. 9). The activation process is started by capturing and rolling of lymphocytes 
on endothelial cells and mainly achieve through shear-induced partial activation of VLA-4 
integrin and the interaction between L-selectin and P-selectin of inflamed endothelium and 
P-selectin glycoprotein ligands1 (PSGL1) of leukocytes (Alon and Shulman, 2011; Ley et 
al., 2007). 
 
 
 
Figure 9. Leukocyte adhesion signalling cascade. Integrin activation plays a crucial role in mediating 
leukocyte rolling and adhesion on endothelial cells. 
  
The chemokines on the surface of inflamed endothelial cells bind to G-protein coupled 
protein receptor (GPCR) on lymphocytes which leads to the activation of leuko-integrins 
through intracellular signalling pathways. This causes lymphocytes to roll slower, arrest, 
strengthen their adhesions and make diapedesis (Alon and Shulman, 2011; Ley et al., 
2007).
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The molecular mechanism of inside-out integrin activation has been studied extensively. 
The critical step of integrin activation is binding of talin and kindlin molecules to 
cytoplasmic tail of integrins (Moser et al., 2009; Nieswandt et al., 2009). Talin is a 270 kD 
protein, composed of an N-terminus 47 kD globular FERM domain with four subdomains 
(F0 to F3) and a 220 kD C-terminal rod domain (Fig. 10). F3 sub-domain of talin is a PTB 
domain and binds to membrane-proximal NPxY motif of β1 or β3 integrin tails (Moser et 
al., 2009). In addition, talin has multiple vinculin and F-actin binding sites as well as a 
second integrin binding site in the C-terminal flexible rod domain that is critical for 
connecting integrins to actin cytoskeleton (Fig. 10). 
  
 
Figure 10. Domain structure of talin. N-terminal globular head of talin is composed of a FERM domain 
with four subdomains (F0 to F3) that is followed by a 220 kD C-terminal rod domain. Talin connects actin 
cytoskeleton to β integrin cytoplasmic tails through a F-actin binding site and vinculin binding sites (red). 
Adopted from (Roberts and Critchley, 2009). 
 
Talin-integrin interaction alone is insufficient to trigger inside-out integrin signalling. 
Recent studies showed that the interaction of the PTB-like subdomain of kindlin FERM 
domain with membrane-distal NxxY motif of β1, β2 and β3 integrin tails is essential, but 
not sufficient for mediating integrin activation (Montanez et al., 2008; Moser et al., 2009; 
Moser et al., 2008). The cooperative interaction of talin and kindlin with the cytoplasmic 
tail of integrins causes separation of integrins heterodimer tails and leads to conformational 
changes in intracellular, transmembrane and ectodomain of integrins. While, 
conformational changes of the ectodomain are well demonstrated, the structural details of 
integrin transmembrane domains remain unknown. The transition from resting to active 
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integrin conformation has been proposed by two main models; Switchblade (Luo et al., 
2007) and Deadbolt (Xiong et al., 2003). Both models suggest conformational change of 
head domain during activation, while integrin ligand-binding occurs before (deadbolt) or 
after (switchblade) extension of integrin ectodomain (Arnaout et al., 2007). Structural 
studies proposed at least three main conformations for integrins: resting low affinity 
integrins with bent ectodomain conformation, intermediate state(s) and active high affinity 
integrins with extended exteracellular domain (Fig. 11). 
 
 
Figure 11. Integrin conformations. (A) Resting low affinity, (B) intermediate state(s) and (C) active high 
affinity integrins with extended exteracellular domain. (D) Domain structure of integrins represented with the 
same color codes in A to C. The cytosolic tails are truncated in B and C panels. Adopted from (Anthis and 
Campbell, 2011). 
 
The precise molecular mechanism of integrin activation remains unknown. It is clear that 
the activation is organized by series of signaling events including activation of agonist 
receptors and engagement of talins, kindlins and Rap1-GTP-interacting adaptor molecule 
(RIAM). The interaction of talin and kindlin with cytoplasmic tail of β integrins is tightly 
regulated at the molecular level (Fig. 12). NMR studies revealed that talin exist in activated 
and autoinhibited states. The inactive talin conformation is characterized by intramolecular 
autoinhibitory interaction of the C-terminal rod domain and the PTB-like subdomain 
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covering the integrin binding site. The autoinhibitory conformation of talin is disrupted 
through interaction with the Rap1-RIAM complex that becomes activated through GPCR 
signaling and binding to phosphatidyl-inositol phosphate Kinase Type-Iγ (PIPKIγ)/ 
phosphatidyl-inositol-4,5-bisphosphate (PIP2). The talin head can also be released from its 
inhibitory interaction by Calpain cleavage. Finally, integrins undergo conformational 
changes and activation through binding of F3 subdomains of talins and kindlins to 
membrane proximal NPXY and membrane distal NXXY motifs of β integrin tails, 
respectively (Fig. 12). 
 
 
Figure 12. Integrin inside-out signalling pathways. (A) Integrin resting state can be stabilized by binding of 
PTB-containig proteins or filamin and tyrosine phosphorylation with SFKs. (B) Cooperative interaction of 
talin and kindlin leads to integrin activation. Agonist stimulation, Calpain cleavage and interaction with 
PIPKIγ/PIP2 trigger talin binding to β integrins cytoplasmic tail. Talin and kindlin F3 subdomains (yellow 
circles) bind to membrane proximal NPXY and membrane distal NXXY motifs of β integrin cytoplasmic 
tails, respectively. This causes separation of integrin cytoplasmic tails, transfer of conformational changes 
from tails to the ectodomain and integrin activation. Adopted from (Anthis and Campbell, 2011). 
 
The low affinity resting conformation of integrins is stabilized by binding to Filamin or 
PTB-containing proteins such as Dock1 and ICAP. Dock1 binding to β integrin tails causes 
integrin inactivation by Src family kinase (SFK)-dependent tyrosine phosphorylation of 
integrin NPXY and NXXY motifs, suggesting that posttranslational modifications can 
regulate integrin activation at the receptor level (Anthis and Campbell, 2011). Although, 
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the levels of β1 integrin tail tyrosine phosphorylation is very low, even in presence of v-
Src, several studies indicated that SFK-dependent tyrosine phosphorylation of β1 integrin 
on NPXY and NXXY motifs (Tyr783 and Tyr795) causes integrin inactivation by blocking 
talin and kindlin binding to β1 integrin. Mutating both β1 integrin Tyr783 and Tyr795 to 
phenylalanine (but not either one) decreases adhesion strength and tumorigenesis, only 
when Src activity is low. However, in present of high Src activity, a Src-FAK signalling 
complex (see section 2.2) promotes tumorigenesis downstream of β1 integrin and 
independent of β1 integrin tyrosine phosphorylation (Meves et al., 2011). 
 
2.2. Integrin outside-in signalling  
 
Integrins mainly traffic to the cell surface in a resting inactive state. Based on the 
switchblade model, the binding of  ECM ligands to integrin ectodomain modifies integrin 
heterodimer conformation to an extended active state and leads to separation of α- and β-
integrin cytoplasmic tails (Arnaout et al., 2007). Consequently, about 200 different proteins 
are recruited to integrin cytoplasmic tails, where they interact and regulate activity of each 
other and trigger a broad range of different signalling pathways. Integrin outside-in 
signalling pathways are referred to signalling events which are triggered intracellularly 
upon integrin binging to ECM ligands. The diversity of ECM molecules and integrin 
heterodimers as well as cell type-/tissue-specific expression of FAs proteins increases the 
complexity and variety of integrins outside-in signalling pathways (Fig. 13). 
Integrins outside-in signalling events can be divided chronologically into: immediate early, 
short term and long term effects (Legate et al., 2009). The early effects of integrin 
activation are fast phosphorylation of FAs proteins and increase of lipid kinases activity 
(Fig. 13A). Phosphatidylinositol 3-kinase (PI3K) and PIPKIγ cause a local increase in 
phosphatidyl-inositol-3,4,5-trisphosphate (PIP3) and PIP2 concentrations, which in turn, 
affect recruitment of many adhesion molecules such as talin, α-actinin, tensin and Shc 
(Legate et al., 2009). Phosphorylation also triggers immediate early signals upon integrin 
activation by modifying conformation, activity and binding properties of FA molecules. 
Short term effects are the activation of signalling pathways such as extracellular signal-
regulated kinase (ERK1/2) and c-jun N-terminal kinase (JNK), elevation of active Ras 
homology protein (Rho) family of small GTPases levels and modulating the activity of 
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proteins that play a role in actin cytoskeleton rearrangements. The final consequence of 
these signaling events are long-term effects of integrin signals, a wide range of diverse 
biological functions, including proliferation, differentiation and survival (Fig 14.A) (Legate 
et al., 2009). 
 
 
Figure 13. Integrin outside-in signalling. (A) Chronological events of integrin activation. (B) Examples of 
signalling modules downstream of integrin activation. From (Legate et al., 2009). 
 
Integrin activation through binding to ECM ligands triggers a broad range of diverse and 
often distinct biological consequences in cells, tissues and developmental stages. This 
diversity and complexity increases even more, since integrin signals cooperate with 
different type of cell receptors including GFRs (see section 4). 
Integrin activation enhances PI3K activity and promotes its recruitment to FAs (Fig. 13B). 
Activated PI3K elevates PIP3 levels at plasma membrane, which in turn, causes RAC-alpha 
serine (Ser)/threonine (Thr) protein kinase (Akt) phosphorylation on Thr308 through PIP3-
dependent recruitment of 3-phosphoinositide-dependent kinase1 (PDK1). Akt can be also 
phosphorylated on Ser407 in presence of mammalian target of rapamycin (mTOR) and 
integrin linked kinase (ILK). The correlation of ILK expression with Akt phosphorylation 
on Ser407 may occur through the influence of ILK on mTOR2 activity (McDonald et al., 
2008). 
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Figure 14. Assembly of c-Src-FAK complex. (A) c-Src has four Src homology domains (SH): SH1 or kinase 
domain, SH2, SH3 and SH4 domains. Immediately after c-Src expression, myristoylation of the SH4 domain 
anchors c-Src to the plasma membrane. Transition from catalytically inactive bent c-Src to active c-Src is 
tightly controlled by a molecular switch that is composed of an inhibitory phospho-Tyr527 and an activatory 
phospho-Tyr416. FAK is omposed of an N-terminal FERM domain, kinase domain and a C-terminal focal 
adhesion targeting (FAT) domain. (B) Plasma membrane-associated c-Src adopts an inactive conformation. 
The c-Src-FAK complex forms by (trans-auto-) phosphorylation on FAK Tyr397 upon integrin clustering 
followed by binding of FAK Tyr397 to SH2 domain of Src. Finally, auto-phosphorylation of c-Src Tyr416 
causes its full activation. Abbreviations are ECM: extracellular matrix; FERM: 4.1, ezrin, radixin, moesin 
domain; FAT: focal adhesion targeting domain ; M: myristoylation. 
 
c-Src belongs to the Src family of non-receptor tyrosine kinases (SFK), of which Src, Fyn 
and Yes are widely and often co-expressed in different tissues during all stages of 
development. c-Src achieves an inactive conformation through interaction of the Src 
homology domain 2 (SH2) domain with the C-terminus phosphorylated tyrosine (Tyr) 527 
(Tyr530 in human) (Fig. 14A). Upon integrin activation and clustering, focal adhesion 
kinase (FAK) is activated through (trans-auto-) phosphorylated on Tyr397. Phosphorylated 
Tyr397 binds to Src SH2 domain and disrupts c-Src inhibitory conformation (Fig. 14). The 
disruption of c-Src inhibitory conformation also occurs through the interaction of c-Src 
SH2 domain with phospho-Tyrs of activated GFRs or, c-Src SH3 domain with proline-rich 
motif of p130 Crk-associated substrate (p130Cas)  (Arias-Salgado et al., 2003; Huveneers 
and Danen, 2009; Mitra et al., 2005). c-Src is then fully activated by auto-phosphorylation 
at Tyr416 (Tyr419 in human). In turn, activated c-Src further promotes FAK activity by 
phosphorylation of FAK on several Tyr residues. Activated c-Src is a small proportion of 
Introduction 
 
 
 
22 
the total c-Src that associated with the plasma membrane and endosomal compartments 
(Huveneers and Danen, 2009; Yeatman, 2004). 
The signalling outcomes of c-Src-FAK complexation are vast including activation of Ras- 
MEK-MAPK/ERK as well as phosphorylation of Paxillin and p130Cas (Fig. 13B and Fig. 
15A). Modulation of the Ras-MEK-MAPK/ERK signalling axis by integrins regulates 
cyclin D1 expression and cell cycle progression, while the activation of Paxillin and 
p130Cas has distinctive signalling outputs depending on the cellular spreading phase (Fig. 
15A) (Legate et al., 2009). 
 
 
Figure 15. Integrin regulation of small GTPases. (A) During early spreading, the c-Src-FAK complex 
activates Rac/Cdc42 through multiple signalling pathways. (B) At late phases of spreading, integrin signals 
promote Rho actomyosin contractility through several Rho GEFs. Modified from (Huveneers and Danen, 
2009). 
 
Both Paxillin and p130Cas can bind to the adaptor molecule CT-10 related kinase (Crk) 
upon its phosphorylation (Fig. 15A). During early spreading, phosphorylated Paxillin on 
Tyr31 and Tyr118 can bind to p120Ras-GTPase activating protein (GAP), release 
p190RhoGAP from it inhibitory complex with p120RasGAP and inhibit Rho activity 
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(Huveneers and Danen, 2009). Moreover, phosphorylated Paxillin recruits Arf GAP 
Paxillin kinase linker-β-PAK-interacting exchange factor (PKL-β-PIX), a complex that 
additionally can be activated by c-Src to enhance Rac/Cdc42 activity (Fig. 15A). Activated 
p130Cas promotes cell migration and spreading through up-regulation of Rac activity via 
the Dock180-Engulfment and Cell Motility (ELMO) complex (Siesser and Hanks, 2006). 
This scenario shifts gradually into the reverse direction during late phase of spreading, 
when integrin signals promote RhoGTPase activity, formation of stress fibers and 
maturation of FAs. α5β1 integrin of FN-seeded cells plays an effective role during late 
phase of spreading by up-regulation of leukemia-associated RhoGEF (LARG), 
p190RhoGEF and p115RhoGEF, probably through SFKs (Huveneers and Danen, 2009). 
 
2.3. Integrin mechanotransduction 
 
Cells sense and react to mechanical environments through activation of a variety of 
receptors including cell-cell and cell-ECM adhesion molecules. The linkage of the ECM to 
the F-actin cytoskeleton by integrins mediates bidirectional transmission of mechanical 
forces. Integrin-mediated conversion of ECM mechanical stimuli to biochemical signals as 
well as actomyosin forces to ECM molecules are referred as integrin mechanotransduction 
(Huveneers and Danen, 2009; Papusheva and Heisenberg, 2010). 
Local tension and ECM stiffness facilitate integrin activation and clustering as well as 
maturation of FAs through tension-dependent modification of conformation, composition 
and signalling properties of adhesion molecules (Papusheva and Heisenberg, 2010). The 
formation of nascent FAs (NFAs) is driven by myosin light chain kinase (MLCK) and 
none-muscle myosin II produces protrusions at the cell edge (Giannone et al., 2007). NFAs 
and further mature actin-linked focal complexes (FCs) are enriched with β3 integrin and 
adhesion molecules such as talin and vinculin (Fig. 16A). Force-induced stretching of talin 
exposes cryptic vinculin binding sites on talin and promotes formation of talin-vinculin 
complexes, which are molecular clutches that mediate integrin-F-actin cytoskeleton 
connection (del Rio et al., 2009). The maturation of FCs and low density FAs in cell 
protrusions into big FAs and α5β1 integrin-rich fibrillar adhesions (FBs) proceeds by 
ROCK-dependent actomyosin forces (Ballestrem et al., 2001).  
Introduction 
 
 
 
24 
It proposed that αVβ3 and α5β1 integrins may differentially mediate the activation of RhoA 
GTPases (Fig. 16B). While αVβ3 integrin-rich FCs and low density FAs in cell protrusions 
trigger Rac/Cdc42 activation, α5β1 integrin-rich FAs and FBs in central region of the cell 
promote RhoA-mediated formation of stress fibers and contractility (Huveneers and Danen, 
2009). Recently, the precise spatiotemporal dynamics of active RhoGTPases was monitored 
by photoactivatable molecules. RhoA is predominantly active in a narrow band at the 
leading edge of cells and in cell central regions, while active Rac/Cdc42 is present in cell 
protrusion (Papusheva and Heisenberg, 2010). 
 
 
Figure 16. Tension-induced remodeling of adhesion composition and cell signalling. (A) NFAs and FCs 
assemble in cell protrusions by myosin light chain kinase (MLCK)-induced forces and maturate to FAs and 
FBs via actomyosine forces. (B) Coordination of RhoA GTPases through molecular composition of cell-ECM 
adhesions. RhoA is activated in a narrow band at the cell edge by an unknown mechanism. αVβ3 containing 
adhesions in cell protrusions induce Rac/Cdc42 activation (red area) that are essential for the stabilization of 
the protrusions, while central α5β1 integrin-rich adhesions elevate active RhoA levels (blue area). From 
(Papusheva and Heisenberg, 2010). 
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Integrin mechanotransduction is also crucial for assembly and organization of ECM 
molecules. α5β1 integrin binds to soluble FN more efficiently (Huveneers et al., 2008) and 
promotes FN fibrillogenesis through cytoskeletal force-induced stretching of soluble FN 
dimers. Integrins also facilitate assembly of collagen matrix, directly, through collagen-
binding integrins and, indirectly, via assembly of FN-matrix (Huveneers and Danen, 2009). 
Moreover, FN fibrillogenesis by α5β1 integrin-dependent mechanical tensions, indirectly, 
facilitates latent TGFβ binding protein (LTBP) binding to FN fibrils during assembly of 
latent TGFβ complex. The binding of αVβ3, αVβ5, αVβ6 and αVβ8 integrins to the RGD 
site in the latency-associated peptide (LAP) of latent TGFβ complex followed by 
actomyosine-mediated contractions release TGFβ in ECM and trigger numerous signalling 
pathways (Worthington et al., 2011). 
Matrix rigidity can causes modifications of integrin signals via change in expression, 
conformation and activation of integrins. Increasing ECM stiffness during tumorigenesis 
has been considered to be essential for regulating tumor growth. Increased substratum 
stiffness stimulates activation of RhoA GTPases and differentiation of breast epithelial 
cells. In addition, elevation of ECM remodeling by increased RhoA-dependent cytoskeletal 
contractility promotes tumor cell proliferation in stiff matrices (Huveneers and Danen, 
2009). Indeed, integrin mechanotransduction has a pivotal role in tissue morphogenesis and 
in vivo signal transduction, although little is known about physiological context of integrin 
mechanosensing in vivo. It requires further efforts to reveal how composition of adhesion 
molecules drives distinctive signalling pathways in different tissues and how integrins 
nano-mechanosensory properties in different cell types orchestrate overall tissue 
morphogenesis. 
 
 
3. Integrin-dependent cell adhesions 
 
The biogenesis of integrin-dependent cell adhesions starts with the interaction of the 
glycocalyx embedded extracellular domain of integrins with ECM ligands. The interaction 
causes assembly of integrin-mediated adhesions with distinctive morphology, molecular 
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composition and dynamics, even in the same cell. Initially, activated ligand-bound integrins 
cluster to an early form of dot-shape integrin-mediated adhesions known as nascent FAs 
(NFAs; <0.1-0.5 µm2), that mainly assemble at the leading edge of migrating cells (Geiger 
and Yamada, 2011). They maturate to FCs and FAs (~1-5 µm2) by further integrin 
clustering and recruitment of actin-linker multiprotein complexes to the cytoplasmic 
platform of NFAs (Fig. 17). FAs that contain α5β1 integrin and are under intracellular 
actomyosine tensions can further develope into elongated fibrillar adhesions (FBs; >5 µm 
long) which are located in the central areas of cells. 
 
Figure 17. Different type of integrin-based adhesions. (A) Nascent Focal adhesions (NFA), focal adhesions 
(FA) and fibrillar adhesions (FB) are visualized by Paxillin (green) and pY-Paxillin (red) immunostaining. (B) 
Podosomes are visualized by Paxillin (red) and actin (green) immunostaining in osteoclasts. From (Geiger and 
Yamada, 2011). 
Podosomes are another type of integrin-based adhesion that is found in smooth muscle 
cells, endothelial cells and cell types of monocytic origin (osteoclasts, machrophages and 
dendritic cells). They are ring-shaped adhesions that assemble around an F-actin core and 
contain matrix degrading enzymes. Podosomes are important for cell adhesion and 
degradation of matrixes such as bone by osteoclasts (Linder and Kopp, 2005). 
So far, only a few in vivo integrin-mediated adhesions have been characterized including 
FAs of endothelial cells at sites of fluid shear stress in blood vessels and smooth muscle 
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dense plaque (Geiger and Yamada, 2011). The morphology, composition and signalling 
properties of integrin-based adhesions are considered to be different in 2D cell cultures and 
in vivo environments (Fig. 18). Fibroblastic cells in 3D environment of tissue show distinct 
morphology and are more biologically efficient during migration and proliferation when 
compared with 2D-matrix cell cultures (Cukierman et al., 2001). 
 
Figure 18. In vivo integrin-based cell adhesions. Immunostaining of Paxillin (red) and α5 integrin (green) 
showed distinctive localization in vivo and in vitro. FAs (filled arrowheads) and FBs (open arrowheads) of 
(A-E) FN-seeded	  NIH-3T3 mouse fibroblast in cell culture compared with (F-J) 3D-matrix adhesion (arrows) 
of craniofacial mesenchymes from transverse cryosections of E13.5 mouse embryo. Scale bar 5µm. From 
(Cukierman et al., 2001). 
 
Recently, the ultra-structure -architecture of FAs has been revealed by cyro-electron 
tomography (Fig 19A-C). Patla et al. (2010) showed that the interaction of the plasma 
membrane with cytoskeleton in FAs of fibroblasts is mediated through hundreds of donut-
like particles with a diameter of 20-30 nm. F-actin connections to particles were in different 
orientations (about 25 different structural classes; Fig 19D) proposing diversity in the 
molecular composition within FAs (Patla et al., 2010). It has been shown that many of FA 
proteins recruited to FAs bind integrin tails directly (Zaidel-Bar and Geiger, 2010). As 
cytoplasmic tails of integrins are short, the simultaneous interaction of all these molecules 
with the same integrin heterodimer is not possible and integrin tail-bound multiprotein 
complexes peobaly contain different composition in the same adhesion site. 
FA proteins can be divided into four classes based on their binding/scaffolding properties: 
1) Integrin-associated proteins that directly bind to F-actin cytoskeleton, such as talin, 
filamin and α-actinin;  2) Integrin-associated proteins that indirectly bind to/regulate the F-
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actin cytoskeleton, such as Paxillin, FAK, ILK and kindlins; 3) Actin-binding proteins that 
are not associated with integrins directly, such as vinculin and Parvins; and 4) 
scaffolding/signalling molecules that tune integrin signals but are not associated with 
integrin/actin (Legate and Fassler, 2009). 
 
 
Figure 19. Ultra-structure of FAs. Correlated microscopy, combining fluorescence microscopy and cryo-
electron tomography. (A) Fibroblasts expressing YFP-Paxillin to visualize FAs (yellow and red arrows). Scale 
bar is 20 µm. (B) A cryo-tomogram slice of the same FA in panel A (yellow arrow) and (C) its surface 
rendering view with F-actin (brown), plasma membrane (blue) and donut-like adhesion-related particles 
(green). (D) Higher magnification of adhesion-related particles (20-30 nm diameters; green) linked to 
differentially oriented F-actin (brown). Adopted from (Patla et al., 2010). 
 
3.1. Integrin-linked kinase (ILK) 
 
ILK was initially found in a yeast-two hybrid screen as a direct binding partner of β1 and 
β3 integrin tails (Hannigan et al., 1996; Pasquet et al., 2002). ILK consists of five N-
terminal Ankyrin homology domains (ANK), a Plekestrin homology (PH) domain and a C-
terminal pseudokinase (PK) domain. ILK predominantly localizes to FAs, although there 
have been reports on ILK recruitment to nucleus, centrosomes and cell-cell adhesions 
(Widmaier et al, 2011). ILK forms an ILK-Pinch-Parvin (IPP) complex in the cytoplasm by 
interacting with Lin-11, Isl-1 and Mec-3 (LIM) domain of Pinch and the second Caplonin 
homology (CH) doman of Parvins (Widmaier et al, 2011). The formation of the IPP 
complex prevents the proteasomal degradation of its components. IPP serves as a signalling 
platform that recruits many other molecules. Post translational modification of IPP 
components and alternative assembly of Pinch and Parvin isoforms give rises to distinctive 
signalling outputs that are cell type-, tissue- and developmental stage-specific. 
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ILK was originally considered to be a Ser/Thr protein kinase; however, X-ray 
crystallography and genetic studies in D. melanogaster, C. elegans and mice demonstrated 
that the ILK kinase domain is catalytically inactive (Wickstrom et al., 2010). ILK controls 
cell polarity, proliferation, differentiation, stability of microtubule tips at the cell cortex and 
the organization of the F-actin cytoskeleton through signalling crosstalks with growth 
GFRs (Grashoff et al., 2003; Lange et al., 2009; Legate et al., 2006; Lorenz et al., 2007; 
Mackinnon et al., 2002; Wang et al., 2008; Wickstrom et al., 2011). However, it remains 
unclear how ILK co-operates with GFR to control F-actin remodeling and downstream 
signalling pathways. For more information the reader is referred to a review article 
presented in the appendix of this thesis (Widmaier et al, 2011). 
 
 
4. Integrins and growth factors signalling crosstalk 
 
Cells must maintain their physiological homeostasis in response to a wide variety of 
environmental challenges with cell surface receptors that transduce extracellular stimuli 
into biochemical signals. Single cells and, particularly, multicellular organisms must have 
been adapted a mechanism to orchestrate the signals of different receptors to achieve an 
appropriate biological response. The integration of distinct signals from different receptors 
into a common downstream effector/response is known as signalling crosstalk. 
Integrin and GFR signalling crosstalk is responsible for a wide range of different biological 
processes such as cell proliferation, survival, differentiation, migration, innate immune 
response, angiogenesis and tumor cell growth (Cabodi et al., 2004; McCall-Culbreath et al., 
2008; Moro et al., 1998; Ross, 2004; Somanath et al., 2009; Soung et al., 2010; Veevers-
Lowe et al., 2011).The mode of integrin-GFR cosignalling could be reciprocal or 
unidirectional. In reciprocal integrin-GFR cosignalling, both integrin and GFR activation 
trigger common downstream effectors observed with αVβ3-insulin-like GFR (IGFR) and 
αVβ3-PDGF signalling. In the unidirectional integrin-GFR crosstalk, one receptor induces 
activation of the other receptor. β1 integrin-dependent activation of epidermal GFR 
(EGFR) through c-Src and EGFR-/c-Met-dependent activation of α6β4 integrin are 
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examples of unidirectional integrin-GFR cosignalling (Cabodi et al., 2004; Soung et al., 
2010). 
Integrin-GFR signalling crosstalk can be achieved through several mechanisms (Fig. 20). 1) 
Integrins form complex with GFRs at plasma membrane (Fig. 20A-B). 2) Integrin signals 
can activate GFRs at receptor levels (Fig. 20C-D). 3) GFRs can activate integrins and 
modulate their signaling output (Fig. 20E-F). 4) Integrins propagate ligand-mediated 
signals of GFRs or synergize on parallel pathways to achieve full biological responses (Fig. 
20G-H). 
 
 
 
Figure 20. Mechanisms of integrin-GFR cosignalling. (A) Integrins form a complex with GFRs directly or 
(B) indirectly through extra-/intra-cellular adaptor molecules. Integrin-induced GFR activation through (C) 
integrin clustering and (D) integrin-induced c-Src activation. (E) GFR-dependent phosphorylation and 
activation of α6β4 integrin via Fyn Tyr kinase. (F) GFR-induced phosphorylation of many FA molecules such 
as FAK and Paxillin, affects the integrin signalling pathway. (G) Propagative integrin-GFR cosignalling 
through common downstream effectors such as Src and FAK. (H) Integrin and GFR signals can synergize on 
parallel pathways to achieve the same biological response. Yellow stars indicate phosphorylation. For details 
refer to text. 
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4.1. Integrin-growth factor receptor complexation 
 
Integrins and GFRs can become physically linked at the plasma membrane (Table 2; Fig. 
20A-B). Integrin-GFR complex formation occurs directly through the interaction of GFRs 
and integrins, or indirectly via extracellular or intracellular adaptor/crosslinking molecules. 
αVβ3 integrin directly binds to fibroblast GFR (FGFR) and IGFR (Mori et al., 2008; 
Saegusa et al., 2009). In FN-seeded mesenchymal stem cells, the association of α5β1 
integrin with phosphorylated PDGF receptor-β (PDGFR-β) is essential for migration 
(Veevers-Lowe et al., 2011). A β1-N-wasp-PDGFR complex has been also shown to be 
crucial for fibroblast chemotactic migration (King et al., 2011). In endothelial cells 
hepatocyte GFR (HGFR/c-Met) forms a hetero-complex with both αVβ3 and α5β1 
integrins through association of HGF with FN and vitronectin in the ECM (Rahman et al., 
2005). 
 
 
Table 2. Examples of integrin-GFR complexation. IGFR: Insulin-like growth factor receptor (GFR); 
FGFR-1: Fibroblast GFR-1; HGFR: Hepatocyte GFR; PDGFR: platelet-derived GFR; VEGFR: Vascular 
Endothelial GFR; EGFR: Epidermal GFR; ErbB2: Erythroblastic Leukemia Viral Oncogene Homolog; Tie-2: 
Tyr kinase with immunoglobulin and EGF homology domains 2; Ron: Receptor d'origine nantais. From 1 
(Saegusa et al., 2009), 2 (Mori et al., 2008), 3 (Rahman et al., 2005), 4 (Soung et al., 2010), 5 (Thomas et al., 
2010), 6 (Veevers-Lowe et al., 2011) and 7 (Liu et al., 2009), 8 (Hollenbeck et al., 2004) and 9 (Yu et al., 
2000). 
 
Local concentration of integrins at GFR-rich lipid rafts promotes integrin-GFR cosignalling 
in breast carcinoma cells. PKC-α-induced phosphorylation of a Ser residue in β4 integrin 
cytoplasmic tail causes disassembly of α6β4 integrin from hemidesmosomes. β4 integrin is 
then recruited to lipid rafts upon palmitoylation on a Cys residue in membrane proximal 
motif of β4 cytoplasmic tail (Soung et al., 2010). The complexation of integrin-GFR at 
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plasma membrane, not only affects integrin and GFR activities at receptor level, but also 
creates a microenvironment, where many integrin-/GFR-tail-bound signalling molecules 
can interact and tune downstream signalling pathways. 
 
4.2. Integrin-dependent activation of growth factor receptor signalling 
pathway 
 
Integrin engagement can directly mediate GFRs activation and phosphorylation. Activation 
of GFRs by integrin clustering at the plasma membrane has been reported in several studies 
(Fig. 20C). Integrin ligand occupancy and clustering using FN-coated beads promotes 
EGFR, PDGFR-α or-β and FGFR aggregation (Miyamoto et al., 1996). Moreover, 
antibody-mediated crosslinking of α6β4 integrin was sufficient to promote RhoA activation 
through cell-surface clustering of EGFR in breast carcinoma cells (Gilcrease et al., 2009). 
In the same manner, αVβ3 integrin induces growth factor-independent activation of IGFR, 
VEGFR2 and PDGFR (Ivaska and Heino, 2011). 
Many αV-containing integrin heterodimers (αVβ3, αVβ5, αVβ6 and αVβ8) directly mediate 
activation of TGFβ receptors by releasing TGFβ from its inactive latent TGFβ complex in 
the ECM (Worthington et al., 2011). Another very well known example is ligand-
independent EGFR phosphorylation by integrins (Moro et al., 1998). Although, such an 
integrin-induced EGFR phosphorylation is much weaker than ligand-mediated EGFR 
activation, it is sufficient for adhesion-mediated cell survival  (Cabodi et al., 2004). The 
process requires c-Src-induced binding of p130Cas to EGFR (Moro et al., 2002) and 
probably aggregation and transactivation of EGFR at plasma membrane through integrin 
clustering (Fig. 20D). 
 
4.3. GFR-dependent modulation of integrin signalling pathway 
 
GFRs can tune integrin signals through phosphorylation of integrin cytoplasmic domains 
and FA proteins (Fig. 20E-F). Activated EGFR induces tyrosine phosphorylation of β4 
integrin cytoplasmic tail via Fyn and Yes tyrosine kinases, leading to disassembly of 
hemidesmosomes in carcinoma cells (Mariotti et al., 2001). PDGF-mediated activation of 
PKC leads to αVβ3 integrin activation and increases matrix binding and proliferation of 
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oligodendrocytes (Soung et al., 2010). Additionally, many FAs proteins undergo GFR-
induced phosphorylation that modifies their binding and signalling properties. For example 
FAK phosphorylation can be triggered by growth factors directly or via GFR-induced c-Src 
activation (Siesser and Hanks, 2006). 
 
4.4. Synergistic/propagative integrin-growth factor receptor cosignalling 
 
Integrins and GFRs can intersect through multiple downstream signalling molecules for 
propagating each other signals (Fig. 20G) or synergizing on parallel pathways to finally 
achieve a full biological response (Fig. 20H). For example, integrins and GFRs share Ras-
MAPK, PI3K-Akt and RhoGTPases signalling pathways (Assoian and Schwartz, 2001; 
Ivaska and Heino, 2011). As integrin and GFRs have many common downstream effectors, 
the evidence for propagative integrin-GFR cosignalling is vast. Integrins and GFRs co-
operatively control Cyclin D1 expression and thereby promote cell cycle progression 
through intersecting with the ERK signalling pathway at several points. Two important 
convergent points of integrin-GFR signalling pathways are FAK and c-Src, as both of them 
can be phosphorylated and activated by GFRs or integrins and trigger many downstream 
signalling molecules (see section 2.2). There are examples of synergistic integrin-GFR 
cosignalling, in which integrin and GFRs triggers signals on parallel pathways. β1 integrin 
induces GFR-independent phosphorylation of Akt on Ser473 and Thr308, while EGFR can 
trigger adhesion-independent Akt activation through c-Src and FAK (Ivaska and Heino, 
2011). 
Recent studies indicate that dimensions of integrin-GFR cosignalling are much broader 
than what has been considered before, as both integrin and GFR, negatively or positively, 
influence trafficking as well as expression levels of each other in different cell types and 
tissues. Although, the integrin-GFRs cosignalling plays a crucial role in regulating cellular 
behaviors, its molecular players and underlying mechanisms have not been 
comprehensively studied due to lack of appropriate readouts and technologies. 
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5. Circular dorsal ruffles 
 
Circular dorsal ruffles/waves (also known as dorsal ruffles (DR) or actin ribbons) are 
transient actin-rich structures that form on the dorsal plasma membrane in response to 
growth factor stimulation. Although it might have been observed in cell cultures earlier, the 
term of DRs was used to describe morphological changes of fibroblasts as early as 1970 
(Abercrombie et al., 1970; Chhabra and Higgs, 2007). DRs have been observed in different 
cell types (e.g. fibroblasts, macrophages, keratinocytes, smooth muscle cells and epithelial 
cells) in response to stimulation with various growth factors such as EGF, PDGF and HGF 
(Buccione et al., 2004). Morphologically, DRs are short-lived condense actin-based 
structures that usually appear 2-5 minutes after growth factor stimulation and disappear 
within 10-30 minutes. By scanning electron microscopy (SEM), DRs appeared as wave-
shape arcs of uniformly sized bumps that protrude out of dorsal plasma membrane, perhaps 
due to upward pushing forces of newly polymerized F-actin (Fig. 21A). The sections of  
transmission electron microscopy (TEM) revealed that DRs are full of actin bundles and 
membranous tubules (~100-200 nm diameter) extending along with the DR crest (Fig. 
21B), indicating that DRs are active site of membrane trafficking (Buccione et al., 2004; 
Orth et al., 2006). 
 
 
Figure 21. Ultrastructure of DRs. (A) Scanning electron microscopy of DRs showed that dorsal ribbons 
composed of numerous uniformly sized bumps. (B) Transmission electron microscopy revealed that DR 
cytosolic extension is rich of membranous tubules. From (Orth et al., 2006). 
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5.1. Signalling cascade to DRs 
 
DRs are the result of a kinase signalling cascade that starts with GFR dimerization and 
transactivation followed by activation of few master kinases including c-Src and PI3K (Fig. 
22). c-Src none-receptor tyrosine kinase plays a crucial role in DR formation through 
activation of other kinases including: PI3K and Abelson leukemia protein tyrosine kinase 
(Abl). c-Src also contributes in DR signalling cascade by elevation of active small GTPase 
levels as well as phosphorylation and activation of actin-binding adaptor molecules such as 
neuronal Wiskott-Aldrich Syndrome protein (N-WASP) and WASP family Verprolin-
homologous protein 1 (WAVE1) (Buccione et al., 2004). PI3K activates P21-associated 
kinase 1 (PAK1) and potentially can recruit other signalling molecules to the plasma 
membrane by modifying membrane lipids. Activated PAK1 promotes DR formation via 
phosphorylation of p41Arc, a subunit of the Arp2/3 complex and actin. Using the PH 
domain of Akt, it was shown that enriched PIP3 in DRs directly affects recruitment and 
activation of gelsolin and dynamin to ruffling plasma membrane (Fig. 22). 
 
 
 
 
Figure 22. DR signalling cascade. GFRs trigger activation of a few master kinases such as Src and PI3K. Src 
also can activate PI3K, which in turn modifies lipids at plasma membrane (PM) and controls recruitment of 
lipid binding signalling molecules. c-Src activates many downstream effectors including: kinases, small 
GTPases and actin binding adaptors that eventually turn on the actin polymerization machinery. 
Consequently, DRs appear as bumps due to upward pushing of nascent actin filaments into the dorsal plasma 
membrane. 
 
 
 
 
   
Introduction 
 
 
 
36 
5.2. Putative function of DRs 
 
Several physiological functions have been attributed to DRs including fast remodeling of 
actin cytoskeleton during migration and metastasis, sequestration and internalization of 
GFRs and macropinocytosis. DRs facilitate transition of static adherent cells to polarized 
motile cells by controlling fast integrin trafficking and disassembly of stress fibers 
(Buccione et al., 2004; Gu et al., 2011). A complex of β1 integrin-N-WASP-PDGFR at 
DRs has been shown to be essential for chemotactic migration of fibroblasts toward a 
PDGF gradient (King et al., 2011). DR might also involve in metastasis process by 
facilitating ECM degradation. Suetsugu et al. (2003) showed that matrix metalloproteinase 
2 (MMP2) are recruited to the tip of DRs and, therefore, proposed that DRs facilitate 3D-
migration in vivo by degrading ECM components. 
It has been shown that DRs have endocytic activity for fast sequestration and 
internalization of GFRs upon growth factor stimulation (Orth and McNiven, 2006). Orth et 
al. (2006) showed that such internalization occurs through EGFR-positive membranous 
tubules extending along DRs perimeter. GFP-tagged EGFRs are actively localized and 
internalized by EGF-induced DRs in NIH/3T3 cells (Krueger et al., 2003). Recently it was 
shown that other GFRs such as PDGFR and HGFR are also internalized by DRs (Abella et 
al., 2011; King et al., 2011).  
The trafficking of both GFRs and integrins (Gu et al., 2011) through DRs suggests that DRs 
might be a signalling compartment for integrin and GFR interaction and cosignalling. 
Moreover, DRs may also play a role as a buffering mechanism to neutralize extra GFR 
signals as well as the signals of activated kinases and small GTPases through ruffling 
actomyosin machinery to protect stressed serum-starved cells. 
During closure of DR rings a large amount of growth media is internalized by 
macropinosomes, suggesting another potential role for DRs (Buccione et al., 2004; Gu et 
al., 2011). Perhaps, macropinocytosis via DRs provide a mechanism to supply cell with 
enough metabolic material that is required for cell cycle progress upon GFR stimulation of 
serum-deprived cells. Since WAVE1-null cells, which are not able to form DRs, have 
normal macropinocytosis, DRs can mediate but are not essential for macropinocytosis 
(Suetsugu et al., 2003). 
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Despite the initial proposed role for DRs in promoting invasiveness (Suetsugu et al., 2003), 
recent evidences showing DR-mediating suppression of GFR signals suggest that DRs exert 
an important anti-cancer mechanism. It would be interesting to investigate therapeutic 
effect of DR formation on controlling tumor cell growth in parallel with other tumor 
suppressor proteins (see Cyld in publication I). 
 
 
6. Dissection of signalling networks by SILAC-based proteomics 
 
The biology of single cells and multicellular organisms regulated through a labyrinthic 
signalling network which engages a large number of molecules acting in parallel. 
Therefore, understanding the mechanism of signalling systems demands comprehensive 
information at all molecular levels. Antibody-based analysis of signalling events are limited 
to only a few signalling molecules and therefore give a limited view of what really 
happening in biological systems. Such limitationa can be overcome by powerful large-scale 
proteomics approaches that are able to accurately identify and quantify thousands of 
proteins and their post translational modifications during signalling events. 
The capacity of proteomics techniques for analysis of biological samples have been 
dramatically enhanced through improvement of mass spectrometry (MS) instruments, 
sample preparation techniques and data processing (Choudhary and Mann, 2010). Coupling 
liquid chromatography to tandem MS/MS (LC-MS/MS) in modern linear ion trap-orbitrap 
instruments improved number of identified proteins without loss of speed and accuracy. 
Many obstacles of feeding different samples into the MS pipeline have been overcome 
during recent years. For example, filter-aided sample preparation method uses the 
advantages of Sodium dodecyl sulfate (SDS)-based solubilization to identify 7093 proteins 
from Hela cell lyzates in a single experiment (Wisniewski et al., 2009). In parallel, 
computational proteomics revolutionized mass spectrometry approaches by open source 
softwares such as MaxQuant, which directly allows high peptide identification rate from 
raw MS data (Choudhary and Mann, 2010). 
Quantitative proteomics is an attractive method in cell signalling research as it provides 
highly accurate quantitative comparison of thousands of proteins between a given control 
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and experiment samples. In simple label-free quantitative proteomics, the intensities of a 
given peptide is normalized by calculating the differences in peptide intensity of each 
sample in separate LC-MS/MS runs. As the variation in peptide intensities from replicates 
could be high, the method is less accurate, but useful for samples whose labeling is 
impossible or difficult (Fig. 23). To accurately quantify two distinct proteomes, stable-
isotopic molecules which are analogous of natural isotopes have been introduced usually by 
chemical modification or metabolic labeling. Chemical strategies can be used for different 
type of cell lysates; however, they restrict measurement sensitivity by chemical side 
products and introducing experimental errors, as labeling is performed after a few steps of 
sample purification and fractionation. Metabolitic labeling allowed direct mixing of 
samples from beginning, therefore leads to more accurate quantitative data by treating 
samples similarly during all steps of preparation (Walther and Mann, 2010). 
 
 
Figure 23. Quantitative proteomics. The accuracy of comparisons is high in SILAC-based proteomics as 
samples are treated similarly during preparation. However SILAC is usually expensive and limited to cells 
growing in culture. The new developed Spike-in SILAC strategy, uses isotopically labeled lyzates that are 
mixed with samples from the beginning and used for quantification as internal (Spike-in) standard. 
Introduction 
 
 
 
39 
 
Stable isotope labeling by amino acids in cell culture (SILAC) is a simple and powerful 
metabolic labeling approach that widely applied to quantitative proteomics (Ong et al., 
2002). Cells are metabolitically labeled by incorporation of Arg and Lys essential amino 
acids that contain certain isotopic H, C and N elements. Up to three SILAC labeling media 
(light, medium and heavy) are available using combination of H, C and N isotopes in Arg 
and Lys structures (Fig. 24). The complete labeling of a proteome requires passaging of 
cells several times (about 2 weeks) in cultures supplied with SILAC media, and therefore 
SILAC technology is limited to cells growing in cell culture (Ong et al., 2002). 
In recent years, researchers tried to expand SILAC applications from cell culture to the in 
vivo environments. Mice, that are entirely labeled over 4 generation, provide an appropriate 
source to apply quantitative proteomics to tissues and cell types that cannot be grown in 
culture (Kruger et al., 2008b). Moreover, using an accurate internal Spike-in SILAC 
standard (or super-SILAC mixture), quantitative proteomics analysis is now possible for 
human tissues that cannot be labeled (Geiger et al., 2010; Geiger et al., 2011). 
 
Figure 24. SILAC-based proteomics of phosphotyrosine signalling pathways. (A) Cells metabolically 
label in culture with essential amino acids that contain isotopic H, C and N elements. Cell lyzates are mixed 
1:1, tyrosine phosphorylated proteins are enriched by affinity purification, digested by trypsin and entered to 
LC-MS/MS pipeline. (B) Direct quantification of intensities are possible as tryptic peptides from each 
labeling condition shows distinctive MS/MS spectra due to difference in the mass of isotopic elements. 
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Signal transduction is derived by synchronized, highly dynamic molecular modifications at 
different levels including signal-induced expression, protein-protein interaction and 
particularly post-translational modification (PTM). PMTs usually affect only a low amount 
of proteins by modification of peptide biochemical structure through phosphorylation, 
ubiquitylation, acetylation, methylation, glycosylation, etc. Consequently, analysis of 
PMTs by MS is problematical due to low quantity and complex MS/MS spectra of 
modified peptides which, in turn, require more data processing to predict all possible 
modification sites on a given peptide (Choudhary and Mann, 2010). Phosphorylation 
usually occurs in eukaryotic organisms through transfer of a phosphate (PO43-) group from 
ATP to a Hydroxyl (OH) group of Ser, Thr or Tyr residues. Among them, phosphotyrosine-
based signal transduction has evolved to conduct many crucial signalling events such as 
GFRs, cell-ECM and cell-cell signalling pathways (Lim and Pawson, 2010). 
Phosphotyrosine signalling machinery is composed of tyrosine kinases, tyrosine 
phosphatases and SH2-/PTB-containing proteins that allow fast and dynamic writing, 
erasing and reading of cellular signals at molecular levels. 
SILAC-based proteomics have been applied as a powerful technique to study 
phosphotyrosine signals in a quantitative, system-wide and site-specific fashion. Affinity 
enrichment of phosphotyrosine proteins is required, as the quantity of tyrosine 
phosphorylated proteins are very low. SILAC-based analysis of EGFR phosphotyrosine 
proteome revealed 31 novel EGFR effectors and kinetics of their tyrosine phosphorylation 
site (Blagoev et al., 2004). The same strategy was used to dissect insulin receptor tyrosine 
phosphoproteome (Kruger et al., 2008a). In an interesting study 6600 phosphorylation sites 
(Ser, Thr and Tyr), identified and quantified in lyzates of EGF-induced Hela cells. The 
study provides new insight on differential frequencies and upregulation profiles of  
phospho-Ser/Thr and -Tyr sites  (Olsen et al., 2006). Recently, the number of pinpointed 
phosphosites in a single project increased to 20000 unique phosphopeptides out of 100 000 
estimated sites in human (Olsen et al., 2011). 
So far, quantitative proteomics have been supported deep mapping of signalling networks 
in large scale and with high accuracy. Analysis of cell type- and tissue-specific proteomes 
from different developmental stages in combination with new progress in proteomics 
technology will help us to further improve our knowledge of how signalling networks 
control the biology of cells. 
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7. The tumor suppressor CYLD 
 
The cylindromatosis gene (Cyld) has been originally identified as a tumor suppressor whose 
germline mutations are associated with familial cylindromas (Bignell et al., 2000). Cyld is 
composed of two N-terminal cytoskeletal-associated protein Glycine-rich (CAP-Gly) 
domains which bind to microtubules (MTs), two proline-rich motifs, a NF-κB essential 
modulator (NEMO)-binding CAP-Gly domain and a C-terminal deubiquitinase (DUB) 
domain that contains a Zink-finger-like B-box domain (Fig. 25). Cyld is a signalling 
molecule that is involved in numerous signalling events through its DUB activity, MT-
binding capability and phosphorylation (Massoumi, 2010). 
7.1. Cyld deubiquitinase activity 
 
Cyld DUB activity targets components of several signalling pathways in different cell 
types. Negative regulation of nuclear factor 'κ-light-chain-enhancer' of activated B-cells 
(NF-κB) signalling pathway through Cyld-mediated deubiquitylation was initially reported 
in three simultaneous publications in 2003. The authors showed that Cyld-mediated 
deubiquitylation of NEMO, tumor necrosis factor receptor (TNFR)-associated factor 2 
(TRAF2) and to a lesser extend TRAF6, negatively affects the recruitment and activation of 
inhibitor of 'κ-light-chain-enhancer' of B-cells, kinase (IκB kinase/IKK) complex and, 
subsequently, reduces translocation of NF-κB complex to nucleus (Fig. 26A). A single 
mutation in Cys601 within the DUB domain is sufficient to abolishes Cyld DUB activity 
(Brummelkamp et al., 2003; Kovalenko et al., 2003; Trompouki et al., 2003). Cyld DUB 
activity is also dependent on the interaction of Cyld’s third CAP-Gly domain with the 
proline-rich domain of NEMO (IKKγ) as well as the direct binding of Cyld with the TRAF 
interacting protein (TRIP) (Massoumi, 2010). 
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Figure 25. The structure of Cyld protein. Two N-terminal CAP-Gly domain bind to microtubules, while the 
third CAP-Gly binds to NEMO and plays a role in negative regulation of the NF-κB signalling pathway. Two 
proline-rich motifs in Cyld potentially can bind to SH3-containing proteins. The C-terminus DUB domain is a 
Lys63-specific deubiquitinase. The zinc-finger-like B-box motif inside DUB domain is essential for Cyld 
intracellular localization. 
 
 
X-ray crystallography of Cyld DUB domain revealed that Cyld specifically removes 
Lys63-linked polyubiquitin chains which mediate non-degradative signals. A catalytic triad 
containing Cys601 residue attacks the isopeptide bond between amine group of Lys and C-
terminal of ubiquitin. In addition, a Zn-finger-like B-box motif identified inside the DUB 
domain is required for DUB activity. Its deletion impairs DUB capacity and leads to a 
sustained nuclear localization of Cyld (Komander et al., 2008). 
Cyld deubiquitylation negatively controls detrimental effects of hyperactive immune 
responses. Cyld deubiquitinates TGFβ-activated kinase (TAK1), which in turn, inhibits 
TAK1 autoactivation and its downstream signalling in T cells (Reiley et al., 2007). Cyld 
also was found as suppressor of T cell receptor signalling by erasing Lys48- and Lys63-
linked polyubiquitin chain from lymphocyte-specific protein tyrosine kinase (Lck) (Reiley 
et al., 2006). B-cell activation, but not development, is dependent on Cyld deubiquitylation. 
Deletion of NEMO and TRAF2 binding motifs of Cyld in mice increases mature B 
lymphocyte population in lymphatic organs (Hovelmeyer et al., 2007). Cyld also negatively 
controls pathogen-induced inflammation which is driven by the NF-κB signalling pathway. 
Lim et al. (2007) showed that Cyld-mediated TRAF6 and TRAF7 deubiquitination protects 
mice from nontypeable haemophilus influenzae (NTHi)-induced inflammatory response. 
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Figure 26. Cyld negatively controls NF-κB signalling pathway. (A) Cyld affects canonical NF-κB 
signalling pathway by deubiquitinating TRAFS (TRAF2, 6 and 7), NEMO (IKKγ), TAK1 and Lck. The 
recruitment of IKK complex and TAK1 is dependent on Lys63 polyubiquitin chain of TRAFs. It has been 
shown that TRAF2 deubiquitylation (red asterisk) by Cyld negatively affects JNK and P38 signalling 
pathways. TAK1 is also upstream of JNK and P38 pathways and triggers phosphorylation (yellow asterisk) of 
IKKβ in canonical NF-κB signalling pathway. Phosphorylation of IκB by IKK triad complex induces its 
proteasomal degradation and releases NF-κB dimer into the nucleus. (B) Cyld can affect noncanonical NF-κB 
signalling pathway by TRAF2 deubiquitination in B lymphocytes, which in turn, downregulates formation of 
IKKα homodimer and reduces phosphorylation of P100 proteasomal degradation to P52. (C) In keratinocytes, 
TPA/UV-induced Cyld-Bcl3 complex formation in prinuclear region, promotes Bcl3 deubiquitylation by 
Cyld, inhibits Bcl3 translocation to nucleus and downregulates Cyclin D1 expression. Moreover, TPA/UV-
induced inhibitory interaction of Cyld with HDAC6 in perinuclear region of keratinocytes elevates acetylation 
of MTs (Act-MT) and facilitates Cyld-Bcl3 complex formation. Abbreviations are TNF-α: tumor necrosis 
factor α; TNFR: TNF receptor; LPS: lipopolysaccharide; TLR: toll-like receptor; TCR: T cell receptor; BCR: 
B cell receptor; CD4/8/40: cluster of differentiation glycoprotein 4/8/40. 
 
In keratinocytes, B-cell CLL/lymphoma 3 (Bcl3)-dependent cyclin D1 gene expression and 
cell cycle progress is regulated by the Cyld DUB activity. Upon TPA or UV treatment, 
Cyld is recruited from cytoplasm to the prinuclear region, where it binds to Blc3, removes 
the Lys-63-linked polyubiquitin chain and thereby prevents Bcl3 nuclear accumulation and 
cyclin D1 expression (Massoumi et al., 2006). 
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The effects of Cyld DUB activity is not restricted to NF-κB pathway and can influence also 
other signalling systems. TAK1 deubiquitylation by Cyld is responsible for the resistance 
against bacterial infections through the crosstalk with the p38 MAPK pathway. Another 
example is Cyld-mediated TRAF2 deubiquitylation that suppresses the TNF-α-induced 
JNK signalling pathway and cell survival (Massoumi, 2010; Reiley et al., 2004; Reiley et 
al., 2007). 
 
7.2. Cyld regulates microtubule stability 
 
Evolutionary conserved CAP-Gly domains are known to bind to MTs and regulate MT 
dynamic, stability and MT-mediated trafficking of vesicles (Steinmetz and Akhmanova, 
2008). The first and second CAP-Gly domains of Cyld directly bind to tubulin and/or MTs. 
Gao et al. (2008) showed that Cyld binding to tubulin through the first CAP-Gly domain 
promotes tubulin polymerization into MTs and facilitates cell migration. In keratinocytes, 
Cyld binds to MTs via the first and second CAP-Gly domains and negatively controls cell 
cycle progression. Mechanistically, TPA-activated Cyld is transferred to the prinuclear 
region, where it binds to the catalytic domain of histone deacetylase 6 (HDAC6), inhibits 
HDAC6 activity and increases acetylation and stability of MTs (Wickstrom et al., 2009). 
This negatively affects cell cycle progression at least by two different mechanisms: firstly, 
the inhibition of HDAC6 by Cyld and hyperacetylation of MTs facilitates TPA-induce 
Cyld-Bcl3 complex formation, blocks Bcl3 translocation to nucleus and downregulates NF-
κB signalling pathway. Secondly, Cyld binding to MTs and inhibition of HDAC6 activity 
in the midbody reduces the rate of cytokinesis (Wickstrom et al., 2009). HDAC6 is a 
multifunctional signalling molecule that controls many biological processes. Negative 
regulation of HDAC6 activity by Cyld could potentially extend the influence of Cyld to all 
HDAC6-induced processes. It remains open to further investigate the potential 
consequences of Cyld-HDAC6 interaction on signalling pathways in different cell types. 
 
7.3. Cyld phosphorylation 
 
Cyld undergoes transient and rapid Ser phosphorylation by members of the IκB kinases 
(IKKs). TNF-α-induced Ser phosphorylation of Cyld by IKKα and IKKβ in Jurkat T cell 
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transiently inactivates Cyld DUB activity, elevates TRAF2 ubiquitylation and activates its 
downstream signalling. The phosphorylation occurs mainly at Ser418 five minutes after 
TNF-α induction and requires IKKγ, the regulatory subunit of IKK complex (Reiley et al., 
2005). The phosphorylation of Cyld Ser418 was much more efficient by IKKε breast 
cancer oncoprotein. The phosphorylation reduced Cyld deubiquitylation activity and 
promoted IKKε-driven transformation (Hutti et al., 2009). Similarly, constitutive Ser 
phosphorylation of Cyld inhibits Cyld-mediated deubiquitylation of the viral oncoprotein 
Tax in transformed T cells (Wu et al., 2011). Transient upregulation of Cyld was identified 
in SILAC-based proteomics of multiprotein complexes that were affinity-purified with anti-
phosphotyrosine antibodies after EGF stimulation (Blagoev et al., 2004). As non-
phosphorylated proteins complexed with phosphor-prtoteins may also be 
immunoprecipitated, authors did not clarify whether Cyld directly undergoes tyrosine 
phosphorylation. Moreover, the consequence of such Tyr phosphorylation has been not 
investigated so far. 
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Publication summaries 
Publication I 
The induction of membrane circular dorsal ruffles requires 
integrin/ILK and EGF receptor co-signalling 
Azimifar S. Babak, Böttcher RT, Zanivan S, Grashoff C, Krugel M, Legate K, Mann M 
and Fässler R. 
 
Here we showed that the formation of transient actin-based circular dorsal ruffles (DRs) is 
the consequence of a signalling crosstalk between a fibronectin/α5β1 integrin/ILK 
signalling module and epidermal growth factor receptor (EGFR). ILK is essential for the 
precise spatial activation of Src at focal adhesions by integrin and EGFR signals, which in 
turn, mediates DR formation. 
To identify novel molecular players linking integrin and EGFR signalling pathways, we 
established a screening strategy using the combination of SILAC-based quantitative 
phosphoproteomics followed by sh/siRNA-mediated depletion of candidate proteins. DRs 
served as readout to identify positive hits during screening. Using SILAC-based proteomic, 
we identified and quantified 2000 proteins and 140 specific phosphorylation sites. To test 
the involvement of these proteins in DR formation and integrin/EGFR signalling crosstalk, 
we monitored DR dynamics in sh/siRNA-mediated knockdowns of candidate genes in 
ILKf/f cells to obtain a shortlist of candidate proteins with high SILAC ratios in 4 
independent SILAC experiments. DR frequencies decreased significantly in tumor 
suppressor Cyld- and Asap2- depleted cells. We decided to further analyse the involvement 
of Cyld in integrin/ILK and EGFR co-signalling pathway. 
We show that Cyld tyrosine phosphorylation controlled by integrin/ILK and c-Src is a 
prerequisite for DR formation. Taken together we found that (i) DR formation is the result 
of fibronectin/α5β1 integrin/ILK and EGFR signalling crosstalk, (ii) DRs can be used as 
readout to screen for novel molecular players that involve in integrin/EGFR signalling 
crosstalk, (iii) integrin/ILK and EGFR signalling pathways crosstalk to mediate fast actin-
based cytoskeletal rearrangements through Cyld tyrosine phosphorylation. 
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Publication II 
Integrin-linked kinase at a glance 
Moritz Widmaier, Emanuel Rognoni, Korana Radovana, S. Babak Azimifar, and Reinhard 
Fässler. 
 
Here we review the biological function of integrin linked kinase (ILK) and highlight the 
recent evidences indicating that ILK is an adaptor molecule rather than a kinase. ILK forms 
a ternary complex with Pinch and Parvin (IPP complex) before being recruited to cell 
adhesion sites. The assembly of distinct IPP complexes, which composed of tissue- or 
developmental stage-specific isoforms of Pinch and Parvin, can mediate multiple 
alternative signalling outputs. ILK has been found predominantly in focal adhesions, while 
it also reported to be in cell-cell adhesion sites, centrosomes and the nucleus. Genetic 
studies in flies, worms and mice demonstrated that ILK is a scaffolding molecule mainly 
regulating F-actin cytoskeletal rearrangement. Recently, it has been shown that ILK locally 
stabilizes microtubule tips in the cell cortex and promotes insertion of caveolin into the 
plasma membrane. Moreover, we discussed why ILK kinase function cannot be executed 
by comparing the crystal structure of the ILK pseudo-kinase domain with Protein Kinase A 
(PKA) kinase domain. Taken together, ILK is an important scaffolding and signalling 
molecule that regulates F-actin cytoskeletal rearrangement and stabilizes microtubule tips at 
the cell cortex. 
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Publication III 
Babak-1 and Babak-2 are novel focal adhesion proteins that 
bind paxillin and regulate the assembly of membrane circular 
dorsal ruffles 
Azimifar S. Babak, Manndoph Wang and Faessler R. 
 
Here, we identified a novel family of focal adhesion (FA) molecules called Babak-1 and -2 
(Plekhh-1, -2) that localized to integrin adhesion sites as well as punctate structures in the 
cytoplasm of mouse fibroblasts and Hela cells. Babak-2 was identified as an intersector of 
integrin and growth factor signalling pathways in the SILAC-based phosphoproteomics 
screen (publication I). Murine Babak-2 and its homolog, Babak-1 are multidomain 
proteins that are highly conserved in vertebrates. 
SILAC-based analysis of Babak-2 immunoprecipitates revealed that Babak-2 undergoes 
Ser/Thr phosphorylation and interacts with Paxillin, a FA-associated adaptor molecule. 
Immunoprecipitation experiments and mutational analysis of Babaks revealed that their 
recruitment to focal adhesions was dependent on their interaction with Paxillin, which was 
mediated through a paxillin binding sequence (PBS) present in the N-terminal half of the 
protein. Quantitative RT-PCR and northern assays revealed that Babak-1 and -2 transcripts 
are expressed at all embryonic stages after E7.5 as well as in most of adult murine tissues. 
To test the functional properties of Babak-2 in vivo, we generated a conditional Babak-2-
null mouse strain. Babak-2-null mice were fertile and did not show an obvious phenotype 
suggesting that Babak-2 function can be compensates by its homologous protein, Babak-1. 
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Summary  
 
Integrin and receptor tyrosine kinase signalling networks cooperate to regulate various 
biological functions. The molecular details underlying the integration of both signalling 
networks remain largely uncharacterized. Here we identify a signalling module composed 
of a fibronectin/α5β1 integrin/ILK complex that, in concert with epidermal growth factor 
(EGF) cues, cooperatively controls the formation of transient actin-based circular dorsal 
ruffles (DRs) in fibroblasts. DR formation depends on the precise spatial activation of Src 
at focal adhesions by integrin and EGF receptor signals, in an ILK-dependent manner. In a 
SILAC-based phosphoproteomics screen we identified the tumor-suppressor Cyld to be 
required for integrin/EGF-induced DR formation. Furthermore, EGF-induced Cyld tyrosine 
phosphorylation is controlled by integrin/ILK and c-Src as a prerequisite for DR formation. 
This study provides evidence for a novel function of integrin/ILK and EGF signalling 
crosstalk in mediating Cyld tyrosine phosphorylation and fast actin-based cytoskeletal 
rearrangements. 
 
Word count: 141 words. 
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Introduction 
 
Cells are exposed to a wide variety of mechanical and chemical stimuli that must be 
integrated at the molecular level to achieve an appropriate biological response. The 
integration of distinct signalling pathways from different cell surface receptors into a 
common downstream response is referred to as signalling crosstalk. Such crosstalk occurs 
between integrins and receptor tyrosine kinases (RTKs) to control important biological 
processes such as cell differentiation, proliferation, survival, migration, innate immune 
response and angiogenesis (Cabodi et al., 2004; Chan et al., 2006; King et al., 2011; 
Loubaki et al., 2010; McCall-Culbreath et al., 2008; Ross, 2004; Somanath et al., 2009). 
However, the molecular details of how distinct signalling pathways arising from integrins 
and RTKs such as epidermal growth factor receptor (EGFR) can converge to regulate these 
processes remain largely unknown. 
Integrins are heterodimeric transmembrane proteins that interact with extracellular matrix 
molecules to trigger intracellular signal transduction cascades leading to the reorganization 
of the actin cytoskeleton and activation of downstream signalling pathways (Hynes, 2002; 
Legate et al., 2009; Wiesner et al., 2005). Integrins assemble in different α/β subunit 
combinations which confer substrate and signalling specificity. As integrins have short 
cytoplasmic domains that lack enzymatic and actin-binding activity, they depend on the 
assembly of adaptor proteins onto their cytoplasmic tails for signal transduction. More than 
180 signalling and scaffolding molecules have been identified that can be recruited to large 
integrin-based signalling hubs called focal adhesions (FAs) (Legate and Fässler, 2009; 
Schiller et al., 2011; Kuo et al., 2011; Zaidel-Bar and Geiger, 2010). Among these 
molecules, integrin-linked kinase (ILK) is a key player that was shown to directly bind the 
β1 and β3 integrin cytoplasmic tails (Hannigan et al., 1996; Pasquet et al., 2002). ILK is a 
multifunctional protein that regulates various cellular processes by associating with 
regulatory and adaptor proteins such as Pinch, α- and β-parvins, IQGAP1 and paxillin 
(Bottcher et al., 2009; Lange et al., 2009; Wickstrom et al., 2011). The analysis of 
constitutive and conditional deletion of the ILK gene in mice,	   D. melanogaster and C. 
elegans revealed that ILK controls the organization of the F-actin cytoskeleton, cell 
polarity, differentiation and proliferation (Esfandiarei et al., 2010; Grashoff et al., 2003; 
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Hannigan et al., 1996; Legate and Fässler, 2009; Lorenz et al., 2007; Mackinnon et al., 
2002; Sakai et al., 2003; Wang et al., 2008; Zervas et al., 2001). 
FAs serve as a signalling nexus to condense and direct numerous signalling molecules, 
including kinases. The proto-oncogene c-Src is one of the kinases that localizes to FAs. Src 
activity is regulated by both integrin and RTK signalling (Huveneers and Danen, 2009; 
Yeatman, 2004) and precise spatiotemporal activation is important for its biological 
functions, including the regulation of FA stability, turnover and integrity (Fincham and 
Frame, 1998; Zou et al., 2002). c-Src also regulates F-actin cytoskeleton remodeling 
through activation of various effector proteins, including small GTPases (Huveneers and 
Danen, 2009; Timpson et al., 2001), kinases such as c-Abl as well as p120-Catenin and 
cortactin (Castano et al., 2007; Chang et al., 1995; Plattner et al., 1999). 
Circular dorsal ruffles/waves (also known as dorsal ruffles (DRs) or actin ribbons) are 
dynamic actin-based structures that assemble on the dorsal plasma membrane in response to 
a variety of growth factors (Abercrombie et al., 1970; Buccione et al., 2004; King et al., 
2011; Schliwa et al., 1984). Growth factor stimulation activates a signalling cascade that 
starts with activation of master kinases such as c-Src and ends with transient cytoskeletal 
rearrangements regulated by cortical actin polymerization (Buccione et al., 2004). The 
exact function of DRs is still unclear, but they have been proposed to be important for 
macropinocytosis, trafficking of β3 integrin, sequestration and internalization of RTKs after 
ligand stimulation, and fast remodelling of the actin cytoskeleton during cell migration and 
invasion (Abella et al., 2010; Buccione et al., 2004; Dowrick et al., 1993; Gu et al., 2011; 
Krueger et al., 2003; Orth et al., 2006; Suetsugu et al., 2003). 
In this study we show that DRs are the result of cooperative signals emanating from 
integrin and RTK signalling pathways. We found that ILK is an essential component in the 
DR signalling cascade downstream of FN/α5β1 integrins. ILK regulates the spatiotemporal 
activation of Src at FAs, which is required for tyrosine phosphorylation of the tumour-
suppressor Cyld and the formation of DRs. The implications of these findings are 
discussed. 
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Results 
 
ILK is crucial for dorsal ruffle formation 
We generated ILK-floxed (ILKf/f) and ILK-deficient (ILK-/-) fibroblasts to investigate the 
consequence of ILK deletion in vitro (Sakai et al., 2003). During our experiments we 
realized that stimulation of starved ILKf/f cells with media containing 10% fetal calf serum 
induced DRs in approximately 30% of ILKf/f cells, while ILK-/- cells very rarely formed 
DRs (Fig. 1A). To study this effect under defined conditions in the presence of specific 
growth factors, we measured epidermal growth factor (EGF)-triggered DR formation in 
serum-starved ILKf/f and ILK-/- fibroblasts that were seeded on FN-coated surfaces. 
Consistent with our observation using 10% fetal calf serum, about 25% of ILKf/f cells 
formed DRs after EGF stimulation whereas ILK-/- cells showed very few ruffles (Fig. 1B, 
C). Similarly, ILK-/- cells formed fewer DRs in response to platelet derived growth factor 
(PDGF) stimulation (Supplementary material Fig. S1A). This reduction in DR formation 
was not a clonal artifact since we consistently found a significant reduction of DRs in all 
ILK-/- clones compared to their ILKf/f counterparts (Supplementary material Fig. S1B). 
Immunostaining of ILK showed no localization to DRs after EGF stimulation 
(Supplementary material Fig. S1C). The reduced DR frequency in ILK-/- cells was not due 
to reduced EGF receptor (EGFR) phosphorylation or ERK1/2 activation as their relative 
levels were similar in ILKf/f and ILK-/- cells with the exception of phosphorylation of EGFR 
Tyr992, which was increased in ILK-/- cells (Fig. 1D, supplementary material Fig. S1D). 
Similarly, EGF-induced Rac1 activation was similar in ILK-/- and ILKf/f cells, although the 
activation was prolonged in ILK-/- cells but the differences were not statistically significant 
(Supplementary material Fig. S1E, F). ILK-/- cells show spreading defect, raising the 
possibility that impaired DR formation is a consequence of the reduced spread area of these 
cells. However, when ILK-/- cells were allowed to spread for longer time periods, up to two 
days they did not show a significantly increased frequency of DR formation despite a 
normal spread area (Fig. 1A; data not shown). Moreover, stable re-expression of FLAG-
tagged ILK (Fig. 1E, F) or ILK-EGFP (Supplementary material Fig. S1G) fully rescued the 
DR defect of ILK-/- cells. 
ILK has been suggested to interconnect integrins with growth factor pathways through 
Pinch1. Additionally, ILK and Pinch1 are components of the ILK-Pinch-Parvin (IPP) 
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complex, whose members depend on complex formation for maintaining their stability 
(Legate et al., 2006). Western blot analysis showed that the Pinch1 expression level is 
strongly reduced in ILK-/- cells (Fig. 1E). To test whether the DR formation defect in ILK-/- 
cells is caused by the diminished Pinch1 protein level, we stably re-expressed FLAG-
tagged N-terminal ANK-repeats of ILK (ANK-FLAG) in ILK-/- cells. The presence of 
ANK-FLAG stabilized Pinch1 expression to wild type levels, but cells were still not able to 
form DRs (Fig. 1E, F).  Hence, the reduced DR frequency in ILK-/- cells was not due to 
reduced Pinch1 protein levels. Expression of ANK-FLAG had no effect on DR formation 
in ILKf/f cells (Supplementary material Fig. S1H, I). Conversely, Pinch1-/- cells showed 
strongly reduced ILK protein (Stanchi et al., 2009) and decreased DR formation 
(Supplementary material Fig. S1J). Together, these data demonstrate that ILK plays an 
essential role in the induction of DRs. 
 
ILK-/- cells have defects in DR-related functions 
The precise biological function of DRs is still uncertain, but various reports ascribe 
macropinocytosis, large scale actin reorganizations prior to migration and growth factor 
receptor internalization as downstream consequences of DR formation (King et al., 2011; 
Orth et al., 2006). We found that ILK-/- cells migrate toward a source of EGF or PDGF less 
efficiently than ILKf/f cells or ILK-FLAG rescued ILK-/- cells (Fig. 2A). Furthermore, the 
internalization of activated EGFR was significantly reduced in ILK-/- cells whereas the 
internalization of transferrin receptor remained unchanged (Fig. 2B, Supplementary 
material Fig. S2). Reduced internalization of EGFR is expected to result in prolonged 
signaling, and indeed the relative level of phosphorylation of EGFR in ILK-/- cells is 
increased, perhaps as a result of impaired downregulation through internalization 
(Supplementary material, Fig S1D). Therefore, ILK-/- cells displayed phenotypic 
differences that are consistent with a reduction in the formation and number of DRs. 
 
DRs are the result of α5β1 integrin and EGFR signalling co-signalling 
The finding that ILK plays a critical role in DR formation suggested a requirement for 
integrin signalling in the formation of these structures. To test whether integrin engagement 
is necessary for DR formation, we monitored EGF-induced DRs in ILKf/f cells seeded on 
fibronectin (FN) or poly-L-lysine (PLL). While FN can be recognized by many integrin 
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receptors, most notably α5β1 and αvβ3, PLL-mediated adhesion is integrin-independent. 
Only FN-seeded ILKf/f cells formed DRs (Fig. 3A), and the rate of DR formation in ILKf/f 
cells increased with the FN-concentration (Fig. 3B). 
To examine whether the formation of DRs depends on a specific integrin heterodimer, we 
evaluated DR assembly in a FN-free system by seeding serum-starved FN-null (FN-/-) 
fibroblasts on FN, vitronectin (VN), collagen1 (Col1), or PLL (Fig. 3C-E). FN-/- cells 
established a distinct morphology on each substratum and formed paxillin-rich focal 
adhesions on FN, VN and Col1 but not on PLL (Fig. 3E). While about 25% of FN-seeded 
FN-/- cells formed DRs, cells adherent to PLL, VN or Col1 formed significantly fewer DRs 
(<5%, Fig. 3F). The spread areas of FN-/- cells on FN, VN and Col1 were comparable, 
indicating that differences in spreading do not contribute to altered DR formation 
(Supplementary material Fig. S3A). In addition, when we limited the spreading time of FN-
seeded FN-/- cells to 30 minutes, so they covered the same spread area as PLL-attached 
cells, they still formed DRs normally (Supplementary material Fig. S3B). Moreover, DR 
formation in FN-/- cells plated on FN was also dependent on ILK (Supplementary material 
Fig. S3C, D). 
Integrin-mediated cell adhesion to FN is mainly achieved through α5β1 and αVβ3 integrins 
while VN is bound by αVβ3 but not α5β1 integrin (Hynes, 2002). Therefore, our results 
suggest that only α5β1 integrin signals trigger DRs. To confirm this, we examined EGF-
induced DRs in serum-starved FN-seeded integrin β1f/f and β1-/- fibroblasts (which lack 
α5β1 but express αVβ3 integrin). In agreement with the previous experiments, about 30% 
of β1f/f cells formed DRs whereas β1-/- cells showed significantly reduced DR frequency 
(Fig. 3G). Re-expression of β1 integrin in β1-/- cells rescued DR formation in these cells 
(Supplementary material Fig. S3E, F). These results suggest that DRs are the consequence 
of FN/α5β1 integrin/ILK and EGFR co-signalling. 
 
ILK affects active c-Src localization to FAs 
Both integrin and RTK signalling stimulate c-Src tyrosine kinase activity, which is known 
to play a central role in DR formation (Chang et al., 1995; Huveneers and Danen, 2009). In 
line with these previous reports, ILKf/f cells pre-treated with a Src inhibitor (PP1) failed to 
form DRs (Supplementary material Fig. S4A). Therefore we decided to investigate the role 
of c-Src in more detail. First, we investigated whether c-Src activation is impaired in ILK-/- 
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cells. Immunostaining with a pY416 c-Src antibody showed that active c-Src levels were 
dramatically reduced in FAs of FN-seeded ILK-/- cells before EGF stimulation and 
remained reduced after EGF stimulation (Fig. 4A, B). Re-expression of ILK-EGFP in ILK-/- 
cells rescued the level of active c-Src in FAs (Supplementary material Fig. S4B-D). 
Western blot analysis showed that total c-Src levels were similar in ILKf/f and ILK-/- cells 
(Fig. 4C) and that non-adherent ILKf/f and ILK-/- cells showed a similar (2-fold) increase in 
c-Src activity after EGF treatment (Fig. 4C, D). Plating cells on FN caused a basal increase 
in c-Src phosphorylation in ILKf/f cells that did not manifest in ILK-/- cells, but EGF-
treatment induced a similar activation of c-Src in both cell lines, resulting in a net decrease 
in active c-Src in ILK-/- cells of about 20% (Fig. 4C, D). Co-immunoprecipitation of ILK 
with anti-c-Src antibody in ILK-FLAG-rescued ILK-/- cells (Fig. 4E), and c-Src with anti-
GFP antibody in ILK-GFP-rescued ILK-/- cells (Fig. 4F) indicated that c-Src and ILK form 
a complex in our fibroblast cell lines. However, a complex between c-Src and endogenous 
ILK was not easily detectable in our cells (data not shown). 
Importantly, transient expression of constitutively active c-SrcY527A-EGFP localized to 
FAs and rescued DR formation in ILK-/- cells (Supplementary material Fig. S4E-G). 
Furthermore, a decreased level of active c-Src at FAs significantly correlated with 
decreased DR frequency, whereas c-Src activity and the number of DRs concomitantly 
increased in ILKf/f cells when seeded on increasing FN concentrations (Supplementary 
material Fig. S4H; compare with Fig. 3B). Together, these experiments suggest that ILK 
affects DR formation through controlling c-Src activity at FAs. 
 
β1 integrin/ILK and EGFR co-signalling triggers tyrosine phosphorylation of proteins 
involved in DR formation 
The kinase signalling cascade leading to DRs is mediated by β1 integrin/ILK and EGFR 
co-signalling, which activates c-Src in FAs. To identify potential ILK-dependent substrates 
for EGFR/c-Src that are involved in DR formation, we compared the phosphoproteome of 
30 sec and 2 min EGF treated ILKf/f and ILK-/- cells by combining phosphotyrosine 
immunoprecipitation and SILAC-based mass spectrometry (Fig. 5A). Candidate proteins 
involved in β1 integrin/EGFR induced DR formation were defined as those which 
displayed increased phosphorylation upon EGF stimulation in ILKf/f cells, but not in ILK-/- 
cells. Our analyses identified and quantified more than 2000 proteins and 140 specific 
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phosphorylation sites (Supplementary material datasets. S1, 2) after excluding proteins that 
are expressed at different levels in ILKf/f and ILK-/- cells, identified in whole proteome 
SILAC-based mass spectrometry experiments (data not shown). The majority of proteins 
identified 2 minutes after EGF stimulation had the same SILAC ratio in ILKf/f and ILK-/- 
cells, while certain proteins were upregulated in an ILK-dependent manner (Fig. 5B). 
To test the involvement of these proteins in DR formation we performed sh/siRNA-
mediated knockdown in ILKf/f cells, of candidate proteins that were consistently 
represented in 4 independent SILAC screens (Fig. 5C). Knock down efficiency was 
evaluated using western blotting and quantitative RT-PCR (Supplementary material Fig. 
S5A, B). DR frequency decreased significantly in Cyld and Asap2 depleted cells (Fig. 5D, 
E). We decided to further analyse the involvement of Cyld in the β1 integrin/ILK and 
EGFR co-signalling pathway. 
 
Cyld tyrosine phosphorylation is essential for DR formation 
The tumor suppressor protein Cyld tunes several signal transduction pathways including 
NF-kB, JNK and Wnt/β-catenin through its deubiquitinating (DUB) activity (Massoumi, 
2010). We prepared Cyld-/- fibroblasts from Cyld-deficient mice (Massoumi et al., 2006) to 
corroborate the crucial role of Cyld in DR formation (Fig. 6A). Re-expression of FLAG-
Cyld normalized DR formation in Cyld-/- fibroblasts (Fig. 6A; Supplementary material Fig. 
S6A), while re-expression of a catalytically inactive Cyld (Cyld C>S) (Brummelkamp et 
al., 2003; Trompouki et al., 2003) failed to restore DR formation in Cyld-/- cells (Fig. 6A). 
Immunostaining of endogenous Cyld in wild type cells (Fig. 6B) and over expression of 
GFP-Cyld in Cyld-/- cells revealed that Cyld was recruited to DRs (Supplementary material 
Fig. S6B-D). Like in ILK-/- cells, Rac1 activation was not impaired in Cyld-/- cells 
(Supplementary material Fig. S6E, F). 
As our phospho-proteomics screen enriched for tyrosine phosphorylated proteins, we tested 
whether Cyld becomes tyrosine phosphorylated when serum-starved cells are seeded on FN 
and stimulated with EGF. Fig. 6C shows that Cyld became tyrosine phosphorylated within 
2-4 minutes after EGF stimulation. This phosphorylation was abrogated when cells were 
treated with the selective EGFR inhibitor, Gefitinib (Iressa), indicating that Cyld 
phosphorylation is indeed downstream of EGFR signaling (Fig. 6D). Cyld became tyrosine 
phosphorylated in response to EGF stimulation when cells were plated on FN but not when 
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they were seeded on PLL, VN or Col1 (Fig. 6E, F). Consistent with our phospho-
proteomics data, Cyld phosphorylation was reduced in FLAG-Cyld rescued Cyld-/- cells in 
which ILK was depleted (Fig. 7A). Similarly, Cyld phosphorylation was diminished in 
ILK-/- cells expressing FLAG-Cyld when compared with control ILKf/f cells (Fig. 7B), 
whereas localization of endogenous Cyld was not changed in ILK-/- cells upon EGF 
stimulation (Supplementary material Fig. S7A). Finally, c-Src inhibition with PP1 
abolished EGF-induced Cyld tyrosine phosphorylation in FLAG-Cyld rescued Cyld-/- cells 
indicating that EGF-induced Cyld tyrosine phosphorylation occurs downstream of c-Src 
(Fig. 7C). Immunostaining of active Src in mCherry-Cyld-expressing Cyld-/- cells 
suggested that cytoplasmic Cyld was not localized to FAs (Fig. 7D). Although 
phosphorylation of Cyld on serine has recently been reported (Hatti et al., 2009), this is the 
first report demonstrating Cyld tyrosine phosphorylation. 
To identify which tyrosine residue(s) are phosphorylated in response to EGF, we conducted 
a mutational analysis. Mutation of 4 tyrosines (FLAG-Cyld-4X) identified in other 
phosphoproteomics experiments (data not shown, for the locations of these tyrosines see 
Supplementary material datasets. S3) reduced neither EGF-induced tyrosine 
phosphorylation of Cyld nor DR formation (Fig. 6A; Supplementary material Fig. S7B). 
The substitutions of additional tyrosines with alanines (FLAG-Cyld-9X and FLAG-Cyld-
18X mutants, Supplementary material datasets S3) led to a significant decrease in EGF-
induced tyrosine phosphorylation and DR formation (Fig. 6A, Fig. 7E). 
Altogether these data demonstrate that Cyld lies downstream of an integrin/ILK-EGFR co-
signalling pathway leading to the formation of DRs in fibroblasts. While the DUB activity 
of Cyld is dispensable for DR formation, tyrosine phosphorylation of Cyld is required, and 
this phosphorylation lies downstream of EGF-mediated and ILK-dependent c-Src 
activation. 
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Discussion 
 
Previous studies have shown that dynamic, transient actin-based DRs form in response to a 
variety of growth factors, including EGF, PDGF, and hepatocyte growth factor (HGF) 
(Buccione et al., 2004). In the present study, we report that integrin and RTK signalling 
pathways cooperatively control the formation of DRs. The integrin-based signalling leading 
to DR formation emanates specifically from α5β1 integrin through a signalling module 
containing ILK, c-Src and Cyld. 
The specificity of the involvement of α5β1 in DR formation can be explained by the 
differential assembly of specific FA signalling complexes at the integrin tails that confers 
distinct signalling specificities to different α/β integrin subunit combinations (Humphries et 
al., 2009). For example, α5β1 and αVβ3 have distinct effects on actin cytoskeletal 
regulation through different modulation of Rho GTPases (Danen et al., 2005; Huveneers et 
al., 2008). While adhesion to FN by α5β1 causes high levels of RhoA activity and low 
levels of Rac activity, adhesion via αvβ3 induces low levels of RhoA activity (Danen et al., 
2002; Huveneers et al., 2008). Additional actin modulators, such as VASP, are also 
regulated differently by β1 and β3 integrins, leading to changes in actin-dependent 
processes such as migratory behavior (Worth et al., 2010). By plating cells on different 
substrates and making use of β1-/- cells we show that the specific signalling complex that 
assembles on α5β1 integrin tails supports DR formation, whereas the signals emanating 
from β3 integrins or collagen-binding integrins do not. This is consistent with a recent 
study demonstrating that β1 integrin is essential for both PDGF-induced DRs and 
chemotaxis in fibroblasts (King et al., 2011). We also show that ILK is a key component of 
the DR signalling complex downstream of α5β1 integrin. ILK-/- cells formed only a few 
DRs, while ILKf/f cells as well as ILK-EGFP- or ILK-FLAG-rescued ILK-/- cells formed a 
full complement of DRs. This effect of ILK is downstream of β1 integrin as β1-/- cells are 
also unable to support DRs despite ample levels of ILK expression. 
ILK has been intensively studied as a FA adaptor molecule that is involved in integrin-
mediated actin cytoskeletal rearrangements (Bottcher et al., 2009; Legate et al., 2006; 
Legate et al., 2009). We found that ILK affects DR formation by regulating the levels of 
active c-Src in FAs in the absence of growth factors. c-Src is a tyrosine kinase that mediates 
signalling pathways involved in actin reorganization and DR formation, and is activated 
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downstream of RTK and integrin signalling (Huveneers and Danen, 2009). There is 
increasing evidence that c-Src activation and its biological functions are tightly controlled 
by its subcellular localization. Whereas c-Src at FAs inhibits Rho GTPase by inducing 
p190GAP activation, it activates Rho GTPase when localized to podosomes (Arthur et al., 
2000; Bass et al., 2008; Berdeaux et al., 2004). In addition, PDGF receptor uses different 
pools of c-Src to initiate distinct pathways; while PDGF activates caveolae-associated c-Src 
for mitogenesis, PDGF-activated c-Src outside of caveolae affects F-actin assembly leading 
to DR formation (Veracini et al., 2006). The absence of ILK strongly reduces the levels of 
active c-Src in FAs, but rescuing ILK-/- cells with ILK-FLAG or ILK-GFP restores its 
presence in FAs, and induces an ILK/c-Src complex. It has been suggested that an ILK/c-
Src complex regulates actin polymerization by phosphorylating cofilin (Kim et al., 2008). 
The ILK/c-Src interaction seems to be important for c-Src activation in FAs, but does not 
appear to play a role in c-Src phosphorylation in response to EGF stimulation. Therefore 
the localization of c-Src to FAs via associating with ILK is necessary for DR formation, 
whereas activation of c-Src in other subcellular compartments is not sufficient for this 
process. However, the precise mechanism by which ILK affects active c-Src levels in FAs 
is still unclear. 
The mechanism by which c-Src, and in particular FA-associated c-Src, induces DR 
formation is largely unknown. c-Src at FAs activates Rac1 locally through phosphorylation 
of specific GEFs, and thereby induces lamellipodia (Huveneers and Danen, 2009). In 
concert with RTK signals active Rac could participate in DR induction (Buccione et al., 
2004). In addition, several c-Src substrates have been implicated in DR formation, such as 
Cortactin (Lai et al., 2009), c-Abl (Plattner R et al., 1999) and c-Cbl (Sirvent et al, 2008). In 
this study we used a SILAC-based phosphoproteomics screen to detect proteins 
differentially phosphorylated by EGF in the presence or absence of functional integrin/ILK 
signalling. We confirmed the reliability of our SILAC list by monitoring DR formation in 
cell lines depleted of selected candidate proteins by sh/siRNA. In this way we identified 
Cyld as a new player in DR formation downstream of c-Src. This screen also identified 
additional candidates that could potentially serve key roles in integrin/RTK crosstalk.  
The function of Cyld in the regulation of signalling pathways has previously been linked to 
its Lysine-63 deubiquitinase activity (Brummelkamp et al., 2003; Kovalenko et al., 2003; 
Massoumi et al., 2006; Reiley et al., 2004) which can be controlled by phosphorylation on 
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serine 418 by IKKε (Hutti et al., 2009). However, the role of Cyld in DR formation is 
independent of its DUB activity. Rather, EGF stimulation resulted in Cyld tyrosine 
phosphorylation which is necessary for DR formation. Cyld phosphorylation is dependent 
on Src activity and occurs downstream of a cooperative EGFR and integrin signalling 
network involving FN, α5β1 integrin and ILK. As ILK does not localize to DRs and Cyld 
does not localize to FAs we propose a model whereby, upon EGF stimulation, activated Src 
localizes to ILK-containing FAs, where it activates substrates that either directly or 
indirectly phosphorylate Cyld, causing it to redistribute to DRs to exert its specific 
function. 
Although we have identified Cyld as an important intermediary for DR formation, the 
precise function of Cyld tyrosine phosphorylation in this process has yet to be elucidated. 
Tyrosine phosphorylation may be required for the interaction of Cyld with yet unknown 
binding partners, including proteins that can directly regulate actin dynamics. On the other 
hand, Cyld associates with α-tubulin and microtubules via its CAP-Gly domains and 
increases the levels of acetylated tubulin through an inhibitory interaction with the histone 
deacetylase-6 (HDAC6) (Gao et al., 2008; Wickstrom et al., 2010). Cyld tyrosine 
phosphorylation might control DR assembly by affecting the ability of Cyld to bind to 
microtubules and influence their dynamic instability, thereby controlling actin/microtubule 
crosstalk. We are currently addressing these possibilities to understand the role of Cyld in 
DR formation more precisely. 
In conclusion, our work has identified Cyld as a key member of an integrin/ILK-EGFR co-
signalling pathway. Interestingly, deregulation of each of these molecules has been 
implicated in cancer progression (Cabodi et al., 2010; Demchenko et al., 2010; Grandal and 
Madshus, 2008; Massoumi, 2010). Although the biological function of DRs is unknown, 
proposed functions such as RTK endocytosis and sites of localized matrix degradation 
could be important for tumourigenesis and metastatic behaviour. Future work to more 
precisely define how integrin/ILK and EGFR collaborate to activate Cyld, and how Cyld 
functions to enable rapid actin reorganizations leading to DRs could provide novel insights 
into how deregulation of these signaling pathways promotes the formation and spread of 
cancer. 
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Materials and methods 
 
Reagents and antibodies 
Human recombinant EGF and PDGF-BB were from Millipore; Boyden chambers were 
from BD Bioscience; PP1 inhibitor was from Cell Signalling Technology. Gefitinib (Iressa) 
was supplied by Selleck. The following antibodies were used: ILK, Rac1 and paxillin (BD 
Bioscience), EGF receptor, pY1173-, pY1068-, pY992- and pY845-EGF receptor and 
pY416-Src (Cell Signalling Technology); pY-4G10 and Lasp-1 (Millipore); β1 integrin and 
Cyld antibodies were homemade antibodies raised in rabbit; anti-FLAG, SHC2, and 
vinculin (Sigma); CDC42BPB, Dock4 (ABNOVA); anti-mouse-HRP, anti-rabbit-HRP, 
anti-Rat-HRP (BioRad); phalloidin-Alexa-488 (Invitrogen); anti-rabbit Cy3, anti-mouse 
Cy3 (Jackson Immunoresearch); Pinch1 (Li et al., 2007). 
 
Immunofluorescence 
Cells were cultured on glass cover slips coated with 10 µg/ml FN (Calbiochem). For 
staining, cells were fixed in 2-4% paraformaldehyde in PBS for 15 min and permeabilized 
for 10 min with 0.2% Triton X-100 in PBS. The cells were blocked with 3% BSA in PBS 
for 1 h and incubated with the primary antibody for 1 h at room temperature or overnight at 
4°C. Secondary antibodies were incubated for 1 h at room temperature. Images were 
collected using a confocal microscope (DMIRE2; Leica, Bensheim, Germany) equipped 
with 63x/1.4 or 100x/1.4 oil objectives and the Leica Confocal Software (version 2.5, build 
1227), or collected with a AxioImager Z1 microscope (Zeiss, Germany) with the 63x/1.4 
oil objective, using Metamorph software. 
 
Immunoprecipitation and western blotting 
Cell lysate was prepared by quickly washing cells in ice-cold PBS prior to addition of lysis 
buffer (50mM Tris-HCl, pH7.6, 150mM NaCl, 1% Triton-X-100, protease inhibitor 
cocktail (Roche) and phosphatase inhibitor cocktail (Sigma-Aldrich)). FLAG-tagged 
protein immunoprecipitation was performed according to the manufacturer’s instructions 
(Sigma, Cat.No. A2220). For other IPs, cell lysates at 0.5-1 mg/ml were pre-cleared by 
centrifugation for 1 hour at 4°C and incubated with antibody for 3 hours or overnight at 
4°C. Protein complexes were captured using protein A or G agarose beads for 1 hour at 
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4°C, washed three times with lysis buffer, eluted with SDS loading buffer and analyzed by 
SDS-PAGE. GTP-Rac1 pulled down by PAK-CRIB peptide from EGF-triggered cell 
lysates and blotted with Rac1 antibody. 
  
Constructs and siRNAs 
cDNA constructs of FLAG-Cyld, FLAG-ILK, FLAG-ANK ILK, pEGFP-ILK were 
amplified by PCR. DUB-dead FLAG-Cyld C>S was kindly donated by Dr. Rene Bernards, 
NKI Amsterdam. FLAG-Cyld Y>A mutant constructs were generated using the 
QuikChange Site-Directed Mutagenesis kit (#200518 Stratagene). Mutations in 9x and 19X 
Y>A FLAG Cyld mutants are summarized in Supplementary material datasets. S3. Mission 
siRNAs were ordered from Sigma. shRNAs were supplied from a shRNAmir30 library 
(Thermo Scientific). For sh/siRNAs sequences, see Supplementary material datasets S3. 
  
Cell cultivation and transfection/transduction 
Cells were transiently transfected with Lipofectamine 2000 (Invitrogen). To generate stable 
cell lines cDNAs were cloned into pCLMFG retroviral vectors and transiently transfected 
into human embryonic kidney (HEK293T) cells; viral particles were used for infection of 
ILK-/- fibroblast as previously described (Pfeifer et al., 2000). For stable knockdowns 
Phoenix viral packaging cells were used to generate virus that was subsequently used to 
infect ILKf/f fibroblasts (Pear et al., 1993). Integrin β1f/f fibroblasts were isolated from 
murine kidney and immortalized by SV40 Large T-antigen. β1-/- cells were generated by 
adenoviral infection of β1f/f cells with GFP-Cre recombinase, followed by flow cytometry 
cell sorting of GFP-positive cells. β1-/- cells were rescued by retroviral infection with β1 
integrin cDNA. For DR experiments, fibroblasts were serum starved overnight, trypsinized, 
seeded on FN, VN, Col1 or PLL coated dishes, stimulated with 50ng/ml EGF and 
monitored for DR formation using a Zeiss Axiovert 200 M microscope (Zeiss, Germany) at 
37°C. Time lapse images were captured for 15 minutes with interval time of 90 seconds. 
We isolated Cyld-/- fibroblasts from kidney of Cyld-/- mice (Massoumi et al., 2006). 
  
EGFR internalization assay 
ILKf/f and ILK-/- fibroblasts were serum starved for four hours at 37°C. Medium was 
exchanged for ice cold medium containing 25 ng/ml Alexa488-EGF (Invitrogen) and cells 
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were incubated on ice for 30 minutes to allow for full ligand binding. Plates were washed 
twice with cold PBS, and prewarmed DMEM was added to induce internalization of EGFR. 
Plates were incubated at 37°C for the indicated times, and placed on ice to stop 
internalization. Cells were washed for 5 minutes with 0.2 M acetic acid/500 mM NaCl, pH 
2.8, washed 3 times with cold PBS and scraped into tubes for counting by FACS. Negative 
and 100% binding controls were kept on ice and either acid washed or directly scraped into 
tubes, respectively. Fluorescence intensity was measured by FACS, and the mean values of 
the peaks were normalized against 100% binding controls to obtain percent internalization. 
 
Chemotaxis assay 
Chemotactic migration assay was performed as previously described (Legate et al., 2011). 
Briefly, 30000 cells were resuspended in serum-free conditions in Cell culture inserts 
(cat#353097; BD Biosciences), that were pre-coated on the underside with 5 µg/ml FN, and 
were allowed to migrate for 4 hours at 37oC toward the lower chamber containing 50ng/ml 
PDGF-BB, 50ng/ml EGF or BSA control. Cells were fixed and stained with 0.1% crystal 
violet in 20% methanol for 5 minutes in room temperature and non-migratory cells were 
manually removed with a cotton swab. Four random fields were captured by a Zeiss 
Axioskop microscope equipped with a LEICA DC 500 digital camera, and cells were 
counted manually. 
 
SILAC-based proteomics  
SILAC-based proteomics was performed as described before (Mann, 2006). Briefly, cells 
were metabolically labelled with SILAC medium, serum starved overnight, trypsinized, 
seeded on FN for 90 minutes and EGF (50ng/ml) stimulated for 30 seconds or 2 minutes. 
Cells lysates were prepared, mixed 1:1 and subjected to immunoprecipitation using 
phosphotyrosine antibodies (4G10 from Millipore and anti-pY100 from Cell Signalling). 
The immunoprecipitated proteins were subjected to in gel digestion; peptides were 
concentrated and desalted using the micropurification system StageTips, separated by 
online reverse phase nanoscale capillary LC and analyzed by ES MS/MS on a linear trap 
quadrupole (LTQ)-Orbitrap mass spectrometer (Thermo Fisher Scientific). Mass spectra 
were processed with the software MaxQuant in combination with the Mascot search engine.  
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Live cell imaging and image analysis 
Images of live cells were acquired at 37°C and 5% CO2 on a Zeiss Axiovert 200 M 
microscope (Zeiss, Germany) with a 10x1.6 objective; the microscope was equipped with a 
motorized stage (Märzhäuser, Germany), an environment chamber (EMBL Precision 
Engineering, Germany) and a cooled CCD camera (Roper Scientific, Princeton, NJ). 
Microscope control, image acquisition and post-acquisition analysis were carried out using 
MetaMorph software (Molecular Devices, Downington, PA). To monitor dynamics of DR 
formation in different cell types, serum starved cells were seeded on FN for 90 minutes, 
stimulated with EGF (50 ng/ml) or PDGF-BB (50 ng/ml) and time-lapse movies were 
captured for 17 minutes in the case of EGF stimulation (40 and 60 minutes for PDGF and 
serum stimulation respectively) with 90 seconds interval time. DRs were classified as 
transient actin-rich structures that appeared after growth factor stimulation. To measure 
active Src levels at FAs, serum starved cells were seeded on FN for 90 min, stimulated with 
EGF, fixed, immunostained with pY416-Src and vinculin antibodies and images were 
captured with a confocal microscope (DMIRE2; Leica, Bensheim, Germany) equipped with 
63x/1.4 oil objectives. Images were then processed by MetaMorph software to calculate the 
intensity of active Src and vinculin at FAs. The averages of active Src intensities 
normalized to vinculin intensities are presented in histograms (means±s.d.). The intensity of 
western blot bands was quantified by MultiGauge software (Fujifilm). 
 
Statistical Analysis 
Results are expressed as means±s.d. or means±s.e.m. Statistical analysis was performed 
using GraphPad Prism (version 5.00, GraphPad Software) or Excel software. ANOVA or t-
test was used for comparisons between different data sets. Asterisks indicate significant 
differences (*P<0.05, **P<0.01 and ***P<0.005). 
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Figure legends 
 
Fig. 1. ILK is required for DR formation. (A) Kinetics of DR formation in serum starved 
ILKf/f and ILK-/- cells when treated with serum or (B) when seeded on FN and stimulated 
with EGF. DR formation is significantly decreased in ILK-/- cells. (C) Actin (green) and 
Cortactin (red) staining of FN-seeded ILKf/f and ILK-/- cells after three minutes of EGF 
stimulation. Arrows indicate DRs in ILKf/f cells. Scale bars: 20µm (D) Western blot 
analysis of EGF-triggered EGFR and ERK phosphorylation in ILKf/f and ILK-/- cells. ILK-/- 
cells expressed higher levels of EGFR, however, downstream ERK signaling was not 
changed (E) Western blot analysis of protein lysates from ILK-/- cells and ILK-/- cells that 
stably express ILK-FLAG or ANK-FLAG. Note the expression level of Pinch1 is rescued 
by expression of both ILK constructs. (F) Re-expression of ILK-FLAG, but not ANK-
FLAG, rescued DR formation in ILK-/- cells. n=4 independent experiments. Data expressed 
as the mean±s.d. Stars indicate P-value for t-test (***P<0.005). 
 
Fig. 2. Functional consequence of aberrant DR formation in ILK-/- cells. (A) 
Chemotaxis migration of ILKf/f, ILK-/- and ILK-FLAG rescued ILK-/- cells toward EGF or 
PDGF. Chemotaxis migration to EGF/PDGF was significantly decreased in ILK-/- cells. 
n=4 independent experiments. (B) EGFR internalization after EGF stimulation is 
diminished in ILK-/- cells. n=3 independent experiments. Data expressed as the mean±s.d. 
Stars indicate P-value for t-test (*P<0.05 and ***P<0.005). 
 
Fig. 3. Integrin dependency of DRs. (A) Quantification of DR formation in FN- or PLL-
seeded ILKf/f cells. DR formation decreased significantly in cells plated on PLL. (B) DR 
frequency is increased in ILKf/f cells by increasing the FN concentration in the coating 
solution. (C) Differential DR formation in serum starved FN-/- cells seeded onto FN, VN, 
PLL or Col1 coated dishes (phase contrast images; scale bar: 50µm) or (D, E) coverslips 
(immunofluorescence; scale bar: 20µm) and stimulated with EGF for three minutes. 
Arrows indicate DRs in FN-seeded FN-/- cells. (D) Overlay of F-actin (green) and Paxillin 
(red) immunostaining. (E) FAs as visualized by Paxillin immunostaining. Note the absence 
of FAs in PLL-seeded FN-/- cells while FN-, VN- and Col1-seeded FN-/- cells form FAs 
with a distinct morphology. (F) Kinetics of EGF-induced DR formation when cells are 
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seeded on FN, VN, PLL or Col1. (G) The frequency of DRs is reduced significantly in 
integrin β1-/- fibroblasts in comparison with control integrin β1f/f cells. n=4 independent 
experiments. Data expressed as the mean±s.d. Stars indicate P-value for t-test 
(***P<0.005). 
 
Fig. 4. ILK affects active Src levels at FAs during spreading on FN. (A) pY416-Src 
(green) and vinculin (red) immunostaining of serum starved FN-seeded ILKf/f and ILK-/- 
cells. Note the reduced pY416-Src staining in ILK-/- cells. Scale bars: 10µm. (B) The 
quantification of pY416-Src/vinculin intensity at FAs in cell stainings showed reduced 
active Src intensity at FAs of ILK-/- cells. Data expressed as the mean±s.d. n=3 independent 
experiments. (C) pY416-Src immuno-blotting of serum starved ILKf/f and ILK-/- cells when 
seeded on FN (FN) or kept on suspension (S) and stimulated with EGF. (D) The 
measurement of pY416-Src band intensity in immunoblots indicated that FN-induced Src 
activation is impaired in ILK-/- cells. Data expressed as the mean±s.e.m. n=6 independent 
experiments. (E) ILK-FLAG was detected in anti-Src immunoprecipitates from ILK-FLAG 
cell lysates. (F) Src was detected in anti-GFP immunoprecipitates from ILK-EGFP rescued 
ILK-/- cells. Stars indicate P-value for t-test (*P<0.05, **P<0.01 and ***P<0.005). 
 
Fig. 5. Analysis of the ILK-dependent phosphoproteome. (A) Schematic representation 
of the SILAC-based phosphoproteomics screening strategy (see material and methods). 
Non-stimulated ILKf/f, EGF-triggered ILK-/- and EGF-triggered ILKf/f cells were labeled 
with light, medium or heavy amino acids isotopes, respectively. These conditions represent 
cells with activated integrin/ILK (L), EGFR (M) or both (H) signalling pathways. (B) The 
panel of identified anti-phosphotyrosine immunoprecipitated proteins after 2 min EGF 
stimulation in ILKf/f cells (x axis), and ILK-/- cells (y axis). The positions of Cyld and 
Asap2 on the graph are indicated. (C) List of candidate proteins that were assayed for their 
involvement in DR formation after sh/siRNAi mediated knock down. Quantification of DR 
formation in Cyld (D) or Asap2 (E) knock down cells demonstrates their involvement in 
the DR pathway downstream of EGF stimulation. n=4 independent experiments. Data 
expressed as the mean±s.d. Stars indicate P-value for t-test (**P<0.01 and ***P<0.005). 
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Fig. 6. DR formation requires EGF-triggered tyrosine phosphorylation of Cyld. (A) 
DR frequency three minutes after EGF induction for Cyld-/- cells, Cyld+/+ cells and Cyld-/- 
cells expressing wild type HA-Cyld, DUB-dead HA-Cyld C>S, wild type FLAG-Cyld, 
FLAG-Cyld-4X and FLAG-Cyld-9X or FLAG-Cyld-18X tyrosine to alanine point mutant 
cDNAs. (B) Immunostaining of endogenous Cyld (green) and α-actinin (red) in FN-seeded 
wild type cells after EGF stimulation. Arrows indicate DR. Scale bar: 10µm. (C) FLAG 
immunoprecipitation from FLAG-Cyld rescued Cyld-/- cells followed by phosphotyrosine 
blotting revealed transient EGF-triggered Cyld tyrosine phosphorylation. (D) Inhibition of 
EGFR signaling by Gefitinib (20nM/ml) abolished Cyld tyrosine phosphorylation. The 
inhibitory effect of Gefitinib on EGFR phosphorylation was verified by immunoblotting for 
EGFR phospho-tyrosine 992 and 1173. (E) EGF-triggered Cyld phosphorylation in cells  
seeded on FN, but not on PLL (E), VN or Col1 (F). Data expressed as the mean±s.d. Stars 
indicate P-value for t-test (***P<0.005). 
 
Fig. 7. ILK and Src are essential for EGF-triggered tyrosine phosphorylation of Cyld. 
(A) SiRNA-mediated depletion of ILK in FLAG-Cyld rescued Cyld-/- cells decreased Cyld 
tyrosine phosphorylation. (B) Western blot analysis of FLAG immunoprecipitates from 
FN-seeded ILKf/f and ILK-/- cells that expressed FLAG-Cyld before and after EGF 
stimulation. Note the reduced Cyld tyrosine phosphorylation and active Src levels in ILK-/- 
cells. (C) Pharmacological inhibition of Src activity by PP1 (5µM/ml) abolished Cyld 
tyrosine phosphorylation. (D) Immunostaining of pY416-Src (green) in Cyld-/- cells that 
expressed mCherry-Cyld, before and after EGF stimulation. mCherry-Cyld was distributed 
throughout the cytoplasm with partial enrichment at the cell periphery and perinuclear 
regions before EGF stimulation, and additionally to DRs after EGF stimulation. Scale bars: 
10 µm. (E) Cyld tyrosine phosphorylation is reduced in FLAG-Cyld-9X or FLAG-Cyld-
18X tyrosine to alanine point mutants. 
 
Supplementary Fig. S1. Impaired DR formation in ILK-/- cells. (A) Kinetics of DR 
formation in starved, FN-seeded ILKf/f and ILK-/- cells treated with PDGF-BB. ILK-/- cells 
formed a few DRs in comparison with control ILKf/f cells. Note the differential kinetics of 
PDGF- and EGF-induced (see Fig. 1B) DR formation. n=5 independent experiments (B) 
DR formation monitored in two different ILKf/f cell lines and their corresponding ILK-/- 
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clones three minutes after EGF stimulation. The frequency of DRs decreased significantly 
in all ILK-/- clones. n=3 independent experiments (C) Immunostaining of serum starved, 
FN-seeded ILKf/f cells after 4 min EGF-stimulation against F-actin (green) and ILK (red). 
ILK immunostaining was absent at DRs. Scale bar: 10 µm. (D) Quantification of EGFR 
phospho-tyrosine levels upon EGF stimulation in ILKf/f and ILK-/- cells. The intensities 
measured from western blots of n=3 independent experiments and normalized to total 
EGFR levels. EGFR phosphorylation was not reduced in ILK-/- cells. (E) Analysis of Rac1 
activation after EGF stimulation in ILKf/f and ILK-/- cells. (F) Quantification of Rac1 
activation upon EGF stimulation in ILKf/f and ILK-/- cells. n=3 independent experiments 
(G) Frequency of DRs in ILKf/f, ILK-/- and ILK-GFP rescued ILK-/- cells after three 
minutes of EGF stimulation. n=3 independent experiments. (H) Expression of ANK-FLAG 
did not affect DR formation in ILKf/f cells. n=4 independent experiments (I) Western blot 
analysis of protein lysates from ILKf/f cells that expressed ANK-FLAG. (J) EGF-induced 
DR formation decreased significantly in PINCH (-/-) cells. n=4 independent experiments. 
Data expressed as the mean±s.d. Stars indicate P-value for t-test (*P<0.05, **P<0.01 and 
***P<0.005). n.s.= not significant. 
 
Supplementary Fig. S2. Transferrin internalization was not affected in ILK-/- cells. 
Internalized transferrin was measured by flow cytometry internalization assay in ILKf/f and 
ILK-/- cells. Transferrin internalization was normal in ILK-/- cells. One example from 3 
independent experiments is shown. 
 
Supplementary Fig. S3. Integrins are crucial for DR formation. (A) Cell spreading area 
is significantly reduced only when FN-/- cells are seeded on PLL. FN-seeded FN-/- cells that 
spread for 30 minutes had same reduced spreading area. n=3 independent experiments. (B) 
Restricting the spreading time to restrict the spread area did not impair DR formation 3 
minutes after EGF stimulation. n=4 independent experiments. (C) Quantification of DR 
formation in ILK-depleted FN-/- cells 3 min after EGF-stimulation. n=3 independent 
experiments. (D) Western blot analysis of ILK levels in ILK-depleted FN-/- cells. (E) 
Rescue of DR formation in integrin β1-/- after re-expression of β1 integrin cDNA. n=4 
independent experiments. (F) Western blot analysis of β1 integrin levels in β1f/f, β1-/- and 
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β1 integrin-rescued β1-/- cell lyzates. Data expressed as the mean±s.d. Stars indicate P-
value for ANOVA in panel A (*P<0.05) and t-test in panel B, C and E (*P<0.05). 
 
Supplementary Fig. S4. DR formation is rescued in ILK-/- cells that expressed GFP-
ILK or constitutively active c-Src. (A) DR formation in ILKf/f cells is blocked when 
treated with Src selective inhibitor PP1. n=4 independent experiments. (B) The 
quantification of pY416-Src/vinculin immunofluorescence intensity at FAs showed 
increased active Src level in FAs of ILK-GFP rescued ILK-/- cells. n=3 independent 
experiments. (C and D) Serum starved ILK-/- cells and ILK-GFP rescued ILK-/- cells were 
seeded on FN, stimulated with EGF and immunostained for pY416-Src (red) and (C) 
vinculin or (D) actin (white). Scale bars: 10 µm. Arrows indicate DRs. (E) Starved ILK-/- 
cells that transiently express Y527A Src-GFP were stimulated with EGF for three minutes 
and immunostained for actin (red) and vinculin. Scale bars: 10 µm. Arrows indicate DR. 
(F) Western blot analysis and (G) the frequency of DRs for ILK-/- cells that transiently 
express pEGFP or Y527A-Src-pEGFP constructs. n=5 independent experiments. (H) The 
levels of active Src at FAs correlate with (compare to Fig. 2B) DR frequencies and FN 
coating concentrations. n=3 independent experiments. Data expressed as the mean±s.d. 
Stars indicate P-value for t-test (*P<0.05 and ***P<0.005). 
 
Supplementary Fig. S5. Evaluation of knock down efficiency for selected candidate 
proteins from the SILAC list, using (A) quantitative RT-PCR or (B) western blotting.   
 
Supplementary Fig. S6. Cyld is essential for DR formation. (A) Dynamics of DR 
formation in Cyld+/+, Cyld-/- and FLAG-Cyld rescued Cyld-/- fibroblasts. n=3 independent 
experiments. (B) Localization of GFP-Cyld to DRs. Staining of F-actin (white) in Cyld-/- 
cells that co-expressed GFP-Cyld (green) and mCherry (red) . (C) Fluorescence intensity 
measured for three different regions (red line) at DR rings for actin (gray), GFP-Cyld 
(green) and mCherry (red). Cells with same background intensities of GFP-Cyld and 
mCherry were selected for further analysis. (D) Graph showing GFP-Cyld and mCherry 
intensities normalized to actin levels for 10 different cells with DR. (E) Rac1 activation in 
Cyld-/- and Cyld+/+ cells after EGF stimulation. (F) Quantification of western blot intensities 
from Rac1 activation assay for Cyld-/- and Cyld+/+ cells. n=3 independent experiments. Data 
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expressed as the mean±s.d. in panel A and D and mean±s.e.m in panel F. Stars indicate P-
value for t-test (**P<0.01 and ***P<0.005). n.s.= not significant. 
 
Supplementary Fig. S7. Cyld is essential for DR formation. (A) Immunostaining of Cyld 
(green) and Vinculin (red) in FN-seeded ILK (-/-) and ILK (f/f) cells before and after EGF-
stimulation. Cyld was distributed in the cytoplasm and partially enriched at perinuclear 
regions in Ilk (-/-) and ILK (f/f) cells. Scale bars: are 10 µm. (B) The EGF-triggered Cyld 
tyrosine phosphorylation was not affected in quadruple tyrosine to alanine FLAG-Cyld 
mutants (4X) or in a triple mutant Cyld (3X) that contains the three N-terminal mutations of 
the FLAG-Cyld-9X mutant. See Supplementary material dataset S3 for mutated amino acid 
positions.  
 
Supplementary dataset. S1. The list of proteins that were identified and quantified in 
our SILAC-based (phospho)-proteomics experiments. Peptides and proteins are listed in 
the sheets. The list of all detected proteins from SILAC experiments (protein groups are 
presented in Excel sheet). The list of identified (phospho)-proteins that showed up-
regulation (>2.5 fold) or down-regulation (<0.4 fold) in ILKf/f cells (_HL>2.5 or <0.4 Excel 
sheets) or ILK-/- cells (_ML>2.5 or <0.4 Excel sheets) when cells were stimulated with 
EGF for 30 seconds or 2 minutes. L, M and H in tables indicate non-stimulated ILKf/f, 
EGF-triggered ILK-/- and EGF-triggered ILKf/f cells respectively. H/L and M/L indicates 
the normalized SILAC up-regulation ratio in EGF-triggered ILKf/f and ILK-/- cells 
respectively as compared with non-stimulated ILKf/f cells. 
 
Supplementary dataset. S2. The Excel list of phospho-(Ser/Thr/Tyr)-peptides that 
were identified and quantified by our SILAC-based (phospho)-proteomics 
experiments. The identified phospho-peptides that were upregulated in ILKf/f or ILK-/- cells 
upon 30 seconds/2 minutes EGF stimulation were shown separately. 
 
Supplementary dataset. S3. The sequence of sh/siRNAs used in this study and the 
position of tyrosine to alanine mutations in FLAG-Cyld mutants. 
 
 
 
Appendix 
 
 
 
92 
 
Appendix 
 
 
 
93 
 
Appendix 
 
 
 
94 
 
Appendix 
 
 
 
95 
 
Appendix 
 
 
 
96 
 
Appendix 
 
 
 
97 
 
Appendix 
 
 
 
98 
 
Appendix 
 
 
 
99 
 
Appendix 
 
 
 
100 
 
Appendix 
 
 
 
101 
 
Appendix 
 
 
 
102 
 
Appendix 
 
 
 
103 
 
Appendix 
 
 
 
104 
 
Appendix 
 
 
 
105 
 
Appendix 
 
 
 
106 
Integrin-linked kinase at a glance 
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Integrins	   constitute	   a	   large	   family	   of	   cell-­‐extracellular	   matrix	   (ECM)	   and	   cell-­‐cell	   adhesion	  
molecules	   that	   regulate	   development	   and	   tissue	   homeostasis	   by	   controlling	   cell	   migration,	  
survival,	   proliferation	   and	   differentiation	   (Hynes,	   2002).	   Integrins	   are	   non-­‐covalently	   associated	  
heterodimers	  consisting	  of	  α	  and	  β	  subunits.	  On	  the	  cell	  surface	  integrins	  exist	  in	  a	  conformation	  
with	  high	  (active)	  or	  low	  (inactive)	  ligand	  affinity.	  Upon	  activation	  (inside-­‐out	  signalling)	  (Moser	  et	  
al.,	  2009),	   integrins	  cluster	  and	  form	  nascent	  focal	  adhesions,	  which	  eventually	  mature	  into	  focal	  
adhesions	   (FAs)	   (outside-­‐in	   signalling)	   (Legate	   et	   al.,	   2009;	   Geiger	   and	   Yamada,	   2011).	   Major	  
functions	  of	   integrins	  in	  FAs	  include	  their	  ability	  to	  link	  the	  ECM	  to	  the	  actin	  cytoskeleton	  and	  to	  
fine	  tune	  growth	  factor	  receptor	  signalling	  (Legate	  et	  al.,	  2009).	  
Since	   integrins	   lack	   intrinsic	   enzymatic	   activity,	   their	   signalling	   critically	   depends	   on	   recruiting	  
adaptor	  and	  signalling	  proteins	  (Schiller	  et	  al.,	  2011).	  One	  of	  the	  best	  described	  of	  these	  proteins	  is	  
integrin-­‐linked	  kinase	  (ILK),	  which	  is	  directly	  recruited	  to	  activated	  β1	  and	  β3	  integrin	  cytoplasmic	  
domains.	  Since	  the	  discovery	  of	   ILK	  15	  years	  ago	   (Hannigan	  et	  al.,	  1996),	   ILK	  has	  been	  shown	  to	  
play	  crucial	  roles	  in	  actin	  rearrangement,	  cell	  polarisation,	  spreading,	  migration,	  proliferation	  and	  
survival	   (Legate	  et	   al.,	   2006).	  Despite	   its	  predominant	   localisation	   in	   FAs,	   ILK	  was	  also	   shown	   to	  
reside	   in	   cell-­‐cell	   adhesion	   sites,	   in	   centrosomes	   and	   in	   the	   nucleus.	   Here	   we	   summarise	   the	  
functional	  properties	  of	   ILK	  and	  highlight	  the	  recent	  evidence	  demonstrating	  that	   ILK	  serves	  as	  a	  
scaffold	  protein	  rather	  than	  a	  kinase.	  
	  
ILK	  and	  the	  Pinch-­‐Parvin	  complex	  
In	  vivo	  studies	  revealed	  that	  ILK	  is	  a	  ubiquitously	  expressed	  protein,	  whose	  predominant	  function	  
is	   to	   organise	   the	   actin	   cytoskeleton	   during	   invertebrate	   and	   vertebrate	   development	   and	  
homeostasis.	   In	   Caenorhabditis	   elegans,	   the	   ILK	   ortholog	   PAT4	   localises	   to	   integrins	   at	   muscle	  
attachment	   sites.	   Deletion	   of	   the	   PAT4	   gene	   causes	   a	   ‘paralysed	   at	   two-­‐fold-­‐stage’	   (PAT)	  
phenotype	   that	   is	   characterised	   by	  muscle	   detachment	   through	   defective	   integrin-­‐actin	   linkage	  
and	  very	  early	  lethality	  (Mackinnon	  et	  al.,	  2002).	  In	  Drosophila	  melanogaster,	  a	  germline	  deletion	  
of	   ILK	   leads	  to	  muscle	  detachment	  and	   lethality	   (Zervas	  et	  al.,	  2001).	  Mice	   lacking	   ILK	  die	  during	  
the	  peri-­‐implantation	  stage	  due	   to	  a	   failure	   to	  organise	   the	  F-­‐actin	  cytoskeleton	   in	  epiblast	   cells	  
(Sakai	   et	   al.,	   2003).	   In	   addition	   to	   the	   constitutive	   deletion,	   the	   ILK	   gene	   has	   been	   deleted	   in	  
several	  organs	  and	  cell	   types	  using	  the	  Cre/loxP	  system.	  The	  outcome	  of	   these	  studies	  has	  been	  
extensively	  reviewed	  elsewhere	  (Rooney	  and	  Streuli,	  2011;	  Ho	  and	  Bendeck,	  2009;	  Hannigan	  et	  al.,	  
2007;	  Wickström	  et	  al.,	  2010b).	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Structurally,	   ILK	   is	   comprised	  of	   three	  different	  domains:	   five	   ankyrin	   repeats	   at	   the	  N-­‐terminus	  
followed	  by	   a	   pleckstrin	   homology	   (PH)-­‐like	   domain	   and	   a	   kinase-­‐like	   domain	   at	   the	  C-­‐terminus	  
(Chiswell	  et	  al.,	  2008;	  Yang	  et	  al.,	  2009)	  (see	  poster).	  Although	  ILK	  was	  shown	  to	  directly	  interact	  
with	  integrin	  cytoplasmic	  tails,	   it	  appears	  that	  the	  recruitment	  of	  ILK	  to	  integrins	  may	  depend,	  at	  
least	  in	  some	  cells,	  on	  Kindlin-­‐2	  (Montanez	  et	  al.,	  2008;	  Chen	  et	  al.,	  2008),	  α-­‐Parvin	  (Fukuda	  et	  al.,	  
2009)	   or	   Paxillin	   (Nikopoulos	   et	   al.,	   2001).	   Structural	   studies	   of	   ILK	   revealed,	   however,	   that	   the	  
proposed	   Paxillin	   interacting	   residues	   are	   buried	   within	   a	   polypeptide	   fold	   and	   thus	   are	   not	  
directly	  accessible	  (Fukuda	  et	  al.,	  2009),	  arguing	  that	  these	  residues	  indirectly	  contribute	  to	  Paxillin	  
binding.	  Prior	  to	  the	  recruitment	  of	  ILK	  to	  FAs,	  ILK	  forms	  a	  ternary	  complex	  with	  the	  two	  adaptor	  
proteins	  Pinch	  and	  Parvin	   (termed	   the	   IPP	   complex).	  Although	   it	   is	   not	  understood	  how	   the	   IPP	  
complex	  forms,	  its	  formation	  ensures	  stability	  of	  the	  individual	  components	  and	  faithful	  targeting	  
to	   the	  adhesion	   site	   (Zhang	  et	   al.,	   2002;	   Fukuda	  et	   al.,	   2003a).	  Mammals	  have	   two	  Pinch	  genes	  
(Pinch-­‐1	   and	   Pinch-­‐2),	   which	   encode	   proteins	   consisting	   of	   five	   cysteine-­‐rich,	   zinc	   binding	   LIM	  
domains	   followed	  by	   a	   nuclear	   export	   signal.	   The	   first	   LIM	  domain	  of	   Pinch-­‐1	   and	   -­‐2	   binds	   to	   a	  
concave	   surface	   that	  extends	   from	   the	   second	   to	   the	   fifth	  ankyrin	   repeat	  of	   ILK	   (Chiswell	   et	   al.,	  
2008;	  Yang	  et	  al.,	  2009)	  (see	  poster).	  The	  three	  mammalian	  Parvin	   isoforms	  (α-­‐,	  β-­‐	  and	  γ-­‐Parvin)	  
are	  comprised	  of	  an	  N-­‐terminal	  polypeptide	  followed	  by	  two	  calponin	  homology	  (CH)	  domains,	  of	  
which	  the	  second	  one	  binds	  to	  the	  kinase-­‐like	  domain	  of	  ILK	  (Tu	  et	  al.,	  2001;	  Fukuda	  et	  al.,	  2009)	  
(see	  poster).	  As	  ILK	  can	  only	  bind	  one	  Pinch	  and	  one	  Parvin	  isoform	  at	  the	  same	  time	  (Chiswell	  et	  
al.,	   2008;	  Montanez	   et	   al.,	   2009),	   ILK	   is	   capable	   of	   forming	   several	   distinct	   IPP	   complexes,	   each	  
resulting	  in	  different	  signalling	  outputs	  (see	  poster	  and	  below).	  
The	  Parvins	  interact	  directly	  with	  F-­‐actin	  (Legate	  et	  al.,	  2006)	  or	  recruit	  actin	  binding	  proteins	  such	  
as	  α-­‐Actinin	  [shown	  for	  β-­‐Parvin	  (Yamaji	  et	  al.,	  2004)]	  or	  Vinculin	  via	  Paxillin	  (Turner,	  2000)	  [shown	  
for	  α-­‐	  and	  γ-­‐Parvin	  (Yoshimi	  et	  al.,	  2006)].	  In	  addition,	  they	  control	  actin	  regulatory	  proteins	  such	  
as	   testicular	   protein	   kinase	   1	   (TESK-­‐1),	   which	   can	   bind	   α-­‐Parvin	   and	   promote	   F-­‐actin	  
polymerisation	   through	   phosphorylation	   of	   Cofilin	   (LaLonde	   et	   al.,	   2005).	   In	   contrast,	   β-­‐Parvin	  
regulates	   actin	  dynamics	   through	  PAK-­‐interactive	  exchange	   factor	   (α-­‐PIX),	   a	   guanidine	  exchange	  
factor	  (GEF)	  for	  Ras-­‐related	  C3	  botulinum	  toxin	  substrate	  1	  (Rac1)	  and	  cell	  division	  cycle	  42	  (Cdc42)	  
(Mishima	   et	   al.,	   2004).	   Finally,	   α-­‐Parvin	   was	   shown	   to	   inhibit	   G-­‐proteins	   by	   recruiting	   Cdc42	  
GTPase-­‐activating	  protein	  (CdGAP)	  to	  FAs	  (LaLonde	  et	  al.,	  2006)	  and	  to	  negatively	  regulate	  RhoA-­‐	  
and	   Rho-­‐associated	   protein	   kinase	   (ROCK)-­‐driven	   contractility	   in	   vascular	   smooth	   muscle	   cells	  
(Montanez	  et	  al.,	  2009).	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Pinch-­‐1	  binds	  the	  Ras	  suppressor	  protein	  1	   (RSU1),	  which	   is	   important	   for	   integrin-­‐mediated	  cell	  
adhesion	   and	   spreading	   (Kadrmas	   et	   al.,	   2004;	   Ito	   et	   al.,	   2010).	   RSU1	   is	   a	   negative	   regulator	   of	  
growth	   factor-­‐induced	   Jun	   N-­‐terminal	   kinase	   1	   (JNK1)	   (Kadrmas	   et	   al.,	   2004).	   Together	   these	  
findings	   suggest	   that	   the	   assembly	   of	   distinct	   IPP	   complexes	   in	   a	   given	   cell	   together	   with	   the	  
differential	   expression	   patterns	   of	   Pinch	   and	   Parvin	   isoforms	   provides	   a	   means	   for	   multiple	  
alternative	  signalling	  outputs	  	  (see	  poster).	  	  
	  
Emerging	  functions	  of	  ILK	  
The	  most	  prominent	  subcellular	  localisation	  of	  ILK	  is	  in	  integrin	  adhesion	  sites.	  In	  the	  past	  years	  it	  
has	   been	   reported	   that	   ILK	   is	   also	   present	   in	   additional	   subcellular	   regions	   and	   compartments	  
where	  it	  may	  exert	  integrin-­‐independent	  functions.	  
	  
MT	  trafficking	  networks	  
Keratinocytes	  and	   likely	  also	  other	  cells	  employ	   ILK	   to	  capture	  microtubule	   (MT)	   tips	   to	  connect	  
them	   to	   the	   cortical	   actin	   network	   (see	   poster).	   ILK-­‐mediated	  MT	   capture	   occurs	   exclusively	   in	  
nascent	   FAs	   and	   is	   mediated	   by	   recruitment	   of	   the	   large	   scaffold	   protein	   IQ	   motif	   containing	  
GTPase	  activating	  protein	  1	   (IQGAP-­‐1)	   (Wickström	  et	   al.,	   2010a).	   The	   capture	  of	  MT	   tips	   can	  be	  
achieved	  either	   directly	   via	   binding	  of	   IQGAP-­‐1	   to	   the	  MT	   tip	   protein	   cytoplasmic	   linker	   protein	  
CLIP170,	  or	  indirectly	  via	  IQGAP-­‐1-­‐mediated	  recruitment	  of	  murine	  diaphanous	  homolog	  1	  (mDia1;	  
Diaphanous-­‐related	  formin-­‐1	  in	  human)	  which	  is	  also	  able	  to	  stabilise	  MTs.	  As	  both	  IQGAP-­‐1	  and	  
mDia1	   are	   also	   able	   to	   bind	   F-­‐actin,	   the	   ILK-­‐IQGAP-­‐1-­‐mDia1	   complex	   connects	   MTs	   with	   actin	  
tracks	   at	   β1	   integrin-­‐containing	   nascent	   adhesion	   sites	   (Wickström	   et	   al.,	   2010a)	   (see	   poster).	  
Exocytotic	   carriers	   that	   are	   transported	   via	  MT	   tracks	   require	   a	   switch	   from	  MT-­‐based	   to	   actin-­‐
based	   motility	   at	   the	   plasma	   membrane	   to	   overcome	   the	   cortical	   F-­‐actin	   network.	   Thus,	   the	  
connection	   of	   both	   networks	   by	   the	   ILK-­‐IQGAP-­‐1-­‐mDia1	   complex	   at	   nascent	   adhesion	   sites	   is	  
essential	   for	   the	  exocytosis	  of	   caveolar	   carriers	   (Wickström	  et	  al.,	  2010a).	  Consequently,	   ILK	  not	  
only	  contributes	  to	  epithelial	  cell	  polarisation	  through	  actin	  remodeling,	  but	  also	  through	  vesicular	  
trafficking	  and	  MT	  organisation.	  
	  
Nuclear	  functions	  
Despite	  its	  prominent	  localisation	  in	  different	  integrin	  adhesion	  sites,	   ILK	  has	  also	  been	  observed	  
in	  the	  nucleus	  of	  several	  cell	  lines,	  including	  COS-­‐1	  cells	  (Chun	  et	  al.,	  2005),	  MCF-­‐7	  cells	  (Acconcia	  
et	   al.,	   2007),	   HeLa	   cells	   and	   keratinocytes	   (Nakrieko	   et	   al.,	   2008a)	   (see	   poster).	   The	   nuclear	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function	  of	   ILK,	  however,	   is	  still	  not	  well	  understood.	   In	  keratinocytes,	  nuclear	   ILK	  was	  shown	  to	  
induce	   DNA	   synthesis	   (Nakrieko	   et	   al.,	   2008a)	   and	   in	   MCF-­‐7	   cells	   it	   was	   found	   to	   control	   the	  
expression	  of	   the	  connector	  enhancer	  of	  kinase	  suppressor	  of	  Ras	  3	   (CNKSR3)	  gene	   (Acconcia	  et	  
al.,	  2007).	  CNKSR3	  was	  shown	  to	  regulate	  the	  epithelial	  Na+	  (ENaC)	  channel	  through	  inhibition	  of	  
MAP	   and	   Erk	   Kinase	   1	   (Mek1)	   (Ziera	   et	   al.,	   2009).	   However,	   the	   significance	   of	   ILK	   regulated	  
CNSKR3	  expression	  is	  not	  understood.	  
It	   is	  also	  not	  well	  understood	  how	  ILK	  translocates	  into	  the	  nucleus.	   It	   is	  not	  known	  whether	  the	  
nuclear	  import	  of	  ILK	  depends	  on	  its	  N-­‐terminus	  (Acconcia	  et	  al.,	  2007)	  or	  on	  a	  C-­‐terminal	  nuclear	  
localisation	   signal	   (Chun	  et	   al.,	   2005).	   The	  nuclear	   export	   of	   ILK	   requires	   the	   kinase-­‐like	   domain	  
(Acconcia	  et	  al.,	  2007;	  Nakrieko	  et	  al.,	  2008a)	  and	   is	  apparently	  controlled	  by	  the	  nuclear	  export	  
factor	   chromosome	   region	  maintenance	   1	   protein	   homolog	   (CRM1),	   the	   integrin-­‐linked	   kinase-­‐
associated	   serine-­‐	  and	   threonine	  phosphatase	  2C	   (ILKAP)	  and	  p21	  protein	   (Cdc42/Rac)-­‐activated	  
kinase	  1	  (PAK1)	  (Acconcia	  	  et	  al.,	  2007;	  Nakrieko	  	  et	  al.,	  2008a).	  
	  
Cell-­‐cell	  contacts	  organisation	  
ILK	  has	  been	   shown	   to	   serve	  as	  a	   scaffold	   for	  promoting	   the	   formation	  of	   cell-­‐cell	   contacts	   (see	  
poster)	   and	   the	   recruitment	   of	   tight	   junction	   proteins	   (Vespa	   et	   al.,	   2003;	   Vespa	   et	   al.,	   2005).	  
Following	  treatment	  of	  cultured	  keratinocytes	  with	  Ca2+,	  they	  undergo	  differentiation.	  This	  process	  
is	  accompanied	  by	  the	  translocation	  of	  ILK	  from	  FAs	  to	  cell-­‐cell	  adhesion	  sites	  (Vespa	  et	  al.,	  2003).	  
This	   translocation	   requires	   the	   N-­‐terminal	   ankyrin	   repeats	   (Vespa	   et	   al.,	   2003),	   however	   it	   is	  
unclear	  whether	  Pinch-­‐1	  or	  -­‐2	  translocate	  together	  with	  ILK.	  In	  contrast	  to	  these	  in	  vitro	  findings,	  
deletion	   of	   the	   ILK	   gene	   in	   keratinocytes	   of	   mice	   neither	   affects	   cell-­‐cell	   adhesion	   nor	   barrier	  
function	  in	  the	  epidermis,	  but	  severely	  impairs	  their	  migration	  on	  and	  adhesion	  to	  the	  epidermal-­‐
dermal	   BM,	   resulting	   in	   skin	   blistering,	   epidermal	   hyperthickening	   and	   hair	   loss.	   (Lorenz	   et	   al.,	  
2007;	  Nakrieko	  et	  al.,	  2008b).	  
	  
Centrosome	  functions	  
A	   proteomic	   search	   for	   novel	   ILK	   interacting	   proteins	   identified	   a	   number	   of	   proteins	   including	  
several	  centrosome-­‐	  and	  mitotic	  spindle-­‐associated	  proteins,	  such	  as	  α-­‐,	  β-­‐tubulin	  and	  the	  tubulin-­‐
binding	  proteins	  RUVB	  like	  protein	  1	  (RUVBL1)	  and	  colonic	  and	  hepatic	  tumor	  over-­‐expressed	  gene	  
protein	  (ch-­‐TOG)	  (Dobreva	  et	  al.,	  2008)	  (see	  poster).	  Although	  ILK	  probably	  binds	  these	  proteins	  in	  
an	  indirect	  manner	  (Fielding	  et	  al.,	  2008),	  it	  co-­‐localises	  with	  them	  in	  centrosomes	  from	  interphase	  
and	  mitotic	  cells	  where	  it	  plays	  an	  essential	  role	  in	  controlling	  centrosome	  function	  during	  mitotic	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spindle	   organisation	   and	   centrosome	   clustering	   (Fielding	   et	   al.,	   2008;	   Fielding	   et	   al.,	   2011).	   The	  
organisation	  of	   the	  mitotic	   spindle	   requires	  Aurora	  A	  kinase	  and	   the	  association	  of	   ch-­‐TOG	  with	  
the	  centrosomal	  protein	  TACC3	  (transforming	  acidic	  coiled-­‐coil-­‐containing	  protein	  3),	  which	  in	  turn	  
promotes	  the	  polymerisation	  and	  stabilisation	  of	  centrosomal	  microtubules	  (Barr	  et	  al.,	  2007).	   In	  
ILK-­‐depleted	  cells,	  Aurora	  A	  kinase,	  although	  active,	  is	  unable	  to	  phosphorylate	  and	  thus	  activate	  
TACC3	   resulting	   in	   disrupted	   mitotic	   spindles.	   Similarly,	   the	   clustering	   of	   supernumerary	  
centrosomes	  in	  cancer	  cells	   is	  also	  achieved	  by	  the	  TACC3-­‐ch-­‐TOG	  complex	  in	  an	  ILK-­‐	  and	  Aurora	  
A-­‐dependent	  manner	   (Fielding	  et	  al.,	   2011).	   ILK	  associates	  with	   ch-­‐TOG,	  but	  neither	  with	  TACC3	  
nor	  with	  Aurora	  A.	  Therefore,	  it	  is	  not	  clear	  how	  ILK	  supports	  phosphorylation	  of	  TACC3	  by	  Aurora	  
A	   kinase.	   Similarly,	   it	   is	   also	   unclear	   how	   ILK	   is	   recruited	   to	   centrosomes.	   The	   centrosomal	  
localisation	  of	  ILK	  requires	  RUVBL1	  expression	  and	  occurs	  without	  the	  known	  ILK	  binding	  partners,	  
α-­‐Parvin	  and	  Pinch	  (Fielding	  et	  al.,	  2008).	  Finally,	   it	   is	  also	  not	  known	  why	  the	  treatment	  of	  cells	  
with	  QLT-­‐0267,	  a	  small	  chemical	  compound	  that	  binds	  to	  the	  ATP	  binding	  site	  of	  ILK,	  is	  as	  effective	  
as	  siRNA-­‐mediated	  depletion	  of	  ILK	  in	  blocking	  the	  association	  of	  TACC3	  with	  Aurora	  A	  (Fielding	  et	  
al.,	  2008).	  The	  mechanistic	  interpretation	  of	  this	  work	  is	  based	  on	  the	  assumption	  that	  ILK	  acts	  as	  a	  
kinase,	   which	   has	   been	   disproved	   by	   genetic	   and	   structural	   studies	   (see	   below).	   A	   potential	  
explanation	  for	  the	  inhibitory	  effect	  of	  QLT-­‐0267	  could	  be	  an	  impairment	  of	  the	  stability	  of	  ILK	  (see	  
end	  of	  next	  paragraph).	  
	  
The	  kinase	  controversy	  
The	  experimental	  evidence	  that	  the	  ILK	  kinase-­‐like	  domain	  lacks	  catalytic	  activity	  is	  overwhelming	  
(Wickström	   et	   al.,	   2010b).	   Although	   ILK	   was	   initially	   identified	   by	   Dedhar	   and	   colleagues	   as	   a	  
serine-­‐	   and	   threonine-­‐kinase	   (Hannigan	   et	   al.,	   1996),	   it	   lacks	   several	   important	   motifs	   that	   are	  
conserved	  in	  most	  kinases	  (Hanks	  et	  al.,	  1988)	  (see	  poster).	  Furthermore,	  genetic	  studies	  in	  flies,	  
worms	  and	  mice	  demonstrated	  that	  the	  putative	  kinase	  activity	   is	  not	  required	  for	  development	  
and	   homeostasis	   (Zervas	   et	   al.,	   2001;	  Mackinnon	   et	   al.,	   2002;	   Lange	   et	   al.,	   2009).	   Despite	   this	  
compelling	  evidence,	  many	  papers	  have	  been	  and	  are	  still	  published	  claiming	  that	  ILK	  is	  a	  bone	  fide	  
kinase,	  with	  only	  marginal	  evidence	  at	  best.	  
The	  crystallisation	  of	  the	  ILK	  kinase-­‐like	  domain	  in	  complex	  with	  the	  CH	  domain	  of	  α-­‐Parvin	  and	  its	  
comparison	  to	  the	  kinase	  domain	  of	  protein	  kinase	  A	  (PKA)	  provided	  a	  mechanistic	  explanation	  for	  
why	   its	   kinase	   function	   is	   not	   executed	   (Fukuda	   et	   al.,	   2009).	   The	   catalytic	   activity	   of	   a	   kinase	  
depends	   on	   a	   coordinated	   interplay	   of	   the	   N-­‐	   and	   C-­‐lobes	   and	   the	   catalytic	   loop	   of	   the	   kinase	  
domain	  with	  the	  substrate	  and	  ATP.	  The	  N-­‐	  and	  C-­‐lobes	  and	  the	  catalytic	  loop	  of	  ILK	  show	  major	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differences	  to	  bona	  fide	  kinases	  that	  render	  the	   ‘kinase’	  of	   ILK	  non	  functional.	  The	  catalytic	   loop	  
lacks	   important	   acidic	   and	   positively	   charged	   residues.	   The	   acidic	   residue	   (D166	   in	   PKA),	   which	  
polarises	  the	  hydroxyl	  group	  of	  the	  substrate	  and	  accepts	  its	  proton,	  is	  substituted	  in	  ILK	  with	  the	  
uncharged	  alanine	  residue	  (A319)	  (Fukuda	  et	  al.,	  2009).	  The	  positively	  charged	  residue	  in	  catalytic	  
loops	   (K168	   in	  PKA),	  which	  stabilises	   the	   intermediate	   state	  of	   the	  phospho-­‐transfer	   reaction	  by	  
neutralizing	   the	   negative	   charge	   of	   the	   γ-­‐ATP	   phosphoryl-­‐group,	   is	   replaced	   in	   ILK	   by	   N321	  
resulting	  in	  a	  misrouting	  of	  ATP	  to	  the	  C-­‐lobe.	  In	  the	  N-­‐lobe,	  the	  ATP	  binding	  p-­‐loop	  captures	  ATP	  
at	  a	  too	  great	  distance	  from	  the	  active	  center	  (10	  Å),	  which	  precludes	  its	  movement	  towards	  the	  
catalytic	  loop;	  and	  the	  lysine	  residue	  K220	  contacts	  the	  α-­‐	  and	  γ-­‐ATP	  phosphoryl-­‐groups	  instead	  of	  
the	  α-­‐	  and	  β-­‐phosphoryl-­‐groups	  resulting	  in	  an	  aberrant	  ATP	  orientation.	  Furthermore,	  the	  C-­‐lobe	  
of	  ILK	  chelates	  ATP	  with	  only	  one	  instead	  of	  the	  expected	  two	  metal	  ions.	  The	  metal	  ion	  is	  bound	  
by	  the	  aspartate	  (D339)	  of	  the	  DVK	  motif	  of	  ILK	  (DFG-­‐motif	  in	  PKA),	  whereas	  the	  second	  potential	  
metal	  binding	   residue	   (S324)	   remains	  unoccupied.	  Another	  divergence	   from	  bona	   fide	   kinases	   is	  
the	   coordination	   of	   the	   γ-­‐ATP	   phosphoryl-­‐group	   by	   the	   lysine	   (K341)	   of	   the	   DVK	   motif,	   which	  
usually	   occurs	   by	   the	   catalytic	   loop	   (Fukuda	   et	   al.,	   2009).	   Nevertheless,	   despite	   this	   structural	  
evidence,	  dissenting	  views	  are	  still	  expressed	  and	  the	  controversy	  rages	  on	  (Hannigan	  et	  al.,	  2011).	  
Thermodynamic	  and	  structural	  analysis	  of	  ILK	  mutants	  revealed	  that	  K220A	  or	  K220M	  mutations,	  
previously	  described	   to	  affect	  kinase	   function,	  destabilise	   the	  global	   ILK	  structure	   (Fukuda	  et	  al.,	  
2011),	   thus	   reducing	   ILK	   stability	   and	   binding	   of	   interaction	   partners	   such	   as	   α-­‐Parvin.	   This	  
observation	  provides	  an	  explanation	  for	  the	  severe	  kidney	  defects	  observed	  in	  mice	  which	  either	  
lack	  α-­‐Parvin	  expression	  or	  carry	  K220A	  or	  K220M	  mutations	  in	  ILK	  (Lange	  et	  al.,	  2009).	  
	  
Redefining	  the	  role	  of	  ILK	  in	  cancer	  
ILK	   is	   overexpressed	   in	   many	   types	   of	   cancer,	   and	   its	   depletion	   or	   inhibition	   with	   the	   small	  
molecule	   inhibitor	   QLT-­‐0267	   was	   reported	   to	   inhibit	   anchorage-­‐independent	   growth,	   cell	   cycle	  
progression	   and	   invasion	   (Hanningan	   et	   al.,	   2005).	   The	   oncogenic	   effects	   of	   ILK	   have	   been	  
attributed	  for	  the	  most	  part	  to	  the	  catalytic	  activity	  of	  the	  kinase	  domain	  resulting	  in	  the	  activation	  
of	   protein	   kinase	   B	   (PKB),	   also	   known	   as	   proto-­‐oncogene	   c-­‐Akt	   (Akt),	   and	   glycogen	   synthase	  
kinase-­‐3	   beta	   (GSK3β)	   which	   in	   turn	   regulates	   the	   stability	   of	   proto-­‐oncogenic	   β-­‐Catenin	  
(Hanningan	  et	  al.,	  2005).	  The	  recent	  findings	  that	  mammalian	  ILK	  lacks	  catalytic	  activity	  and	  serves	  
as	  a	  scaffold	  protein	  in	  FAs	  of	  mammalian	  cells	  (Lange	  et	  al.,	  2009;	  Fukuda	  et	  al.,	  2009)	  raise	  the	  
question	  of	  how	  ILK	  mediates	  its	  oncogenic	  potential	  despite	  this	  functional	  twist.	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One	  possibility	   is	  that	  ILK	  controls	  the	  activity	  of	  oncogenes,	  such	  as	  PKB/Akt	  by	  controlling	  their	  
subcellular	   localisation.	   For	   example,	   the	   ILK	   binding	   partners	   α-­‐	   and	   β-­‐Parvin	   promote	   the	  
recruitment	  of	  PKB/Akt	  to	  the	  plasma	  membrane	  where	  the	  kinase	  mediates	  its	  oncogenic	  activity	  
(Fukuda	  et	  al.,	  2003b;	  Kimura	  et	  al.,	  2010).	  An	  alternative	  possibility	  is	  that	  ILK	  and	  ILK-­‐interacting	  
protein(s)	   regulate	   oncogenic	   kinases	   by	   controlling	   the	   activity	   of	   phosphatases.	   This	   has	   been	  
shown	   for	   Pinch-­‐1,	   which	   binds	   to	   and	   inhibits	   the	   protein	   phosphatase	   1α	   (PP1α)	   resulting	   in	  
sustained	   PKB/Akt	   phosphorylation	   and	   activity	   (Eke	   et	   al.,	   2010).	   Consequently,	   reducing	   the	  
amounts	   of	   the	   IPP	   complex	   in	   FAs	   will	   concomitantly	   result	   in	   an	   increased	   PP1α	   activity	   and	  
decreased	   PKB/Akt	   function.	   It	   is	   also	   conceivable	   that	   ILK	   exerts	   its	   oncogenic	   function	   by	   its	  
ability	   to	   cluster	   supernumerary	   centrosomes	   in	   cancer	   cells,	   which	   prevents	   their	   genomic	  
instability	   and	   death	   (Fielding	   et	   al.,	   2011).	   Finally,	   ILK	   may	   also	   promote	   oncogenesis	   by	  
regulating	   gene	   expression	   in	   the	   nucleus,	   or	   by	  modulating	   the	   assembly	   of	   ECM	   proteins,	   as	  
shown	   for	   fibronectin	   (Wu	  et	  al.,	   1998),	  which	  has	  been	   reported	   to	  affect	   cancer	  development	  
and	  invasion	  (Akiyama	  et	  al.,	  1995).	  
	  
Outlook	  and	  perspectives	  
ILK	   research	   has	   significantly	   advanced	   in	   the	   past	   years	   by	   settling	   the	   long-­‐lasting	   debate	  
regarding	   the	   catalytic	   activity	   of	   ILK	   and	   by	   identifying	   novel	   functions	   for	   ILK,	  many	   of	   which	  
occur	   outside	   of	   FAs.	   Most	   of	   the	   emerging	   functions	   of	   ILK	   (e.g.	   in	   the	   nucleus,	   at	   cell-­‐cell	  
adhesion	  sites,	  in	  the	  centrosome)	  have	  only	  been	  studied	  in	  cultured	  cells	  thus	  far	  and	  still	  await	  
confirmation	  in	  vivo.	  
In	  addition,	  several	  basic	  functions	  of	   ILK	  in	  FAs	  are	  still	  open,	   including	  the	  mechanism(s)	  of	  the	  
recruitment	  of	  ILK	  to	  FAs,	  ILK’s	  role	  in	  FA	  maturation	  and	  as	  a	  potential	  stretch	  sensor	  (Bendig	  et	  
al.,	  2006),	  the	  turn-­‐over	  and	  modifications	  of	  ILK,	  to	  name	  a	  few.	  It	  is	  currently	  debated	  whether	  
the	   recruitment	   of	   ILK	   to	   FAs	   occurs	   through	   a	   direct	   association	  with	   the	   integrin	   cytoplasmic	  
domains	   or	   indirectly,	   e.g.	   through	   binding	   to	   Kindlins	   (Montanez	   et	   al.,	   2008)	   or	   Paxillin	  
(Nikopoulos	  et	  al.,	  2001).	  In	  this	  regard	  it	  is	  also	  not	  known	  whether	  ILK	  binds	  or	  associates	  with	  all	  
β	   integrin	   tails,	   or	   is	  more	   selective.	   A	   co-­‐crystallisation	   of	   the	   kinase-­‐like	   domain	   of	   ILK	  with	   β	  
integrin	  tails	  should	  help	  to	  answer	  some	  of	  these	  questions.	  Similarly,	  a	  structural	  analysis	  of	  the	  
predicted	  PH	  domain	  of	  ILK	  would	  clarify	  whether	  it	  adopts	  a	  classical	  PH	  fold	  as	  predicted	  in	  the	  
original	  publication	  (Hannigan	  et	  al.,	  1996),	  or	  a	  different	  motif	  whose	  function	  would	  then	  have	  to	  
be	   determined.	   Zebrafish	   studies	   point	   to	   a	   stretch	   sensing	   function	   of	   ILK	   in	   cardiomyocytes	  
(Bendig	  et	  al.,	  2006).	  This	  observation	  raises	  the	  question	  of	  whether	  mechanical	  stress	  sensing	  by	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ILK	   is	   restricted	   to	   cardiomyocytes	   or	   also	   occurs	   in	   other	   cells,	   and	   how	   ILK	   is	   executing	   this	  
function	  at	  the	  molecular	  level.	  Finally,	  it	  will	  be	  important	  to	  re-­‐evaluate	  the	  role	  of	  ILK	  in	  cancer.	  
Ideally,	  these	  experiments	  are	  performed	  in	  an	  unbiased	  manner	  with	  tumor	  models	  in	  mice	  (e.g.	  
colon	   cancer	   and	  mammary	   cancer	  models)	   that	   lack	   ILK	   expression,	   and	   are	   complemented	  by	  
sophisticated	  in	  vitro	  studies	  with	  cells	  derived	  from	  the	  tumors.	  
It	   is	  obvious	  that	  despite	  the	  rapid	  progress	  in	  ILK	  research	  many	  questions	  are	  still	  unanswered.	  
Recent	  advances	  in	  imaging	  and	  proteomics	  combined	  with	  genetics,	  cell	  biology	  and	  biochemistry	  
will	  make	  the	  years	  to	  come	  exciting	  for	  all	  ILK	  aficionados.	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Babak-1 and Babak-2 are novel focal adhesion proteins that 
bind paxillin and regulate the assembly of membrane circular 
dorsal ruffles. 
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Summary  
Integrin-based adhesion sites are multiprotein complexes that link the actin cytoskeleton to 
the extracellular matrix (ECM) and trigger intracellular signalling pathways. Here, we 
identified a novel family of focal adhesion (FA) molecules called Babak-1 and -2 (Plekhh-
1, -2) that localized to integrin adhesion sites as well as punctate structures in the cytoplasm 
of mouse fibroblasts and Hela cells. SILAC-based proteomics of Babak-2 
immunoprecipitates identified paxillin, a FA-associated signalling adaptor, as interaction 
partner. Immunoprecipitation experiments with GFP-tagged Babak-1 showed that also 
Babak-1 associates with paxillin. Indeed, the recruitment of both Babaks to FAs was 
dependent on their interaction with paxillin, which was mediated through a paxillin binding 
sequence (PBS) present in the N-terminal half of the protein. Quantitative RT-PCR and 
northern assays revealed that Babak-1 and -2 are expressed in most adult murine tissues. To 
test the functional properties of Babak-2 in vivo, we generated a conditional Babak-2-null 
mouse strain. Babak-2-deficient mice were fertile and did not show an obvious phenotype 
suggesting that Babak-2 function can be compensated by Babak-1. 
   
Word count: 169 words. 
 
Appendix 
 
 
 
123 
Introduction 
Cell adhesion to extracellular matrix (ECM) molecules controls a broad range of biological 
functions. Integrins are prominent mediators of cell-ECM adhesions. They link the actin 
cytoskeleton to the ECM and signal into as well as out of cells. Integrin cytoplasmic tails 
are short and lack enzymatic activity. Therefore, integrins recruit signalling and adaptor 
molecules to their cytoplasmic tails resulting in the formation of a large signalling hub 
called focal adhesions (FAs) that mediate the signalling task of integrins. About 200 FAs 
molecules have been identified so far that control the numerous functions of integrins 
including actin dynamics, biochemical signalling and the crosstalk with growth factors (1, 
2). 
Integrin signals converge with growth factor receptor (GFR) cues to collaboratively control 
a cellular functions (3). As integrins and GFRs diversify in different tissues and 
developmental stages, the consequence of integrin-GFR co-signalling is vast and complex 
and ranges from influencing cell proliferation to cell survival, migration, angiogenesis and 
immune response (4). We showed recently that transient actin-based, circular dorsal ruffles 
(DRs) are the consequence of a collaborative signalling effort between the fibronectin/α5β1 
integrin/ILK complex and epidermal GFR (EGFR) in mouse fibroblasts (Azimifar et al., 
2011). We used DRs to establish a screening strategy that combined stable isotope labeling 
by amino acids in cell culture (SILAC)-based phosphoproteomics and siRNA-mediated 
depletion of candidate proteins to identify new molecular players in the integrin-EGFR 
signalling crosstalk. Among the identified proteins that were specifically phosphorylated 
upon integrin adhesion and EGF treatment was a FERM domain-containign proten that we 
termed Babak-2. It belongs to a new family of proteins that consist of Babak1 (Plekhh1 or 
Max-1) and -2 (Kia2028 or Plekhh2). They are members of the H family of Pleckstrin 
homology (PH) domain-containing proteins. Loss-of-function mutations of the Babak-1 
orthologue in C. elegance cause axon guidance defects (5), and depletion of Babak-1 in 
Zebrafish leads to patterning abnormalities of intersegmental blood vessels (6). Murine 
Babak-2 was reported to be expressed in kidney podocytes (7) and its locus was linked to 
diabetic nephropathy (8). 
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The number of signalling and scaffolding proteins in FAs is vast (1, 9). Paxillin is such a 
FA-associated, phosphotyrosine-modifiable adaptor protein that ssociates integrin and 
growth factor receptor signaling pathways. Paxillin consists of five N-terminal leucine- and 
aspartate-rich (LD) motifs followed by a proline-rich motif and four C-terminal Lin11, Isl-1 
and Mec-3 (LIM) domains. In addition, it contains several tyrosine, serine and threonine 
residues scattered throughout the molecule that can become phosphorylated (10). Paxillin 
LD motifs form amphipathic α-helices that, despite their small size and similar sequence, 
are able to mediate distinctive interaction with paxillin binding sequence (PBS)-containing 
proteins such as vinculin, focal adhesion kinase (FAK), α-parvin (actopaxillin) and ILK 
(11-13). Paxillin phosphorylation mainly mediated by kinases downstream of growth factor 
signaling pathways regulates the interaction with other proteins (10). As paxillin serves as a 
molecular nexus intersecting integrin and growth factor signaling pathways, it is important 
to ascertain novel paxillin interactors and their potential role in cell signaling networks. 
In the present study, Babak-2 was identified in a SILAC-based phosphoproteomics screen 
to be required for growth factor-induced dorsal ruffle (DR) formation in fibroblasts. 
Expression of Babak-2 and its homologous Babak-1 in fibroblasts and Hela cells showed 
that they localize to FAs and punctate structures in the cytoplasm. Furthermore, we found 
that Babak-2 is recruited to FAs through a N-terminal PBS motif that binds to paxillin. 
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Results 
Identification and modular composition of the murine Babak-1 and -2 proteins 
We identified Babak-2 in a SILAC-based phosphoproteomics analysis as a possible 
intersector of integrin and EGFR signaling pathways (Azimifar et al., 2011). To confirm 
the involvement of Babak-2 in the integrin-EGFR dependent induction of DRs, we depleted 
Babak-2 in fibroblasts using specific siRNA and indeed observed reduced EGF-triggered 
DR formation in fibroblasts (Supplementary material Fig. S1A-C). 
Since the biological function of Babak-2 in mouse is unknown, we decided to further 
investigate the functional properties of Babak-2 in vitro and in vivo. Mining the National 
Center for Biology Information (NCBI) database revealed that Babak-2 together with a 
homologous protein that we termed Babak-1 (kiaa1200/Plekhh1) form a novel family of 
proteins that are highly conserved among vertebrates (Fig. 1A-C). Murine Babak-1 and -2 
are highly homologous in their C-terminal segments which contain two PH domains, a 
Myosin tail homology 4 (Myth4) domain and a 4.1 protein, Ezrin, Radixin and Moesin 
(FERM) domain. The low homology N-terminal part of both Babak proteins revealed 
different hits of several low-scored, overlapping small domains including a structural 
maintenance of chromosomes (SMC) homology domain for Babak-2, a DNA polymerase 
III subunits gamma and tau (PRK05563) for Babak-1, and a coiled coil motif for both 
Babak-1 and -2 at the very N-terminus. Moreover, we found several conserved proline-rich 
motifs and phosphorylation sites throughout the protein sequence of Babak-1 and -2 (Fig. 
1A-B). Altogether, these data show that Babak-1 and -2 are highly conserved multi-domain 
proteins and that they link integrin and growth factor signaling pathways. 
 
Babak-1 and -2 localize to cell-matrix adhesion sites 
Next we tested the subcellular localization of both Babak proteins using GFP-tagged cDNA 
constructs that were transiently expressed in mouse fibroblasts. Babak-1 and -2 co-localized 
with paxillin in nascent and mature FAs (Fig. 2A, B). In addition, Babak-1 and 2 signals 
were also observed in punctate structures that were present throughout the cytoplasm (Fig. 
2A, B). EGFP-tagged Babak-1 fully overlapped with Cherry-tagged Babak-2 in the 
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cytoplasmic puncta and in FAs (Fig. 2C). However, Babak-positive puncta neither 
colocalized with Rab5 (endosomal marker), nor with EE1 (early endosomal marker), Rab7 
(late endosomal marker), Rab21 (marker of β1 integrin-containing recycling endosomes), 
Lamp1 (lysosomal marker), GM130 (Golgi marker), caveolin-1, flotillin-1 and transferrin 
receptor (recycling endosomes; Supplementary material Fig. S3A). Taken together, these 
data indicate that Babak-1 and -2 localize to FAs and cytosolic punctate structures whose 
identity is unknown. 
 
SILAC-based analysis of the Babak-2 interactome 
Next we used SILAC (14), followed by EGFP-Babak2 immunoprecipitation and mass 
spectrometry to identify Babak-2 interaction partners (Fig. 3A). To exclude nonspecific 
interactions, EGFP-expressing fibroblasts were labeled by light SILAC media and used as 
control experiment. We identified 360 proteins and ranked them based on SILAC ratios 
(Supplementary dataset 1). Babak-2 ranked first in the list of proteins with the highest 
SILAC ratio, indicating specificity and accuracy of the interactome list. We also identified 
several Babak-2 serine/threonine phosphopeptides (Fig. 3B). Interestingly, paxillin a FA-
associated signaling and adaptor protein (10) was among the proteins potentially binding to 
Babak-2. Consistent with the proteomic data and our immunostaining (Fig. 2A), paxillin 
was immunoprecipitated together with EGFP-tagged Babak-2 in fibroblasts (Fig. 3C). 
These results indicate that Babak-2 undergoes phosphorylation and forms a complex with 
paxillin. 
 
Babak-1 and -2 are recruited to FAs through a paxillin binding sequence 
To examine the significance of the Babak-2 interaction with paxillin, we generated a series 
of EGFP-tagged Babak-2 expression plasmids (Fig. 4A). Paxillin was readily 
immunoprecipitated from Hela cells that transiently expressed GFP-tagged full-length 
Babak-2 (GFP-Babak-2) or GFP-tagged C-terminally truncated Babak-2 (GFP-B2-ΔCT), 
but not from N-terminally truncated Babak-2 variants (GFP-B2-ΔNTP and GFP-B2-ΔNT), 
indicating that Babak-2 binds paxillin through its N-terminal part (Fig. 4B). Several 
Appendix 
 
 
 
127 
paxillin interacting proteins bind to paxillin via a conserved PBS motif  (amino acids 377-
396 in ILK, 919-938 in FAK and 951-970 in vinculin) (13). Homology search revealed a 
potential PBS motif in the N-terminal part of both, Babak-1 and -2 (residue 128 to 139) that 
is conserved in the sequence of other vertebrate Babaks (Fig. S2A). The interaction of 
paxillin with Babak-2 was dramatically reduced when conserved residues of PBS motif 
were mutated in the full length or N-terminal half of the Babak-2 polypeptide (GFP-Babak-
2VT>GG or GFP-B2-ΔCTVT>GG) (Fig. 4C). Furthermore, the immunoprecipitation of paxillin 
with GFP-Babak-1 was also abolished when the PBS motif of Babak-1 was mutated (Fig. 
4D). 
Consistent with the immunoprecipitation experiments, GFP-Babak-2 and GFP-B2-ΔCT, 
but not GFP-B2-ΔNTP or GFP-B2-ΔNT co-localized with paxillin in FAs of Hela cells 
(Fig. 4E). N-terminally truncated GFP-B2-ΔNTP and GFP-B2-ΔNT were unable to localize 
to FAs and the punctate structures and distributed diffusely throughout the cytoplasm. 
Interestingly, GFP-B2-ΔCT was recruited to FAs but not to the cytoplasmic puncta, while 
GFP-B2-ΔCTVT>GG or GFP-B1-ΔCTVT>GG localized to the punctate structures but were 
absent from FAs (Fig. 4E, F). These results showed that N-terminal PBS motifs of Babak1 
and 2 are mediating their interaction with Paxillin and recruitment to FAs and that both the 
C-terminal and N-terminal parts of the polypeptides are required for the recruitment to the 
punctuate structures. 
 
In vivo analysis of Babak-2 in mice 
To evaluate the expression pattern of Babak-1 and -2 in mouse tissues, cDNAs of different 
tissues from 4-week old normal mice were subjected to quantitative RT-PCR and Northern 
blot analysis (Fig. 5A,B). Babak-1 and -2 were highly expressed in gonads, brain, lung, 
stomach, small intestine and kidney, and to a lesser extent in spleen, skin, liver, organs of 
immune system and muscle (Fig. 5A,B). Babak-1 expression was dominant in brain, 
stomach, small intestine and kidney, while Babak-2 showed high expression levels in testis, 
spleen and bone marrow (Fig. 5A). In addition, RT-PCR analysis of whole embryonic 
cDNAs indicated strong expression of Babak-1 and -2 throughout all embryonic stages 
tested, from E7.5 to E17.5 (Fig. 5C). 
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To examine the role of Babak-2 in mouse development and homeostasis, we generated a 
conditional floxed (f) allele of the Babak2 gene by flanking exons 12 and 13 with loxP 
sequence (Fig. 6A). Out of 800 embryonic stem cell clones, we found only one clone with a 
correct integration of the targeting cassette (Fig. 6B). Cre recombinase-mediated deletion of 
floxed exons in Babak-2f/f mice or in kidney-derived Babak-2f/f fibroblasts led to a frame-
shift mutation followed by premature stop codon in all splice variants of Babak-2 mRNAs 
(Fig. 6C-F). Offspring from Babak-2f/- intercrosses yielded a normal Mendelian distribution 
of Babak-2-/- mice (Fig. 6G). Moreover, Babak-2-/- mice were fertile and did not develop 
any apparent defects. These results indicate that Babak-2 protein is not essential for mouse 
development and reproduction. 
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Discussion 
 
FAs are integrin-nucleated multi-protein complexes that are involved in many cell 
signalling events. The composition and molecular interaction at FAs govern the nature of 
their signalling response and are diversified in a cell type-, tissue- and developmental stage-
specific manner. A large number of proteins have been identified that are recruited to 
integrin-mediated adhesion sites (1). Here, we identified a novel family of FA proteins, that 
we intelligently termed Babak-1 and -2. Both Babak isoforms are expressed in different 
tissues and are conserved among vertebrates. Using SILAC-based quantitative proteomics, 
we identified paxillin as interaction partner of both Babak proteins. Paxillin serves as a 
scaffold that recruits many signaling molecules to FAs, where they can interact with and 
modulate downstream signaling pathways. Like many other paxillin-binding FA proteins 
(10, 13), the recruitment of Babaks to FAs was mediated through a conserved PBS motif, 
suggesting PBS as an evolutionary conserved versatile module that mediates recruitment of 
various FA molecules to a specific signaling compartment within FAs. 
In addition to FAs, Babaks localized to the punctate structures that are scattered throughout 
the cytoplasm. The nature of these structures remains unclear, as they did not colocalize 
with the Golgi apparatus, endosomes, lysosomes, caveolin-1, flotilin-1, Rab21 and 
transferrin receptor. One possibility is that the Babak proteins are part of molecular 
machinery organizing a novel intracellular trafficking route. Since integrins do not localize 
to the Babak-positive puncta, these routes must serve integrin-independent functions. 
Membrane trafficking is essential to the functions of eukaryotic organisms through 
transporting cargoes to specific cellular sites as well as providing microenvironments for 
signalling events (15, 16). Therefore, it requires further efforts to characterize the potential 
role(s) of Babak-positive punctate structures in the cellular context. 
Babak-2-null mice were viable, fertile and showed no obvious phenotype, indicating that 
Babak-2 alone is not essential for normal murine physiology. As both Babak-1 and Babak-
2 share same molecular structure and subcellular distribution, it is possible that Babak-1 
compensates for Babak-2 functions in vivo. This assumption can be further examined by 
constitutive or conditional deletion of Babak-1, or both Babak-1 and -2 in mice. 
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Materials and methods  
 
Reagents and antibodies 
The following antibodies were used: paxillin, caveolin1, flotillin1, GM130 and EEA1 (BD 
Bioscience); Rab5 and Rab7 (Cell Signalling Technology); Rab21 and phalloidin-TRITC 
(Sigma); anti-mouse-HRP and anti-rabbit-HRP (BioRad); transferrin receptor (Invitrogen); 
anti-rabbit Cy3 and anti-mouse Cy3 (Jackson Immunoresearch). 
Southern and northern blotting 
For Southern blotting, 15 µg of DNA was digested by restriction enzyme(s), separated on a 
0.8% agarose gel and transferred onto Hybond N+ membranes (GE Healthcare). For 
northern blotting, 10 µg of total RNA was extracted with TRIzol (Invitrogen) from four-
week murine tissues, separated on a denaturing agarose gel and transferred onto Hybond 
N+ membranes (GE Healthcare). Probe preparation and membrane hybridization were 
described previously (17). 
Immunofluorescence, immunoprecipitation and western blotting 
Cell immunostainings and confocal microscopy were performed as described previousely 
(Azimifar et al., 2011). Cell lyzates were prepared by quickly washing cells in ice-cold PBS 
prior to addition of lysis buffer (50mM Tris-HCl, pH7.6, 150mM NaCl, 1% Triton-X-100, 
protease inhibitor cocktail (Roche) and phosphatase inhibitor cocktail (Sigma-Aldrich)). 
GFP-tagged protein immunoprecipitation was performed according to the manufacturer’s 
instructions (MiltenyiBiotech). For western blotting, a total of 10-25 µg of protein per lane 
was separated on a 6% SDS-PAGE and transferred onto a PVDF membrane (Millipore). 
Membrane blocked with Tris-buffered saline (TBS) pH 7.6 containing 5% (w/v) skimmed 
milk powder (Fluka) and 0.1% Tween 20 (Serva). Membranes were incubated for 1 hour at 
room temperature or overnight at 4°C with primary antibodies and were incubated with 
appropriate HRP-coupled secondary antibodies (BioRad) for 30 minutes at room 
temperature. Subsequently, membranes were washed, developed with chemiluminescence 
detection kit (Western Lightning, PerkinElmer) and images were captured by ImageReader 
LAS-4000 (Fujifilm). 
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Constructs, siRNAs and primers 
Full-length Babak-1 and Babak-2 cDNAs were amplified as a single amplicon from E15.5 
embryonic brain and cloned into pEGFP-C1 plasmid (Clontech). Truncated Babaks 
constructs were PCR amplified from full-length pEGFP-Babak-1 and -2. Mission siRNAs 
for depletion of Babak-2 mRNA were ordered from Sigma. These primers were used: for 
Babak-1 quantitative RT-PCR: 5'-AGA CAT GAT GGC CAC CAA GTG-3' and 5'-AGT 
AGG GAT AAG TGA TGT TCA CCT G-3'; Babak-2 quantitative RT-PCR: 5'-ACT GTA 
TTT CTC AGT GCA AGC TC-3' and 5'-GCC TTG CAC TGG TTA GTC ACA G-3'; PCR 
genotyping of Babak-2 mice: 5'-ATG TCT TTT AAT ACG GCG CAC-3' and 5'-CCA 
CAT TGA ACT GAG TGC ATC C-3'; RT-PCR for Babak-2 mice: 5'-CCC TTT CCT 
GGA TGA CTC CTC-3' and 5'-TGG TGA GCA AGC CCT TTA CTG-3'. 
Cell culture and transfection/transduction procedures 
Cells were transiently transfected with Lipofectamine 2000 (Invitrogen). Babak-2f/f 
fibroblasts were isolated from 4-week murine kidney and immortalized by retroviral 
transduction of the SV40 Large T-antigen. Babak-2-/- cells were generated by adenoviral 
infection of Babak-2f/f cells with Cre recombinase. Knock down and DR experiments were 
as described previously (Azimifar et al., 2011). 
SILAC-based quantitative proteomics  
SILAC-based proteomics was performed as described (Mann, 2006). Briefly, cells were 
metabolically labelled with SILAC culture media and transfected with EGFP or EGFP-
Babak-2 constructs for 24 hours. Cells lyzates were prepared and subjected to GFP-
immunoprecipitation (MiltrnyiBiotech). The immunoprecipitated proteins were digested 
with trypsin in columns, eluted, mixed 1:1 and separated by online reverse phase nanoscale 
capillary LC and analyzed by MS/MS on a linear trap quadrupole (LTQ)-Orbitrap mass 
spectrometer (Thermo Fisher Scientific). Mass spectra were processed with MaxQuant and 
Mascot search engine. 
Statistical Analysis 
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Results are expressed as means±sd. Statistical analysis was performed using Excel 
software. Student’s t-test was used for comparisons between different data sets. Asterisks 
indicate significant differences (*P<0.05, **P<0.01 and ***P<0.005). The deviation from 
Mendelian ratios measured by χ2 test for codominant inheritance. 
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Figure legends 
 
Fig. 1. Domain structure of murine Babak-1 and Babak-2 proteins. Conserved motifs 
of (A) Babak-1 and (B) Babak-2 were predicted by NCBI-CDD and Motif Scan servers. 
Babaks could potentially mediate interactions with other proteins/lipids through conserved 
phosphosites, proline-rich motifs and lipid-binding sequences. Abbreviations: Structural 
maintenance of chromosomes (SMC) protein homology domain; DNA polymerase III 
subunits gamma and tau (PRK05563); Pleckstrin homology (PH) domain; Myosin tail 
homology 4 (MyTH4) domain; 4.1 protein, ezrin, radixin and moesin homology (FERM) 
domain. (C) Pairwise alignment scores for Babak-1 and -2 proteins and DNAs sequences in 
human, mouse, dog and Zebrafish. Alignment scores are according to the National Center 
for Biotechnology Information (NCBI) database. 
 
Fig. 2. Cellular localization of Babak-1 and Babak-2. (A) Immunostaining of paxillin 
(red) in fibroblasts that expressed EGFP-Babak-2 or EGFP-Babak-1. EGFP-Babak-2 and -1 
colocalized with paxillin at FAs, and localize punctate structures that distributed throughout 
the cytoplasm. (B) Immunostaining of F-actin (red) in fibroblasts that expressed EGFP-
Babak-2 or -1. EGFP-Babak-2 localized to focal complexes (arrow) at the leading edge of 
the cell. (C) EGFP-Babak-1 and mCherry-Babak-2 signals overlap in cytoplasmic puncta. 
Scale bars are 10µm. 
 
Fig. 3. SILAC-based analysis of Babak-2 interactome. (A) Schematic representation of 
the SILAC-based proteomics experiment. EGFP (control) or EGFP-Babak-2 was expressed 
in fibroblasts that labeled with light (L) or heavy (H) SILAC media, respectively. Cell 
lyzates were affinity purified by anti-EGFP antibody and digested with trypsin in columns. 
Tryptic peptides were mixed 1:1 and subjected for LC-MS/MS analysis. (B) Short list of 
Babak-2 phosphopeptides identified by LC-MS/MS analysis. The potential kinases 
triggering the phosphosites were predicted by PHOSIDA server (18). (C) Paxillin was 
detected in anti-GFP immunoprecipitates from fibroblasts that expressed EGFP-Babak-2. 
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Fig. 4. The interaction of Babak-2-PBS with paxillin is essential for its recruitment to 
FAs. (A) Schematic diagram of the various EGFP-Babak-2 constructs used. (B) Paxillin 
was detected in anti-GFP immunoprecipitates from cells that expressed full length EGFP-
Babak-2 or EGFP-B2-ΔCT, but not EGFP-B2-ΔNT and EGFP-B2-ΔNTP. Paxillin 
immunoprecipitation with Babak-2 was dramatically reduced by mutating the PBS site 
(VT>GG) in (C) EGFP-Babak-2, EGFP-B2-ΔCT and (D) EGFP-Babak-1. (E) Paxillin 
(red) immunostainings colocalized with EGFP-Babak-2 or EGFP-B2-ΔCT (green) in FAs 
of Hela cells. EGFP-B2-ΔNT and EGFP-B2-ΔNTP were diffusely distributed through the 
cytoplasm and did not localize to FAs and the punctate structures. Mutating the PBS motif 
of Babak-2 (EGFP-B2VT>GG) strongly reduced its recruitment to FAs, while it did not 
affects Babak-2 localization to the punctate structures. (F) Mutating PBS of Babak-1 
(EGFP-B2VT>GG) strongly disturbed its FA recruitment in Hela cells. 
 
Fig. 5. Expression pattern of Babak-1 and Babak-2. (A) Quantitative RT-PCR of Babak-
1 and Babak-2 in different murine tissues. (B) Northern blot of Babak-2 extracted from 
different murine tissues. (C) RT-PCR of Babak-1 and Babak-2 expression during different 
embryonic stages. 
 
Fig. 6. Babak-2-deficient mice (A) Schematic representation of Babak-2 locus and 
targeting construct. (B) Southern blotting of Babak2-recombinant ES cell clones with the 
3’-arm external probe. (C) Southern blotting of Babak-2 mice with the 5’-arm external 
probe. (D) Genotyping of Babak-2 mice with PCR. (E) cDNAs derived form mRNA 
extracted from Babak-2f/f and Babak-2-/- fibroblasts and brain, were analyzed by RT-PCR. 
A wild-type band of 614 bp (black arrow), an exon 11>14 frame shift mutant band of 330 
bp (grey arrow) and an exon 11>15 frame shift mutant band of 270 bp (white arrow) were 
amplified by RT-PCR and (F) analyzed by DNA sequencing. (G) Offspring statistics of 
Babak-2f/- intercrosses  did not show significant deviation from normal codominant 
Mendelian ratios (2 degree of freedom, χ2: 3.62). 
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Supplementary Fig. S1. DR formation is reduced in Babak-2-depleted fibroblasts. (A) 
Babak-2 expression levels were evaluated by quantitative RT-PCR for two different Babak-
2 knock down cell lines. (B) Phase contrast images of Babak-2 knock down (siRNA-II) and 
control cells (siRNA-ctl) when serum starved, seeded on fibronectin and stimulated with 
EGF (50ng/ml) for 3 minutes (scale bar: 50µm). Note absent of EGF-induced DRs (arrows) 
and morphological changes in the Babak-2 knock down. (C) DR formation was 
significantly reduced three minutes after EGF stimulation in Babak-2 knock down cells in 
comparison with their corresponding control cells, n=4 independent experiments. Data 
expressed as the mean±sd. Stars indicate P-value for t-test (**P<0.01). 
 
Supplementary Fig. S2. Conserved PBS motif in the N-terminus parts of Babak-1 and 
-2. (A) Alignment of N-terminal PBS (red boxes) of Babak-1 and -2 in different species. 
Red arrows indicate conserved K and E residues that are also present in the PBS motif of 
FAK, Vinculin and ILK (Nikolopoulos et al., 2001). 
 
Supplementary Fig. S3. Babak-2 localizes to cytoplasmic puncta of unknown origin. 
(A) No colocalization of EGFP-Babak2 (green) with EEA1, Rab5, Rab7, Rab21, GM130, 
transferrin receptor (tfr), caveolin-1 (Cav1) and flotillin-1 (flot1) (all red) in Hela cells. 
Scale bar is 10 µm. 
 
Supplementary dataset. S1. The list of Babak-2 interactome obtained by SILAC-based 
quantitative proteomics. All identified and quantified proteins were ranked based on their 
normalized SILAC ratio. L and H indicate SILAC labeling that represent EGFP (control) 
and EGFP-Babak-2 immunoprecipitates, respectively. H/L indicates the normalized SILAC 
ratio from EGFP-Babak-2 immunoprecipitates as compared with immunoprecipitates of 
control EGFP-expressing cells. 
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